Quarterlytics / Industrials / Agricultural - Machinery / Growth International / FY2019 Annual Report

Growth International
Annual Report 2019

AFN · TSX Industrials
Claim this profile
Ticker AFN
Exchange TSX
Sector Industrials
Industry Agricultural - Machinery
Employees 1001-5000
← All annual reports
FY2019 Annual Report · Growth International
Loading PDF…
Annual Report | 2019

CEO MESSAGE

Technology products have made us all accustomed to having progress symbolized 
by a version number, whether it’s our phones or the software we use each day. An 
increasing version number denotes thoughtful, customer-based improvements to 
enhance functionality, capabilities, service and ease of use while also addressing 
prior deficiencies.  A higher number succinctly communicates that a lot of work has 
gone into producing a better product.  We are deploying this concept in the launch 
of version 2.0 of our AGI SureTrack platform and then extending this concept to 
apply to all of AGI as we advance on a continuous path to improve our business 
with an eye to growth, sustainability and increasing value for our customers, 
employees, shareholders and related stakeholders.

AGI 2.0 signals the beginning of the next phase of our progress.  Whereas 1.0 was 
defined by product and geographic growth, 2.0 will be defined by deep integration 
of our products, services, engineering, systems, product management, data 
management, capacity expansions and internal projects to deliver an enhanced 
customer experience.  

In 2018 we introduced our 5-6-7 strategy to communicate our path and vision to 
our team members and stakeholders to identify the markets and geographies 
we are in and are targeting.  5-6-7 broadened our objectives to leverage the core 
capabilities we developed in grain markets to deliver full solutions across the full 
food production complex.  

E
G
A
S
S
E
M

O
E
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

1
1

 
 
 
 
 
 
 
CEO MESSAGE

We closed out our AGI 1.0 phase in 2019 by delivering on several significant pillars 
of our strategy.  We gained critical market expansion with our entry into India and 
we built a technology platform to surface and deliver the data our customers need 
from their infrastructure and by doing so we also distinctly differentiate our platform 
and product offering.  We completed a substantial expansion of our manufacturing 
facilities in Italy and key locations in the US and built out our financing business 
in Brazil.  We built our Corporate Technology team and approach to development 
to bring focused execution on internal and customer facing initiatives to improve 
processes and productivity for us and our dealers.  This team delivered enhanced 
dealer portals, automated product configuration for quoting and production, 
automated our warranty process, and controls integration.  We also completely 
rebuilt our corporate website which has gone on to accumulate several awards for 
design and functionality.

Through our purchase of Milltec Machinery in India we added a robust platform 
in a high priority geography while adding turnkey capabilities in rice processing 
equipment.  This has been a cornerstone platform objective for many years. We 
now have an outstanding team in India leading our platform, focused on growing 
our market share in India and the broader region.  We have visibility on the products 
and the markets for continued organic growth as we expand the AGI platform into 
South East Asia.

Our acquisitions of Intellifarms and Affinity, along with our investment in Farmobile, 
have been brought together in our AGI SureTrack platform.  AGI SureTrack is a big 
idea built on the simple premise that the basic application of technology beside and 

into our products will enable more productive use of the equipment and make it 
easier for our customers to access the data and turn that data into the information 
needed to run their businesses.  Agriculture is an interesting mix in terms of 
technology.  Auto steering tractors have been in use for over a decade, satellite 
and drones have been streaming data to farms for years, but at the same time 
growers struggle to collect, access, store, and organize the data and information 
from their operations.  The need for ready and sophisticated collection and 
application of information is greater than ever as crop prices remain low, weather 
and moisture issues seem to get more extreme, input prices pressure earnings 
and changes in trade directly impact growers more than anyone else.  The lack of 
technology tools on the farm has led to the proliferation of AgTech start-ups looking 
to harness farm data to automate insights and allow more informed decisions in 
the very complicated business of farming.  There are many fantastic companies 
that are developing and implementing tools to save time and take out some of the 
complexity a farmer faces in growing and marketing a crop.  Our simple goal is to 
provide the operating system that facilitates integration of all these sources into 
one, independent platform built for farmers and grain buyers.

Our contribution to the AgTech space is grounded in our unique lens coming from 
a food infrastructure perspective.  We supply the core equipment solutions across 
the complete food complex providing the infrastructure needed to bring inputs to 
the field, for grain production, grain marketing, and grain processing equipment to 
facilitate the production of feed and food.  We look at a farm and see a complex 
business with inputs that have volatile prices, a production facility (the fields) 
that require constant investment but have volatile production capacity despite 

E
G
A
S
S
E
M

O
E
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

2
2

 
 
 
 
 
 
 
your investment, and end markets with volatile product prices.  In a business 
with more complexity and volatility than most, there is virtually a complete lack 
of tools to manage the business.  In our own business we use MRP, ERP, CRM, 
HRIS systems, CAD and quoting tools to deal with complexity, while on farms 
there are often just basic spreadsheets and most data is simply not collected or 
not well used.  In the absence of information decisions are less informed and 
productivity declines.  From this lens and given that our equipment handles the 
inputs and the final product, we developed a complete operating system for the 
business of farming.  This operating system also connects the farm to grain buyers 
in robust and new ways including bid and price discovery, depth of markets and 
grain content-based bids which results in live visibility of economics and the means 
to enhance profitability.   For commercial buyers of grain our system is built to 
enable deep supply chain discovery and visibility that extends to true and verifiable 
traceability of grain characteristics, live grain monitoring and farming practices.  

Ultimately our AGI SureTrack system brings together all of our equipment solutions 
to produce an enhanced customer experience.  AGI SureTrack 2.0 is the customer 
facing representation of the deep integration that defines AGI 2.0 as we launch 
internal initiatives to bring together our engineering, systems, products, services, 
technologies and project execution to support and deliver a next level customer 
experience.

You can see that I am excited about our future.  I am writing this note in the midst 
of the unprecedented COVID 19 pandemic and coming off a tough year in 2019 and 
yet my notes thus far jumped right to the opportunities I see in our business.  As 
we entered 2020 our substantial investments in Brazil, India, fertilizer, US farm and 
technology have been coming together and creating substantial optimism as we 
move on to build AGI 2.0.

Looking back to the prior year it is important to frame and inform our strategy 
going forward even before we come to the COVID impacts. We faced substantial 
headwind in 2019 including severe weather in North America and trade tension 
that resulted in the largest buyer of US soya beans withdrawing from the market.  
The China / US trade dispute resulted in the US cutting soya exports by half in 
2019, significantly changing world grain trade.  Real and potential tariffs escalated 
steadily from 2017, peaked in early 2019 and created an environment of uncertainty 
that lasted throughout much of the year.  The environment in 2019 impacted many 
industries and North American farms were stuck in the middle of the political 
sparring.  Global grain flows were interrupted with more grain remaining on the 
farm in North America and more grain flowing from Brazil and Russia to fill the 
gap.  Understandably, mid to large capital projects were largely put on hold in 
this environment as our customers paused to assess what facilities they needed 
by geography to account for the changes in trade flows.  This pause in spending 
started to impact our sales intake in the first quarter of 2019 and persisted until the 
fourth quarter, substantially impacting our commercial business globally in 2019.  
The late pickup in project activity also impacted the timing of our backlog once it 
did pick up, pushing project deliveries out to the back half of 2020.  On the farm, 
our customers largely continued their core operations resulting in a relatively stable 
year.

Despite the trade and weather issues our overall results in 2019 were essentially 
flat to the prior year with revenue increasing 7%, coming very close to the $1 
billion threshold, and we delivered adjusted EBITDA of $144 million ending the 
year at 97% of 2018.  From a revenue perspective, our results represented resilient 
performance aided by our acquisitions in the year.  Our adjusted EBITDA margin 
was impacted by increased spending in our strategic areas, mentioned earlier, to 
build our brands through increased marketing, by our investment in building our 
technology platform and our internal projects focused on taking time out of our 
processes to reduce cost and improve our customer experience.  We are confident 

E
G
A
S
S
E
M

O
E
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

3

 
 
 
 
 
 
 
that these investments will make us more competitive and more productive, 
resulting in improved and more sustainable margins going forward.  The 2019 
EBITDA number is also adjusted for issues in our commercial division that resulted 
in the material rework of important projects.  We are adjusting for these numbers 
given the one-time nature of the issues as we are confident that we moved quickly 
to uncover the root cause of the issue and mitigated and built redundancies and 
improvements in our engineering processes.  By no means am I minimizing this 
issue, as a customer focused business any issue that impacts our execution 
becomes our top priority.  We moved quickly to ensure that AGI is defined by how 
we support our customers in all circumstances. 

The COVID crisis interrupted our plans for 2020 in many ways. However, in the early 
days of COVID we implemented our Preparation with Progress initiative to account 
for the massive uncertainties the crisis created while still keeping an eye to the 
future with continued focus on our strategic projects.  Our businesses in Northern 
Italy were in the middle of an intensely hit region and we moved immediately 
to learn how to operate through the crisis.  Our team in Italy deserves special 
recognition for helping set the policies and procedures that became so important 
to our execution during the crisis.  Distancing, cleaning, taking temperatures, PPE, 
and staggered workplace activity were implemented in Italy before these were 
widely used.  It is easy to forget that these were all completely new concepts only 
weeks ago.  We moved quickly to implement these procedures across AGI with 
the health and safety of our team members as our top priority.  Along with these 
measures, our Preparation with Progress strategy included reducing our capex, 
limiting hiring, and prioritizing all expenditures. We made substantial amendments 
to our credit facility to increase liquidity and flexibility and we also implemented a 
substantial reduction in our dividend.  Each of these actions were to account for a 
crisis with an unknown duration and unknown near, mid and long-term impacts on 
our customers and markets.  That said, we are confident that AGI is well positioned 
to resume our growth post crisis.  The COVID 19 experience has confirmed that 

our products, services and technologies provide the critical infrastructure the 
world requires.  This infrastructure is easily taken for granted in good times but is 
recognized as essential in times like these. 

Writing these comments in Mid-April 2020 I am incredibly proud of how the AGI 
team has responded to this crisis.  I certainly hope to never be tested to this extent 
again however there is no team I would rather be with to face the next test.

I would like to thank the entire AGI team and our partners for persevering and 
excelling in the challenging times we faced through 2019 and now in 2020.  These 
times have brought AGI together and in many ways accelerated our strategic plans 
around integration, collaboration and customer focus. I am confident it will result in 
a likewise acceleration of the value we provide our customers and be recognized in 
market share gains and accelerated growth across our business as we move on to 
AGI 2.0.

On behalf of our board, our employees and your management team, thank you for 
your continued support.

TIM C LOSE 
President & CEO

E
G
A
S
S
E
M

O
E
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

4

 
 
 
 
 
 
 
Canada

 10

USA

 14

Europe

06

04

India

01

Brasil

MANUFACTURING FACILITIES

35 MANUFACTURING  FACILITIES  
AROUND  THE WORLD

SALES INTO 
95 COUNTRIES

E
G
A
S
S
E
M

O
E
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

5

 
 
 
 
 
 
 
E
G
A
S
S
E
M

O
E
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

6

 
 
 
 
 
 
 
S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

77

 
 
 
 
 
 
 
 
MANAGEMENT’S DISCUSSION  
AND ANALYSIS

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

8
8

 
 
 
 
 
 
 
 
This Management’s Discussion and Analysis (“MD&A”) should be read in 
conjunction with the audited consolidated comparative financial statements and 
accompanying notes of Ag Growth International Inc. (“AGI”, the “Company”, “we”, 
“our” or “us”) for the year ended December 31, 2019.

The financial information contained in this MD&A has been prepared in accordance 
with International Financial Reporting Standards [“IFRS”]. All dollar amounts are 
expressed in Canadian currency, unless otherwise noted.

Throughout this MD&A, references are made to “trade sales”, “EBITDA”, “adjusted 
EBITDA”, “gross margin”, “funds from operations”, “payout ratio”, “adjusted profit” 
and “diluted adjusted profit per share”. A description of these measures and their 
limitations are discussed below under “Non-IFRS Measures”.

This MD&A contains forward-looking information. Please refer to the cautionary 
language under the heading “Risks and Uncertainties” and “Forward-Looking 
Information” in this MD&A and in our most recently filed Annual Information Form, 
all of which are available under the Company’s profile on SEDAR [www.sedar.com].

SUMMARY OF RESULTS

(THOUSA ND S  OF DOLLARS   
EXCE PT PER SHA RE AM OUNTS)

Trade Sales [1][2]

Adjusted EBITDA [1][3]

(Loss) Profit

THREE MONTHS ENDED
DECEMBER 31

YEAR ENDED
DECEMBER 31

2 019
$

2018
$

2019
$

2018
$

229,591

214,195

999,935

934,063

23,196

28,014

144,279

148,195

(8,286)

(11,861)

14,633

26,618

Diluted (loss) profit per share

(0.44)

(0.66)

0.77

1.56

Adjusted (loss) profit [1]

(1,180)

11,766

41,559

58,148

Diluted adjusted (loss) profit per share [1][4]

(0.06)

0.66

2.20

3.38

(1)  See “Non-IFRS Measures”.

(2)  See “OPERATING RESULTS – YEAR ENDED DECEMBER 31, 2019 – Trade Sales” and “OPERATING RESULTS –  
      THREE MONTHS ENDED DECEMBER 31, 2019 – Trade Sales”.

(3)  See “OPERATING RESULTS – YEAR ENDED DECEMBER 31, 2019 – EBITDA and Adjusted EBITDA” and “OPERATING     
      RESULTS – THREE MONTHS ENDED DECEMBER 31, 2019 – EBITDA and Adjusted EBITDA”.

(4)  See “OPERATING RESULTS – YEAR ENDED DECEMBER 31, 2019 - Diluted profit per share and diluted adjusted profit  
      per share” and “OPERATING RESULTS – THREE MONTHS ENDED DECEMBER 31, 2019 - Diluted loss per share and  
      diluted adjusted profit (loss) per share”.

AGI results in Q4 2019 were mixed as strong demand for portable grain handling 
and drying equipment, a solid performance in India and significantly improved 
results in Brazil were offset by a combination of factors that resulted in a decrease 
in Q4 2019 adjusted EBITDA compared to the prior year. In 2019, AGI demonstrated 
the success of its AGI SureTrack subscription model as demand exceeded our 
capacity and retail equivalent sales increased by 70%. In the fourth quarter of 2019, 
AGI increased its investment in sales, marketing and technical resources at AGI 
SureTrack to address capacity and accelerate the future pace of new user additions, 
resulting in negative Q4 2019 adjusted EBITDA at AGI SureTrack of $2.7 million. 
Secondly, a very wet and late harvest in the United States and a continuation of 
the weak macro environment negatively impacted AGI’s grain storage systems 
business, resulting in lower adjusted EBITDA compared to Q4 2018. Lastly, at the 
request of our customers, several Commercial projects in Canada and offshore 
were postponed into 2020, resulting in a deferral of sales and earnings. Adjusted 
EBITDA as a percentage of sales in AGI’s seasonally weak Q4 decreased to 10% in 
2019 from 13% in the prior year due to the investment in AGI SureTrack, the impact 
of poor growing conditions in the United States in 2019 and the negative effect of 
trade disruption. In Q4 2019, adjusted loss and adjusted loss per share decreased 
from the prior year, largely due to lower adjusted EBITDA and higher finance costs, 
while loss and loss per share improved as the Company recorded non-cash losses 
on foreign exchange and the equity compensation swap in Q4 2018, compared 
against non-cash gains in Q4 2019.

BASIS OF PRESENTATION - ACQUISITIONS

When comparing 2019 results to 2018, we have in some cases noted the impact of 
acquisitions made in 2019 and 2018. When noted, both the 2019 and 2018 periods 
exclude results from acquisitions made in those years, namely Danmare Group 
Inc. and its affiliate Danmare, Inc. [collectively, “Danmare”] [February 22, 2018], 
Cobalt Investissement and its wholly owned subsidiaries [collectively “Sabe”] 
[July 26, 2018], Improtech Ltd. [“Improtech”] [January 18, 2019], IntelliFarms, LLC 
[“IntelliFarms”] [March 5, 2019], and Milltec Machinery Limited [“Milltec”] [March 
28, 2019].

In the disclosure that follows, Danmare, Sabe, Improtech and Milltec are 
categorized as Commercial divisions. IntelliFarms is categorized as a Farm division.

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

9
9

 
 
 
 
 
 
 
 
OUTLOOK

COVID-19

The emergence of COVID-19 will have a significant adverse impact on AGI’s 
business, including the disruption of production, its supply chain and product 
delivery. The extent, duration and ultimate impact of COVID-19 and governmental 
and societal responses thereto is unknown, and accordingly management is 
unable to provide specific guidance on its impact on AGI. We can comment on the 
business fundamentals as they stand today to provide context to the very uncertain 
period going forward. Multiple state and provincial governments have declared 
manufacturers of agriculture equipment and infrastructure as essential services 
highlighting the continuing need for AGI’s products and services through this 
period.

As it stands, AGI has suspended manufacturing at its plants in Italy, India, France 
and Brazil due to government mandated shutdowns and/or regional requirements. 
These shutdowns are scheduled to last 2-3 weeks. Interruptions are possible in 
North America over the coming weeks as the crisis evolves. Engineering, design 
and quoting activity is continuing in each of these businesses which will support 
resumption of operations. We are utilizing vacation time, leave, and government 
programs to mitigate the impact of these short suspensions. The impact on AGI 
would be more pronounced should the duration extend. We do not currently have 
enough information to gauge the likelihood of longer suspensions.

As a relevant data point, Brazil, France and Italy currently have record level backlogs, 
and India has robust backlogs. Although AGI’s business will be substantially 
impacted by these disruptions in production, management believes that post crisis 
demand will be positively impacted as the world builds additional redundancy into 
the global food infrastructure to account for similar events in the future.

Q4 2019

Despite strength across many of AGI’s businesses, sales and adjusted EBITDA in 
the fourth quarter of 2019 were negatively impacted by historically poor growing 
and harvesting conditions in the U.S. and by the impact of trade disputes and 
tariffs. Consistent with recent commentary, management expects those factors 
were poised to negatively impact the first and second quarters of 2020 but that 
AGI’s Farm business was anticipated to gain momentum along with the planting 
season in Q2 2020. On the Commercial side of AGI’s business trade uncertainty in 

2019 resulted in late customer commitments and a backlog that is more weighted 
towards the second half of 2020. Accordingly, management expected sales and 
adjusted EBITDA in 2020 to be weighted toward the second half of 2020 as 
compared to prior years.

Q1 2020

Much of the first quarter was completed prior to broad impacts of COVID-19, which 
were restricted mostly to our European operations. Consistent with management 
expectations pre-COVID-19, adjusted EBITDA in the first quarter of 2020 will be 
below the strong results of Q1 2019. We do not expect overall organic growth in 
the first quarter of 2020 due largely to the timing considerations noted above, but 
also because the first quarter of 2019 included a large contribution from Canadian 
Commercial projects and a strong contribution from Brazil. Although management 
anticipates results in Brazil in 2020 will exceed those of the prior year, AGI Brazil 
reported positive EBITDA in the first quarter of 2019 and accordingly there is 
not a significant year-over-year delta in Q1 2020. Results at Milltec in Q1 2020 
have been directionally consistent with expectations, however there was a small 
negative impact related to timing of the monsoon and banking liquidity. The first 
quarter of Q1 2020 includes an investment in our growing AGI SureTrack platform 
of approximately $2 million and other technology and marketing initiatives of 
approximately $1 million. Finally, results in Q1 2020 were negatively impacted by 
the outbreak of COVID-19 as our operations in EMEA were impacted by supply 
chain, delivery and production disruptions. In summary, management expects 
adjusted EBITDA in Q1 of 2020 to approximate Q4 2019 results.

Going Forward

While COVID-19 is raising substantial uncertainties, we will outline current 
fundamentals across the business to add context to operating during this crisis. 
Prior to the outbreak of COVID-19, our internal metrics and traditional external 
reference points exiting Q1 2020 appeared favourable:

Farm

•  Farmers are currently preparing for planting season leading to input and required 

equipment purchases. Current order intake trends are at normal levels.

•  The underlying demand drivers for AGI Farm equipment were expected to remain 
strong, and management expected demand for Farm products to increase with 
the new planting season in the second quarter of 2020 due to: 

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

10

 
 
 
 
 
 
 
 
•  An anticipated increase in U.S. planted acres, including a significant increase in 

•  AGI Brazil has made progress both in manufacturing efficiencies and market 

corn acres.

•  Improved weather conditions compared to historically poor conditions in 2019.

•  Better farmer economics and sentiment should the U.S. and China fully 

implement Phase 1 of a trade agreement.

•  Backlog (February 29, 2020) - Despite a tough 2019, our Farm backlog in 

the U.S. is 14% higher than the prior year, with increases in most product 
categories including portable grain handling and grain storage systems. 
Overall, our Farm backlog is consistent with the strong backlog at the same 
time in 2019 as gains in the U.S. are offset by lower backlogs in Canada 
that have resulted partially from strong deal pull-through and the timing off 
preseason order programs. 

•  The extent and duration of the COVID-19 crisis will determine the impact on 

our Farm business.

Commercial North America

•  In the United States, Commercial Grain handling activity has been stable but for 
the last number of years has been restrained by depressed agricultural markets 
and international trade disputes. The potential of an improved trade environment, 
increased crop production and an improved ag sector may benefit Commercial 
sales in 2020. AGI’s sales order backlog in the United States is higher than the 
prior year due to progress in the Fertilizer and Food categories.

•  In Canada, the Commercial market has been very active due to continued 

investment in grain infrastructure, however the Canadian Commercial backlog 
has decreased compared against the very high levels of a year ago.

•  Backlog (February 29, 2020) - Overall, our North American Commercial backlog is 

7% lower than a year ago.

Commercial International

•  The pace of customer commitments accelerated in the second half of 2019. As 

many contracts were finalized later in 2019, sales related to many of these orders 
are expected to be recognized in the second half of 2020.

development. The backlog in Brazil is at a record high and is currently 28% higher 
than at the same time in 2019.

•  Performance at Milltec, our platform acquisition in India, has met expectations 

and is well positioned for long-term growth.

•  Backlog (February 29, 2020) - Overall, excluding Milltec because their backlog is 
not included in the 2019 comparative (acquisition date of March 29, 2019), our 
international backlog is 30% higher than at the same time in 2019.

•  Capital decisions related to Commercial projects, particularly in international 

markets, appear to be slowing due to the uncertainty surrounding COVID-19. The 
extent and duration of the crisis will impact the ongoing pace of development of 
our project pipeline.

Technology

•  In 2019, AGI demonstrated the success of its AGI SureTrack subscription model 
as demand exceeded our capacity and we increased retail equivalent sales by 
70%. In the first quarter of 2020, we expect the increase in retail equivalent 
sales to approximate 200% year over year growth.

•  Continued growth in the SureTrack platform is expected to deepen AGI’s 

relationships with processors, merchandisers, grain buyers and producers 
throughout North America and provide a significant opportunity for equipment 
cross-sales.

Summary

Activity in the first quarter of 2020, absent COVID-19, has been consistent 
with management expectations, and results in the second quarter, to a lesser 
degree, are expected to be impacted by similar factors, namely the carryover 
impact of very poor conditions in the U.S. in 2019 and the timing of international 
orders. AGI entered 2020 with expectations that adjusted EBITDA would grow 
significantly over 2019, and we expected that growth over the prior year would 
occur primarily in the second half fiscal 2020. Positive Farm sentiment and an 
improving trade environment, evidenced by strong Farm and Commercial backlogs, 
supported our expectations. The emergence of COVID-19, discussed above, has 
created substantial uncertainly and is expected to have negative impacts in the 
short-term and management is focused on mitigating its impact. Management 
remains optimistic with respect to the business of AGI and its longer-term growth 
prospects.

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

1111

 
 
 
 
 
 
 
 
Trade sales and adjusted EBITDA will be influenced by, among other factors, the 
extent, duration and impact of the COVID-19 outbreak, weather patterns, crop 
conditions, the timing of harvest and conditions during harvest and changes in 
input prices, including steel. The Company endeavors to mitigate its exposure to 
higher input costs through strategic procurement of steel, sales price increases 
and limiting the length of time commercial quotes remain valid; however, the pace 
and volatility of input price increases may negatively impact financial results. Other 
factors that may impact results include the impact of existing and potential future 
trade actions, the ability of our customers to access capital, the rate of exchange 
between the Canadian and U.S. dollars, changes in global macroeconomic factors 
as well as sociopolitical factors in certain local or regional markets, and the timing 
of Commercial customer commitments and deliveries.

Amendment and extension of credit facility

On March 20, 2020, AGI announced it had amended and extended its credit facility 
with a syndicate of five Canadian banks, led by the Canadian Imperial Bank of 
Commerce and including TD Bank, National Bank of Canada, HSBC Bank Canada 
and the Bank of Nova Scotia. The facility was extended to March 20, 2025 and 
the amendments include an increase in the maximum senior debt leverage ratio 
to 3.75x for the balance of 2020 and an improved pricing grid. As at December 
31, 2019, AGI’s senior debt leverage ratio, as defined in the Company’s credit 
agreement, was 2.65x.

IFRS 16, Leases [“IFRS 16”]

In 2019, the Company adopted IFRS 16 and recorded a right-of-use asset and a 
lease liability of $9.1 million as at January 1, 2019. The Company applied IFRS 16 
using the modified retrospective approach and accordingly comparative information 
has not been restated. In the comparative three- and twelve-month periods ended 
December 31, 2018, adjusted EBITDA included expenses related to operating 
leases of $1.0 million and $3.7 million of which $0.7 million and $2.7 million 
would have related to right-of-use assets under IFRS 16. In the three- and twelve-
month periods ended December 31, 2019 under IFRS 16, these payments are not 
categorized as an operating expense and instead AGI has recorded depreciation 
expense of $0.8 million and $3.0 million related to its right-of-use assets.

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

12

 
 
 
 
 
 
 
 
OPERATING RESULTS – YEAR ENDED DECEMBER 31, 2019

Trade Sales 
[see “Non-IFRS Measures” and “Basis of Presentation - Acquisitions”]

Trade Sales by Category

[T HOUSANDS OF  DOL LARS]

YEAR ENDED DECEMBER 31

2019
$

2018
$

CH AN GE
$

Farm

[THOUSA ND S  OF DOLLARS]

Trade Sales

Foreign exchange loss [1]

Total Trade Sales

(1)  A portion of foreign exchange gains and losses are allocated to sales.

Trade Sales by Geography

[THOUSA ND S  OF DOLLARS]

Canada, excluding acquisitions

Acquisitions

Total Canada

U.S., excluding acquisitions

Acquisitions

Total U.S.

999,935

934,063

(4,148)

(2,399)

995,787

931,664

65,872

(1,749)

64,123

YEAR ENDED DECEMBER 31

2019
$

2018
$

CH AN GE
$

318,371

326,680

6,710

3,098

325,081

329,778

399,679

378,886

26,129

4,482

425,808

383,368

(8,309)

3,612

(4,697)

20,793

21,647

42,440

International, excluding acquisitions

184,631

213,634

(29,003)

Acquisitions

Total International

64,415

7,283

249,046

220,917

57,132

28,129

Total excluding acquisitions

902,681

919,200

(16,519)

Total acquisitions

Total Trade Sales [1]

(1)  See “Non-IFRS Measures”.

97,254

14,863

999,935

934,063

82,391

65,872

YEAR ENDED DECEMBER 31

2019
$

2018
$

CHA NGE
$

465,994

449,267

12,522

—

478,516

449,267

16,727

12,522

29,249

436,687

469,933

(33,246)

84,732

14,863

521,419

484,796

999,935

934,063

68,869

36,623

65,872

Farm – acquisitions

Total Farm

Commercial

Commercial – acquisitions

Total Commercial

Total Trade Sales [1]

(1)  See “Non-IFRS Measures”.

The movement in trade sales for the year ended December 31, 2019 compared to 
the prior year is summarized below:

Canada

•  Trade sales in Canada, excluding acquisitions, decreased 3% from 2018:

•  Farm sales increased as gains in dryer market share and wet harvest 

conditions in western Canada resulted in higher sales of aeration and drying 
equipment. These gains were partially offset by lower storage sales that 
resulted from a challenging growing and harvest season in western Canada.

•  Commercial sales decreased as strong sales of Commercial grain handling 

and storage equipment were offset by lower sales of fertilizer equipment, as 
2018 included several large, lower margin, fertilizer projects and there were no 
similar projects in the current year.

•  Sales from acquisitions relate primarily to Danmare and Improtech.

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

1313

 
 
 
 
 
 
 
 
United States

•  Trade sales in the U.S., excluding acquisitions, increased 5% over 2018:

•  Farm sales increased compared to 2018 as demand for portable grain handling 
equipment remained strong despite poor growing and harvest conditions and 
wet harvest conditions stimulated demand for drying and aeration equipment.

•  Sales of Commercial equipment in 2019 were level with the prior year as 

higher sales of fertilizer equipment were offset by lower Commercial grain 
handling sales, which were negatively impacted by a poor growing season and 
challenging macro conditions, including trade uncertainties.

•  Trade sales from acquisitions in the United States increased as a result of 

Danmare, Sabe and IntelliFarms.

Gross Margin 
[see “Non-IFRS Measures”]

[T HOUSANDS OF  DOL LARS]

Trade sales [1]

Cost of inventories [1]

Gross margin [1]

Gross margin as a % of trade sales

(1)  See “Non-IFRS Measures”.

YEAR ENDED DECEMBER 31

2019
$

2018
$

999,935

934,063

688,764

642,284

311,171

291,779

31.1%

31.2%

Gross margin percentages remained consistent with the prior year as a strong 
operational performance in India and improving results in Brazil were offset by the 
impact of poor conditions in the U.S.

International

•  International trade sales, excluding acquisitions, decreased 14% over 2018:

•  Sales in Brazil increased over the prior year due to increasing brand and 
product awareness and improving economic conditions in the country.

•  International Farm sales decreased from 2018 due to poor growing conditions 

in Europe and Australia.

•  International sales in 2019 were negatively impacted by global economic 

uncertainties, including trade disputes. Consistent with recent commentary, 
our international sales order backlog is currently higher than at the same time 
in 2019.

•  International sales from acquisitions relate primarily to Milltec sales in India and 

France based Sabe.

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

14

 
 
 
 
 
 
 
 
EBITDA and Adjusted EBITDA  

[see “Non-IFRS Measures”]

The following table reconciles profit before income taxes to EBITDA and Adjusted 
EBITDA.

[THOUSA ND S  OF DOLLARS]

Profit before income taxes

Finance costs

Depreciation and amortization

Share of associate’s net loss

EBITDA

Loss (gain) on foreign exchange

Share based compensation

Loss on financial instruments [2]

M&A expenses

Other transaction and transitional costs [3]

Loss on sale of PP&E

Fair value of inventory from acquisitions [4]

Equipment rework [5]

Impairment [6]

Adjusted EBITDA [1]

(1)  See “Non-IFRS Measures”.

(2)  See “Equity compensation hedge”.

YEAR ENDED DECEMBER 31

2019
$

18,404

44,793

48,188

2,352

2018
$

38,564

37,067

33,031

—

113,737

108,662

(2,534)

19,004

5,968

1,503

1,588

11,562

260

1,962

10,000

233

8,003

2,061

2,283

6,582

185

1,183

—

232

144,279

148,195

(3)  Includes restructuring and other acquisition related transition costs, as well as the accretion and other movement in  
      contingent consideration and amounts due to vendors.

(4)  Non-cash expenses related to the sale of inventory that acquisition accounting required be recorded at a value higher  
      than manufacturing cost.

(5)  To record the pre-tax charge for the estimated cost of rework for equipment supplied to two distinct projects.  
      The charge relates to additional, time, material and services.

(6)  To record assets held for sale at estimated fair value.

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

1515

 
 
 
 
 
 
 
 
S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

1616

 
 
 
 
 
 
 
 
DETAILED OPERATING RESULTS

[THOUSA ND S  OF DOLLARS]

Sales

Trade sales

Foreign exchange loss

Cost of goods sold

Cost of inventories

Fair value of inventory from acquisitions

Equipment rework

Depreciation / amortization

Selling, general and administrative expenses

SG&A expenses

M&A expenses

Other transaction and transitional costs [1]

Depreciation / amortization

Other operating expense (income)

Net loss on disposal of PP&E

Net loss on financial instruments

Other

Impairment charge

Finance costs

Finance (income) expense

Share of associate’s net loss

Profit before income taxes

Income tax expense

Profit for the period

Profit per share

Basic

Diluted

YEAR ENDED DECEMBER 31

Impact of Foreign Exchange

2019
$

2018
$

999,935

934,063

(4,148)

(2,399)

995,787

931,664

688,764

642,284

1,962

10,000

27,321

1,183

—

20,038

728,047

663,505

177,096

154,056

1,588

11,562

20,867

2,283

6,582

12,993

211,113

175,914

260

1,503

(4,001)

(2,238)

233

44,793

(6,917)

2,352

18,404

3,771

14,633

0.79

0.77

185

2,061

(2,267)

(21)

232

37,067

16,403

—

38,564

11,946

26,618

1.58

1.56

Gains and Losses on Foreign Exchange

The 2019 loss (gain) on foreign exchange in finance expense (income) was a non-
cash loss (gain) and related primarily to the translation of the Company’s U.S. dollar 
denominated long-term debt at the rate of exchange in effect at the end of the 
year ended December 31, 2019. As at December 31, 2019, AGI has no outstanding 
foreign exchange contracts. See also “Financial Instruments – Foreign exchange 
contracts”.

Sales and Adjusted EBITDA

AGI’s average rate of exchange for the year ended December 31, 2019 was 
$1.33 [2018 - $1.29]. A weaker Canadian dollar relative to the U.S. dollar results 
in higher reported sales for AGI, as U.S. dollar denominated sales are translated 
into Canadian dollars at a higher rate. Similarly, a weaker Canadian dollar results in 
higher costs for U.S. dollar denominated inputs and SG&A expenses. In addition, a 
weaker Canadian dollar may result in higher input costs of certain Canadian dollar 
denominated inputs, including steel. On balance, adjusted EBITDA increases when 
the Canadian dollar weakens relative to the U.S. dollar.

Selling, General and Administrative Expenses [“SG&A”]

SG&A expenses for the year ended December 31, 2019 excluding M&A expenses, 
other transaction and transitional expenses and depreciation/amortization, were 
$156.2 million [17.3% of trade sales] versus $154.1 million [16.5% of trade sales] in 
2018.

Excluding acquisitions, SG&A expenses for the year ended December 31, 2019 
were $156.3 million [15.6% of trade sales] versus $152.0 million [16.5% of trade 
sales] in 2018. Variances to the prior year include the following:

•  Sales & marketing expenses increased $4.3 million as AGI continued to invest in 
market growth initiatives including further investment in branding initiatives and 
its digital platform.

•  Share based compensation expense decreased $2.0 million due to a change in 

anticipated achievement levels.

•  No other individual variance greater was than $1.0 million.

(1)  Includes restructuring and other acquisition related transition costs, as well as the accretion and other movement in  
      contingent consideration and amounts due to vendors.

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

1717

 
 
 
 
 
 
 
 
Finance costs

Finance costs for the year ended December 31, 2019 were $44.8 million versus 
$37.1 million in 2018. In 2019, finance costs have increased due to new debt drawn 
in conjunction with new investments, most significantly the March 2019 acquisition 
of Milltec.

Income tax expense

Current income tax expense

Current tax expense in 2019 was $5.5 million [2018 - $10.5 million]. Current tax 
expense relates primarily to AGI’s U.S., India and France subsidiaries.

Finance (income) expense

Deferred income tax (recovery) expense

Finance (income) expenses for the year ended December 31, 2019 were $(6.9) 
million versus $16.4 million in 2018. The (income) expense in both periods relates 
primarily to non-cash translation of the Company’s U.S. dollar denominated long-
term debt at the rate of exchange in effect at the end of the year.

Deferred tax recovery in 2019 was $1.8 million [2018 – expense of $1.4 million). 
Deferred tax recovery in 2019 relates to the increase of deferred tax assets 
plus a decrease in deferred tax liabilities that relate to recognition of temporary 
differences between the accounting and tax treatment of Intangible Assets, 
Accruals and long-term provisions, and tax loss carryforwards.

Share of associate’s net loss

Share of associate’s net loss for the year ended December 31, 2019 was $2.4 
million versus nil in 2018. The net loss relates to AGI’s proportionate share of the 
net loss of the associate, since the date of AGI’s investment.

Effective tax rate

[T HOUSANDS OF  DOL LARS]

Other operating income

Other operating income for the year ended December 31, 2019 was $2.2 million 
versus $0.1 million in 2018. Other operating income includes non-cash gains and 
losses on financial instruments, including AGI’s equity compensation hedge [see 
“Equity compensation hedge”], and interest income.

Current tax expense

Deferred tax (recovery) expense

Total tax

Profit before income taxes

Total tax %

YEAR ENDED DECEMBER 31

2019
$

5,521

(1,750)

3,771

18,404

20.5%

2018
$

10,517

1,429

11,946

38,564

31.0%

Depreciation and amortization

Depreciation of property, plant and equipment; depreciation of right-of-use assets 
and amortization of intangible assets are categorized in the income statement in 
accordance with the function to which the underlying asset is related. The increase 
in the year ended December 31, 2019 primarily relates to the acquisitions of Milltec, 
Danmare, Sabe, Improtech and IntelliFarms as well as depreciation of right-of-use 
assets totaling $3.0 million in the year ended December 31, 2019, that resulted 
from the adoption of IFRS 16. Included in amortization in the year ended December 
31, 2019 is an expense of approximately $1.8 million related to the amortization 
of the backlog intangible recorded upon the acquisition of Milltec, which was fully 
amortized in Q3 2019.

The effective tax rate in 2019 was impacted by items that were included in the 
calculation of earnings before tax for accounting purposes but were not included 
or deducted for tax purposes. Significant items are included in the tables under 
“Diluted profit per share and diluted adjusted profit per share”. The effective tax rate 
in 2019 was also impacted by the India corporate income tax rate decrease.

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

18

 
 
 
 
 
 
 
 
Diluted profit per share and diluted adjusted profit per share

Diluted profit per share for the year ended December 31, 2019 was $0.77 versus 
$1.56 in 2018. Profit per share in 2019 and 2018 has been impacted by the items 
enumerated in the table below, which reconciles profit to adjusted profit.

Selected Annual Information (thousands of dollars, other than per share 
amounts and payout ratio) [2]

YEAR ENDED DECEMBER 31

Sales [2]

EBITDA [1][2]

Adjusted EBITDA [1][2]

Profit from continuing operations [2]

14,633

26,618

33,623

(2,534)

19,004

Fully diluted profit per share from continuing operations [2]

Basic profit per share from continuing operations [2]

2019
$

14,633

0.77

2018
$

26,618

1.56

1,962

1,588

11,562

1,503

260

233

10,000

2,352

41,559

2.20

1,183

2,283

6,582

2,061

185

232

—

—

58,148

3.38

Profit [2]

Basic profit per share [2]

Fully diluted profit per share [2]

Funds from operations [1][2]

Payout ratio [1][2]

Dividends declared per Common Share

Total assets [2]

Total long-term liabilities [2]

(1)  See “Non-IFRS Measures”.

YEAR ENDED DECEMBER 31

2019
$

2018
$

2017
$

995,787

931,664

749,397

113,737

108,662

110,850

144,279

148,195

121,797

0.79

0.77

1.58

1.56

2.11

2.08

14,633

26,618

33,664

0.79

0.77

1.58

1.56

2.11

2.08

81,267

96,067

72,933

55%

2.40

42%

2.40

53%

2.40

1,462,980

1,233,559

1,139,173

833,979

570,684

568,373

(2)  The Company adopted IFRS 15 in 2018 without retrospective application and as a result reversed sales and adjusted  
     EBITDA of $5.3 million and $1.5 million, respectively, that under IAS 18 had previously been recognized in 2017. For  
     purposes of comparability, where applicable, these amounts have been adjusted for in the 2017 figures in the above  
     table.

The following factors impact comparability between years in the table above:

•  Acquisitions in 2018 and 2019 (see “Basis of Presentation – Acquisitions”) and 
the 2017 acquisitions of Global Industries, Inc., CMC Industrial Electronics Ltd. 
And CMC Industrial Electronics USA, Inc. and Junge Control, Inc. significantly 
impact information in the table above.

•  Sales, gain (loss) on foreign exchange, profit and profit per share are significantly 

impacted by the rate of exchange between the Canadian and U.S. dollars.

[THOUSA ND S  OF DOLLARS EXC EPT  PER  SHA RE  AMOUNT S]

Profit

Diluted profit per share

Loss (gain) on foreign exchange

Fair value of inventory from acquisition [2]

M&A expenses

Other transaction and transitional costs [3]

Loss on financial instruments

Loss on sale of PP&E

Impairment charge [4]

Equipment rework [5]

Share of associate’s net loss

Adjusted profit [1]

Diluted adjusted profit per share [1]

(1)  See “Non-IFRS Measures”.

(2)  Non-cash expenses related to the sale of inventory that acquisition accounting required be recorded at a value higher  
      than manufacturing cost.

(3)  Includes restructuring and other acquisition related transition costs, as well as the accretion and other movement in  
      contingent consideration and amounts due to vendors.

(4)  To record assets held for sale at estimated fair value.

(5)  To record pre-tax charge for the estimated cost of rework for equipment supplied to two distinct projects. The charge  
      relates to additional time, material and services.

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

1919

 
 
 
 
 
 
 
 
QUARTERLY FINANCIAL INFORMATION

[thousands of dollars other than per share amounts and exchange rate]:

farm level. The seasonality of AGI’s business may be impacted by several factors 
including weather and the timing and quality of harvest in North America. AGI’s 
continued expansion into the seed, fertilizer, feed and food verticals should lessen 
the seasonality related to annual grain volumes and harvest conditions.

Average  
USD/CAD  
Exchange Rate

1.33

1.34

1.32

1.32

1.33

Average  
USD/CAD  
Exchange Rate

1.26

1.29

1.31

1.31

1.29

2 019

Sales
$

215,035

291,938

260,198

228,616

995,787

Profit (Loss)
$

13,222

12,516

(2,819)

(8,286)

14,633

2 018

Sales
$

213,666

260,155

242,166

215,677

931,664

Profit (Loss)
$

4,943

12,792

20,744

(11,861)

26,618

Basic
Profit (Loss)  
per Share
$

Diluted
Profit (Loss)
per Share
$

0.71

0.68

(0.15)

(0.44)

0.79

0.70

0.67

(0.15)

(0.44)

0.77

Basic
Profit (Loss)  
per Share
$

Diluted
Profit (Loss)
per Share
$

0.30

0.78

1.26

(0.66)

1.58

0.30

0.75

1.14

(0.66)

1.56

Q1

Q2

Q3

Q4

YTD

Q1

Q2

Q3

Q4

YTD

The following factors impact the comparison between periods in the table above:

•  AGI’s acquisitions of Danmare [Q1 2018], Sabe [Q3 2018], Improtech [Q1 2019], 
IntelliFarms [Q1 2019] and Milltec [Q1 2019] significantly impacts comparisons 
between periods of assets, liabilities and operating results. See “Basis of 
Presentation - Acquisitions”.

•  Sales, gain (loss) on foreign exchange, profit (loss), and profit (loss) per share in 

all periods are impacted by the rate of exchange between the Canadian and U.S. 
dollars.

OPERATING RESULTS – THREE MONTHS ENDED   
DECEMBER 31, 2019

Trade Sales 
[see “Non-IFRS Measures” and “Basis of Presentation - Acquisitions”]

[T HOUSANDS OF  DOL LARS]

Trade Sales

Foreign exchange loss [1]

Total Trade Sales

(1)  A portion of foreign exchange gains and losses are allocated to sales.

Trade Sales by Geography

[T HOUSANDS OF  DOL LARS]

Canada, excluding acquisitions

Acquisitions

Total Canada

U.S., excluding acquisitions

Acquisitions

Total U.S.

International, excluding acquisitions

Acquisitions

Total International

THREE MONTHS ENDED DECEMBER 31

2019
$

2018
$

CHA NGE
$

229,591

214,195

(975)

1,482

228,616

215,677

15,396

(2,457)

12,939

THREE MONTHS ENDED DECEMBER 31

2019
$

58,055

2,396

60,451

89,588

7,236

96,824

45,212

27,104

72,316

2018
$

74,717

919

75,636

76,848

1,521

78,369

55,471

4,719

60,190

CHA NGE
$

(16,662)

1,477

(15,185)

12,740

5,715

18,455

(10,259)

22,385

12,126

Total excluding acquisitions

192,855

207,036

(14,181)

Interim period sales and profit historically reflect seasonality. The second and third 
quarters are typically the strongest primarily due to the timing of construction 
of commercial grain and fertilizer projects and higher in-season demand at the 

Total acquisitions

Total Trade Sales [1]

(1)  See “Non-IFRS Measures”.

36,736

7,159

229,591

214,195

29,577

15,396

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

20

 
 
 
 
 
 
 
 
Trade Sales by Category

[THOUSA ND S  OF DOLLARS]

Farm

Farm – acquisitions

Total Farm

Commercial

Commercial – acquisitions

Total Commercial

Total Trade Sales [1]

(1)  See “Non-IFRS Measures”.

THREE MONTHS ENDED DECEMBER 31

Danmare, Sabe and IntelliFarms.

•  Trade sales from acquisitions in the United States increased as a result of 

2019
$

94,057

2,846

96,903

98,798

33,890

2018
$

89,569

—

89,569

117,467

7,159

132,688

124,626

229,591

214,195

CH AN GE
$

International

4,488

2,846

7,334

(18,669)

26,731

8,062

15,396

•  International trade sales, excluding acquisitions, decreased 18% over a strong 

Q4 2018 comparative:

•  Q4 2018 was a very strong quarter with sales increasing 69% over 2017.

•  Sales in Brazil in the fourth quarter were strong and slightly higher than a 

strong Q4 2018.

•  International sales in 2019 have been negatively impacted by global economic 
uncertainties, including trade disputes. Consistent with recent commentary, 
our sales order backlog in 2020 is higher than at the same time in the prior 
year.

•  International sales from acquisitions relate primarily to Milltec and Sabe.

The movement in the three months ended December 31, 2019 trade sales 
compared to the prior year is summarized below:

Canada

•  Trade sales in Canada, excluding acquisitions, decreased 22% over Q4 2018:

Gross Margin 
[see “Non-IFRS Measures”]

•  Farm sales decreased as strong demand for drying and aeration equipment 

[T HOUSANDS OF  DOL LARS]

were more than offset by lower sales of storage equipment that were 
negatively impacted by a challenging growing and harvest season.

•  Commercial sales decreased as Q4 2018 included a large fertilizer project and 
there was no similar project in the current year, and sales related to large grain 
storage and handling projects were lower than the very strong sales that were 
recognized in Q4 2018.

•  Sales from acquisitions relate primarily to Danmare and Improtech.

Trade sales [1]

Cost of inventories [1]

Gross margin [1]

Gross margin as a % of trade sales

(1)  See “Non-IFRS measures”.

THREE MONTHS ENDED  
DECEMBER 31

2019
$

229,591

163,375

66,216

28.8%

2018
$

214,195

149,518

64,677

30.2%

United States

•  Trade sales in the U.S., excluding acquisitions, increased 17% over Q4 2018:

Gross margin percentages declined compared to the prior year as a strong 
operational performance in India and improving results in Brazil were offset by the 
impact of poor conditions in the U.S.

•  Farm sales in Q4 2019 were higher than the prior year due to robust demand 

across most product lines, including drying, aeration and portable grain 
handling equipment.

•  Sales of Commercial equipment in Q4 2019 increased due to higher fertilizer 

and controls sales compared to the prior year.

Selling, General and Administrative Expenses [“SG&A”]

SG&A expenses for the three months ended December 31, 2019 excluding 
M&A expenses, other transaction and transitional expenses and depreciation/
amortization, were $45.9 million [20.0% of trade sales] versus $38.6 million [18.0% 
of trade sales] in 2018.

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

2121

 
 
 
 
 
 
 
 
Excluding acquisitions, SG&A expenses for the three months ended December 31, 
2019 were $38.7 million [20.0% of trade sales] versus $37.3 million [18.0% of trade 
sales] in 2018. Variances to the prior year include the following:

•  Salaries and wages decreased $1.0 million as the Company’s bonus accrual was 

adjusted downwards to reflect a change in anticipated achievement levels.

•  No other individual variance greater was than $0.5 million.

EBITDA and Adjusted EBITDA  
[see “Non-IFRS Measures”]

The following table reconciles profit before income taxes to EBITDA and Adjusted 
EBITDA.

THREE MONTHS ENDED DECEMBER 31

[THOUSANDS  OF  DOLLARS]

Loss before income taxes

Finance costs

Depreciation and amortization

Share of associate’s net loss

EBITDA

Loss (gain) on foreign exchange

Share based compensation

Loss (gain) on financial instruments [2]

M&A expenses (recovery)

Other transaction and transitional costs [3]

Loss on sale of PP&E

Fair value of inventory from acquisitions [4]

Equipment rework [5]

Impairment [6]

Adjusted EBITDA [1]

(1)  See “Non-IFRS Measures”.

(2)  See “Equity Compensation Hedge”.

2019
$

(8,487)

11,329

11,922

1,564

16,328

(121)

1,326

(1,557)

(1,458)

5,135

136

220

3,000

187

23,196

2018
$

(14,397)

8,968

8,798

—

3,369

9,084

1,018

10,562

833

3,108

40

—

—

—

28,014

(3)  Includes restructuring and other acquisition related transition costs, as well as the accretion and other movement in  
      contingent consideration and amounts due to vendors.

(4)  Non-cash expenses related to the sale of inventory that acquisition accounting required be recorded at a value higher  
      than manufacturing cost.

(5)  To record the pre-tax charge for the estimated cost of rework for equipment supplied to two distinct projects.  
      The charge relates to additional, time, material and services.

(6)  To record assets held for sale at estimated fair value.

KNOW  
YOUR SEED

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

22

 
 
 
 
 
 
 
 
GROW WITHOUT 
GUESSWORK

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

23
2323

 
 
 
 
 
 
 
 
Diluted loss per share and diluted adjusted profit (loss) per share

Diluted loss per share for the three months ended December 31, 2019 was $(0.23) 
versus $(0.66) in 2018. Loss per share in 2019 and 2018 has been impacted by the 
items enumerated in the table below, which reconciles loss to adjusted profit.

Facility [as defined below], to fund the Company’s working capital requirements, 
capital expenditures, acquisitions and dividends. The Company believes that the 
debt facilities and debentures described under “Capital Resources”, together with 
available cash and internally generated funds, are sufficient to support its working 
capital, capital expenditure, dividend and debt service requirements.

[THOUSANDS  OF  DOLLARS EXC EPT  PER  SHA RE  AMOUNT S]

Loss

Diluted loss per share

Loss (gain) on foreign exchange

Fair value of inventory from acquisition [2]

M&A expenses (recovery)

Other transaction and transitional costs [3]

Loss (gain) on financial instruments

Loss on sale of PP&E

Impairment charge [4]

Equipment rework [5]

Share of associate’s net loss

Adjusted profit (loss) [1]

Diluted adjusted profit (loss) per share [1]

(1)  See “Non-IFRS Measures”.

THREE MONTHS ENDED  
DECEMBER 31

2019
$

(8,286)

(0.44)

(121)

220

(1,458)

5,135

(1,557)

136

187

3,000

1,564

(1,180)

(0.06)

2018
$

(11,861)

(0.66)

9,084

—

833

3,108

10,562

40

—

—

—

11,766

0.66

(2)  Non-cash expenses related to the sale of inventory that acquisition accounting required be recorded at a value higher  
      than manufacturing cost.

(3)  Includes restructuring and other acquisition related transition costs, as well as the accretion and other movement in  
      contingent consideration and amounts due to vendors.

(4)  To record assets held for sale at estimated fair value.

(5)  To record pre-tax charge for the estimated cost of rework for equipment supplied to two distinct projects. The charge  
      relates to additional time, material and services.

LIQUIDITY AND CAPITAL RESOURCES

AGI’s financing requirements are subject to variations due to the seasonal and 
cyclical nature of its business. Sales historically have been higher in the second and 
third calendar quarters compared with the first and fourth quarters and cash flow 
has been lower in the first half of each calendar year. Internally generated funds 
are supplemented when necessary from external sources, primarily the Credit 

CASH FLOW AND LIQUIDITY

[T HOUSANDS OF  DOL LARS]

Profit before tax

Items not involving current cash flows

Cash provided by operations

Net change in non-cash working capital

Non-current accounts receivable and other

Long-term payables

Settlement of EIAP obligation

Income tax paid

Cash flows provided by operating activities

Cash used in investing activities

Cash provided by financing activities

Net increase (decrease) in cash during the period

Cash, beginning of period

Cash, end of period

YEAR ENDED DECEMBER 31

2019
$

18,404

56,107

74,511

(13,585)

(8,060)

—

(2,553)

(9,894)

40,419

2018
$

38,564

81,794

120,358

(63,017)

(3,942)

(280)

(1,953)

(9,975)

41,191

(223,134)

(88,635)

197,526

17,073

14,811

33,610

48,421

(30,371)

63,981

33,610

Cash provided by operating activities in 2019 approximated 2018 levels as an 
improvement in cash used by working capital was offset by lower net income, 
adjusted for non-cash items. Cash used in investing activities relates primarily to 
the acquisitions of Improtech, IntelliFarms and Milltec. Cash provided by financing 
activities relates to bond issuances offset by the redemption of debentures, debt 
repayments and dividends paid.

Working Capital Requirements

Interim period working capital requirements typically reflect the seasonality of the 
business. AGI’s collections of accounts receivable in North America are weighted 

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

24

 
 
 
 
 
 
 
 
towards the third and fourth quarters. This collection pattern, combined with historically high sales in the second and third quarters that result from seasonality, typically 
lead to accounts receivable levels in North America increasing throughout the year and peaking in the third quarter. Inventory levels in North America typically increase in 
the first and second quarters and then begin to decline in the third or fourth quarter as sales levels exceed production. The recent expansion of AGI’s fertilizer business has 
had the effect of increasing working capital requirements in Q4 and Q1, and Milltec’s seasonality is opposite of that described above. In addition, AGI’s growing business in 
Brazil is less seasonal due to the existence of two growing seasons in the country and the increasing importance of Commercial business in the region. Growth in overall 
international business has resulted in an increase in the number of days accounts receivable remain outstanding and may result in increased usage of working capital in 
certain quarters. Overall, requirements for AGI in 2019 are expected to be generally consistent with historical patterns.

Capital Expenditures

Maintenance capital expenditures in 2019 were $14.8 million [1.5% of trade sales] versus $11.3 million [1.2% of trade sales] in 2018. Maintenance capital expenditures in 
2019 relate primarily to purchases of manufacturing equipment and building repairs.

AGI defines maintenance capital expenditures as cash outlays required to maintain plant and equipment at current operating capacity and efficiency levels. Non-maintenance 
capital expenditures encompass other investments, including cash outlays required to increase operating capacity or improve operating efficiency. AGI had non-maintenance 
capital expenditures in 2019 of $33.7 million versus $25.3 million in 2018. In 2019, non-maintenance capital expenditures relate primarily to the purchase of manufacturing 
equipment and facility expansions.

Management generally anticipates maintenance capital expenditures in a fiscal year to approximate 1.0% - 1.5% of sales. Non-maintenance capital expenditures are 
expected to decrease in 2020 compared to 2019. Maintenance and non-maintenance capital expenditures in 2020 are anticipated to be financed through bank indebtedness, 
cash on hand or through the Company’s Credit Facility [see “Capital Resources”].

CONTRACTUAL OBLIGATIONS

The following table shows, as at December 31, 2019 the Company’s contractual obligations for the periods indicated:

[THOUSA ND S  OF DOLLARS]

2015 Debentures [1]

2017 Debentures

2018 Debentures

2019 March Debentures

2019 November Debentures

Long-term debt [2]

Lease liability

Short term and low value leases

Due to vendor

Contingent consideration

Preferred shares liability

Purchase obligations [3]

Leases committed not yet commenced

Total obligations

(1)  The 2015 Debentures were redeemed in January 2020.
(2)  Updated to reflect amended Credit Facilities, see SUBSEQUENT EVENTS
(3)  Net of deposit.

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

2525

TOTA L
$

75,000

86,225

86,250

86,250

86,250

395,862

9,932

49

8,370

5,270

30,258

8,488

8,342

886,546

20 20
$

75,000

—

—

—

—

722

2,798

34

4,541

5,270

—

8,488

485

97,338

20 21
$

—

—

—

—

—

348

2,102

9

3,066

—

18,155

—

869

24,549

20 22
$

—

86,225

86,250

—

—

208

1,652

5

763

—

12,103

—

884

188,090

2023
$

—

—

—

—

—

115

1,028

1

—

—

—

—

776

1,920

2024
$

—

—

—

86,250

86,250

106

759

—

—

—

—

—

2025+
$

—

—

—

—

—

394,363

1,593

—

—

—

—

—

787

174,152

4,541

400,497

 
 
 
 
 
 
 
 
The Debentures relate to the aggregate principal amount of the debentures [see “Capital Resources - Debentures”] and long-term debt is comprised of the Credit Facility 
and non-amortizing notes [see “Capital Resources – Debt Facilities”].

CAPITAL RESOURCES

Assets and Liabilities

(THOUSANDS  OF  DOLLARS)

Total assets

Total liabilities

Cash

The Company’s cash balance at December 31, 2019 was $48.4 million [2018 - $33.6 million].

December 31
2019
$

1,462,980

1,089,585

December 31
2018
$

1,233,559

799,360

Debt Facilities

[THOUSANDS  OF  DOLLARS]

Canadian Swing Line

Canadian Revolver Tranche A [4]

Canadian Revolver Tranche B

U.S. Revolver [3][5]

Series B Notes [6]

Series C Notes [6]

Equipment Financing [6]

Total

Currency

Maturity

Total Facility [CAD][1][2] $

Amount Drawn[1] $

Effective Interest Rate

CAD

CAD

USD

USD

CAD

USD

various

2025

2025

2025

2025

2025

2026

2025

40,000

135,000

51,952

227,209

25,000

32,470

1,121

512,752

345

90,511

50,000

196,379

25,000

32,470

1,121

395,826

4.91%

4.91%

4.98%

5.20%

4.44%

3.70%

Various

(1)  USD denominated amounts translated to CAD at the rate of exchange in effect on December 31, 2019 of $1.2988.
(2)  Excludes the $200 million accordion available under AGI’s credit facility.
(3)  Inclusive of USD $10 million swing-line facility.
(4)  Interest rate fixed for $40 Million via interest rate swaps. See “Interest Rate Swaps”.
(5)  Interest rate fixed for USD $38 Million via interest rate swaps. See “Interest Rate Swaps”.
(6)  Fixed interest rate.

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

26

 
 
 
 
 
 
 
 
The Company has a credit facility [the “Credit Facility”] with a syndicate of 
Canadian chartered and other banks that includes committed revolver facilities of 
CAD $175 million and USD $215 million. AGI amended and extended its facility in 
March 2020 and amounts drawn under the Credit Facility now bear interest at BA 
or LIBOR plus 1.20% to BA or LIBOR plus 2.5% and prime plus 0.20% to prime 
plus 1.5% per annum based on performance calculations.

The Company has issued USD $25.0 million and CAD $25.0 million aggregate 
principal amount of secured notes through a note purchase and private shelf 
agreement [the “Series B and Series C Notes”]. The Series B and C Notes are non-
amortizing.

AGI is subject to certain financial covenants, including a maximum leverage ratio 
of 3.75 as at December 31, 2019 and in 2020 (3.25 in 2021 and forward), and a 
minimum debt service ratio of 1.0, and is in compliance with all financial covenants. 
(See “SUBSEQUENT EVENTS”).

On redemption or at maturity, the Company may, at its option, elect to satisfy its 
obligation to pay the principal amount of the Debentures by issuing and delivering 
common shares. The Company may also elect to satisfy its obligation to pay 
interest on the Debentures by delivering sufficient common shares. The Company 
does not expect to exercise the option to satisfy its obligations to pay the principal 
amount or interest by delivering common shares. The number of shares issued will 
be determined based on market prices at the time of issuance.

The Company redeemed its 2014 Debentures on April 2, 2019. Upon redemption, 
AGI paid to the holders of the 2014 Debentures $52,435,000 equal to the 
outstanding principal amount of the 2014 Debentures redeemed including all 
accrued and unpaid interest up to but excluding the redemption date, less taxes 
deducted or withheld. Consequently, the Company expensed the remaining 
unamortized balance of $425,000 of deferred fees related to the 2014 Debentures. 
The expense was recorded to finance costs in the consolidated statements of 
income.

Debentures

Convertible Debentures

The following table summarizes the key terms of the convertible unsecured 
subordinated debentures of the Company that were outstanding as at December 
31, 2019:

Year Issued /  
 TSX Symbol 

Aggregate 
Principal  
Amount
$

Coupon

Conversion 
Price
$

Maturity 
Date

Redeemable 
at Par (1)(2)

Debentures

On March 19, 2019, the Company closed the offering of $75 million aggregate 
principal amount of senior subordinated unsecured debentures and on March 26, 
2019, closed the over-allotment option of $11.25 million. On November 19, 2019, the 
Company closed the offering of $75 million aggregate principal amount of senior 
subordinated unsecured debentures and on November 22, 2019, closed the over-
allotment option of $11.25 million.

The following table summarizes the key terms of the Debentures that were 
outstanding as at December 31, 2019:

2015 [AFN.DB.C]

75,000,000

5.00%

2017 [AFN.DB.D]

86,225,000

4.85%

2018 [AFN.DB.E]

86,250,000

4.50%

60.00

83.45

88.15

Dec 31, 2020

Jan 1, 2020

Jun 30, 2022

Jun 30, 2021

Dec 31, 2022

Jan 1, 2022

Year Issued /  
 TSX Symbol 

Aggregate  
Principal Amount
$

Coupon

Maturity Date

(1)  At the option of the Company, at par plus accrued and unpaid interest. AGI redeemed its 2015 Debentures, AFN.DB.C  
      above, in January 2020.

(2)  In the twelve-month period prior to the date on which the Company may, at its option, redeem any series of  
      convertible debentures at par plus accrued and unpaid interest, such convertible debentures may be redeemed,  
      in whole or in part, at the option of the Company at a price equal to their principal amount plus accrued and unpaid  
      interest, provided that the volume weighted average trading price of the common shares (“Common Shares”) of the  
      Company during the 20 consecutive trading days ending on the fifth trading day preceding the date on which the  
      notice of redemption is given is not less than 125% of the conversion price.

2019 March [AFN.DB.F]

2019 November [AFN.DB.G]

86,250,000

86,250,000

5.40%

5.25%

June 30 2024

December 31, 2024

On redemption or at maturity, the Company may, at its option, elect to satisfy its 
obligation to pay the principal amount of the 5.40% Debentures by issuing and 
delivering common shares. The Company may also elect to satisfy its obligation to 
pay interest on the 5.40% Debentures by delivering sufficient common shares. The 
number of shares issued would be determined based on market prices at the time 
of issuance.

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

2727

 
 
 
 
 
 
 
 
COMMON SHARES

The following number of Common Shares were issued and outstanding at the 
dates indicated:

Dividends in a fiscal year are typically funded entirely through cash from operations, 
although due to seasonality dividends may be funded on a short-term basis by the 
Company’s operating lines. In the year ended December 31, 2019 dividends paid 
to shareholders of $44.7 million [2018 – $39.3 million] were financed from cash on 
hand and nil [2018 – $1.4 million] by the DRIP. AGI suspended its DRIP in Q2 2018.

December 31, 2018

Settlement of EIAP obligation

Conversion of convertible unsecured subordinated debentures

December 31, 2019

Settlement of EIAP obligations

March 25, 2020

At March 25, 2020

# Common Shares

18,363,780

294,400

299

18,658,479

39,381

18,697,860

•  18,697,860 Common Shares are outstanding;

•  1,215,000 Common Shares are available for issuance under the Company’s 
Equity Award Incentive Plan [the “EIAP”], of which 1,156,560 have been 
granted and 58,440 remain unallocated;

•  87,946 deferred grants of Common Shares have been granted under the 
Company’s Directors’ Deferred Compensation Plan and 18,436 Common 
Shares have been issued; and

•  3,261,698 Common Shares are issuable on conversion of the outstanding 

convertible debentures, of which there are an aggregate principal amount of 
$248 million outstanding.

AGI’s Common Shares trade on the TSX under the symbol AFN.

DIVIDENDS

AGI declared dividends to shareholders in the year ended December 31, 2019 of 
$44.7 million versus $40.1 million in 2018. AGI’s policy is to pay monthly dividends. 
The Company’s Board of Directors reviews financial performance and other 
factors when assessing dividend levels. An adjustment to dividend levels may 
be made at such time as the Board determines an adjustment to be appropriate. 

FUNDS FROM OPERATIONS AND PAYOUT RATIO 
[see “Non-IFRS Measures”]

Funds from operations [“FFO”], defined under “Non-IFRS Measures”, is adjusted 
EBITDA less cash taxes, cash interest expense, realized losses on foreign exchange 
and maintenance capital expenditures. The objective of presenting this measure is 
to provide a measure of free cash flow. The definition excludes changes in working 
capital as they are necessary to drive organic growth and have historically been 
financed by the Company’s operating facility [See “Capital Resources”]. Funds from 
operations should not be construed as an alternative to cash flows from operating, 
investing, and financing activities as a measure of the Company’s liquidity and cash 
flows.

[T HOUSANDS OF  DOL LARS]

Adjusted EBITDA

Interest expense

Non-cash interest

Cash taxes

Maintenance CAPEX

Funds from operations [1]

Dividends

Payout Ratio

(1)  See “Non-IFRS Measures”.

YEAR ENDED DECEMBER 31

2019
$

144,279

(44,793)

6,485

(9,894)

2018
$

148,195

(37,067)

6,206

(9,975)

(14,810)

(11,292)

81,267

44,705

55%

96,067

40,650

42%

The increase in payout ratio is partially related to the acquisition of Milltec. Milltec’s 
sales and adjusted EBITDA reflect agricultural seasonality in India, and historically 
approximately 70% of their sales have occurred in the first and fourth calendar 
quarters. Milltec was acquired on March 29, 2019 and accordingly the table above 
does not include Milltec’s seasonally high Q1. In addition, AGI added 1.9 million 
common shares in Q4 2018, the proceeds of which contributed to funding the 
acquisition of Milltec on March 28, 2019.

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

28

 
 
 
 
 
 
 
 
FINANCIAL INSTRUMENTS

Foreign exchange contracts

Risk from foreign exchange arises as a result of variations in exchange rates 
between the Canadian and the U.S. dollars and to a lesser extent to variations 
in exchange rates between the Euro and the Canadian dollar. AGI may enter into 
foreign exchange contracts to partially mitigate its foreign exchange risk. AGI has no 
foreign exchange contracts outstanding as at December 31, 2019.

Interest Rate Swaps

The Company has entered into interest rate swap contracts to manage its exposure 
to fluctuations in interest rates.

Currency

Maturity

CAD

USD

2022

2020

Amount of Swap 
[000’s] $

40,000

38,000

Fixed Rate [1]

3.6 – 4.1%

3.8%

Canadian dollar contracts

U.S. dollar contracts

(1)  With performance adjustments.

The interest rate swap contracts are derivative financial instruments and changes 
in the fair value were recognized as a gain (loss) on financial instruments in other 
operating income. Through these contracts, the Company agreed to receive 
interest based on the variable rates from the counterparty and pay interest based 
on fixed rates between 3.6% and 4.1%. The notional amounts are $89.4 million 
in aggregate, resetting the last business day of each month. The contracts expire 
between November 2020 and May 2022.

During the year ended December 31, 2019, a loss of $1.5 million [2018 - loss of 
$78,000] was recorded in gain (loss) on financial instruments.

Equity compensation hedge

The Company is party to an equity swap agreement with a financial institution to 
manage the Company’s cash flow exposure due to fluctuations in its share price 
related to the EIAP. As at December 31, 2019, the equity swap agreement covered 
722,000 Common Shares at a weighted average price of $38.76 and the maturity 
date of the agreement is April 6, 2021.

As at December 31, 2019, the unrealized gain on the equity swap was $5.6 million, 
and in the three-months and fiscal year-ended December 31, 2019, the Company 
recorded a gain (loss) in the consolidated statements of income of $1.4 million and 
$(9.8) million [2018 – gain of $4.5 million and $5.7 million].

2018 ACQUISITIONS

Danmare

In February 2018, AGI acquired 100% of the shares of Danmare. Danmare provides 
engineering solutions and project management services to the food industry, with 
a specialization in automated systems for pet food, rice and pasta, confectionery, 
ready-to-eat foods, sauces and meat processing. Sales and adjusted EBITDA for 
Danmare in its fiscal year-ended August 2017 were $6.4 million and $1.7 million, 
respectively.

Sabe

In July 2018, AGI acquired 100% of the outstanding shares of Sabe. Based in 
France, Sabe offers design, manufacturing, installation and commissioning of 
turnkey solutions to the food industry. The acquisition further evolves AGI’s ability to 
provide complete solutions to a broad customer base. Sales and adjusted EBITDA 
for Sabe in its fiscal year-ended May 2018 were €16.4 million and €2.2 million, 
respectively.

2019 ACQUISITIONS

Improtech

In January 2019, AGI acquired 100% of the outstanding shares of Improtech. 
Improtech is a professional engineering services firm specializing in providing 
engineering design, project management and integration of new machinery and 
processes within the food and beverage industry. The acquisition further evolves 
AGI’s ability to provide complete solutions to a broad customer base.

IntelliFarms

In March 2019, AGI acquired IntelliFarms, a provider of hardware and software 
solutions that benefit grain growers, processors, and other participants in the 

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

2929

 
 
 
 
 
 
 
 
agriculture market. IntelliFarms was founded in 2001 and is headquartered in 
Archie, Missouri. Sales at IntelliFarms for the year ended December 31, 2018 were 
approximately $11.0 million USD.

The net proceeds of the Offering will be used to repay indebtedness and for 
general corporate purposes.

Milltec

In March 2019, AGI acquired 100% of the outstanding shares of Milltec. The 
purchase price for Milltec was $113.1 million, plus the potential for up to an 
additional $30.8 million based on the achievement of EBITDA targets. Milltec 
is headquartered in Bangalore, India, and is a market leading manufacturer of 
rice milling and processing equipment in India. For the twelve months ended 
January 31, 2019, Milltec’s sales and EBITDA were $56.2 million and $10.1 million, 
respectively.

SUBSEQUENT EVENTS

On January 2, 2020, the Company redeemed its 5.00% convertible unsecured 
subordinated debentures due December 31, 2020 [“2015 Debentures”] in 
accordance with the terms of the supplemental trust indenture dated September 
29, 2015 [note 21].

On January 16, 2020, the Company acquired 100% of the shares outstanding 
of Affinity Management Ltd. [“Affinity”]. The transaction was funded from the 
Company’s operating facilities. Affinity, headquartered in Oakville, Ontario, is a 
provider of software solutions to the agriculture industry under the brand name 
Compass® and includes a comprehensive Enterprise Resource Planning [“ERP”] 
system for growers and ag retailers, as well as an agronomy tool. The Compass® 
product suite is highly complementary to AGI’s current offering and will be a key 
component of the full AGI SureTrack platform.

On February 13, 2020, the Company entered an agreement with a syndicate of 
underwriters, pursuant to which AGI will issue on a “bought deal” basis, subject to 
regulatory approval, $85 million aggregate principal amount of senior subordinated 
unsecured debentures [the “2020 Debentures”] at a price of $1,000 per Debenture 
(the “Offering”). On March 5, 2020, the Company closed the offering of the 2020 
Debentures. AGI has also granted to the Underwriters an over-allotment option, 
exercisable in whole or in part for a period expiring 30 days following closing, 
to purchase up to an additional $12,750,000 aggregate principal amount of 
Debentures at the same price. If the over-allotment option is fully exercised, the 
total gross proceeds from the Offering to AGI will be $97.75 million.

The Debentures bear interest at 5.25% per annum, payable semi-annually in 
arrears on June 30 and December 31 each year commencing June 30, 2020. The 
Debentures have a maturity date of December 31, 2026.

The Debentures are not be redeemable by the Company before December 
31, 2022, except upon the occurrence of a change of control of the Company 
in accordance with the terms of the indenture [the “Indenture”] governing the 
Debentures. On and after December 31, 2022 and prior to December 31, 2023, 
the Debentures may be redeemed at the Company’s option at a price equal to 
103.9375% of their principal amount plus accrued and unpaid interest. On and 
after December 31, 2023 and prior to December 31, 2024, the Debentures may be 
redeemed at the Company’s option at a price equal to 102.625% of their principal 
amount plus accrued and unpaid interest. On and after December 31, 2024 and 
prior to December 31, 2025, the Debentures may be redeemed at the Company’s 
option at a price equal to 101.3125% of their principal amount plus accrued and 
unpaid interest. On and after December 31, 2025 and prior to maturity, the 
Debentures will be redeemable at the Company’s option at a price equal to their 
principal amount plus accrued and unpaid interest.

The Company has the option to satisfy its obligation to repay the principal amount 
of the Debentures due at redemption or maturity by issuing and delivering that 
number of freely tradeable common shares in accordance with the terms of the 
Indenture.

The Debentures are not convertible into common shares of the Company at the 
option of the holders at any time.

On March 20, 2020, the Company amended and extended the Credit Facility. Under 
the amended and extended Credit Facility, the revolving facilities bear interest at 
bankers’ acceptance (BA) or London Interbank Offered Rate (LIBOR) plus 1.20% 
to BA or LIBOR plus 2.50%, and the swing lines bear interest at prime plus 
0.20% to prime plus 1.5% per annum, in each case based on certain performance 
calculations. The Credit Facility matures on March 20, 2025. Collateral for the Credit 
Facility ranks pari passu with the collateral for the Series B and Series C Secured 
Notes and includes a general security agreement over all assets, first position 
collateral mortgages on land and buildings, assignments of rents and leases and 
security agreements for patents and trademarks.

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

30

 
 
 
 
 
 
 
 
Since December 31, 2019, the outbreak of the novel strain of coronavirus, 
specifically identified as “COVID-19”, has resulted in governments worldwide 
enacting emergency measures to combat the spread of the virus. These measures, 
which include the implementation of travel bans, self-imposed quarantine periods 
and social distancing have caused material disruption to businesses globally 
resulting in an economic slowdown. Global equity markets have experienced 
significant volatility and weakness. Governments and central banks have reacted 
with significant monetary and fiscal interventions designed to stabilize economic 
conditions. The duration and impact of the COVID-19 outbreak is unknown at this 
time, as is the efficacy of the government and central bank interventions. It is not 
possible to reliably estimate the length and severity of these developments and 
the impact on the financial results and condition of the Company and its operating 
subsidiaries in future periods.

OTHER RELATIONSHIPS

Burnet, Duckworth & Palmer LLP provides legal services to the Company, and a 
Director of AGI is a partner of Burnet, Duckworth & Palmer LLP. During the year 
ended December 31, 2019, the total cost of these legal services related to general 
matters was $0.4 million [2018 – $1.4 million], and $0.5 million is included in 
accounts payable and accrued liabilities as at December 31, 2019.

These transactions are measured at the exchange amount and were incurred during 
the normal course of business.

CRITICAL ACCOUNTING ESTIMATES

Described in the notes to the Company’s 2019 audited annual consolidated 
financial statements are the accounting policies and estimates that AGI believes 
are critical to its business. Please refer to note 4 to the audited consolidated 
financial statements for the year ended December 31, 2019 for a discussion of the 
significant accounting judgments, estimates and assumptions.

RISKS AND UNCERTAINTIES

The Company and its business are subject to numerous risks and uncertainties 
which are described in this MD&A and the Company’s most recent Annual 
Information Form, which are available under the Company’s profile on SEDAR 

[www.sedar.com]. These risks and uncertainties include but are not limited to 
the following: general economic and business conditions and changes in such 
conditions locally, in North America, South America, South Asia and globally; the 
effects of global outbreaks of pandemics or contagious diseases or the fear of 
such outbreaks, such as the recent coronavirus (COVID-19) pandemic, including 
on our operations, our personnel, our supply chain, the demand for our products, 
our ability to expand and produce in new geographic markets or the timing of such 
expansion efforts, and on overall economic conditions and customer confidence 
and spending levels; the ability of management to execute the Company’s business 
plan; fluctuations in agricultural and other commodity prices and interest and 
currency exchange rates; crop planting, crop conditions and crop yields; weather 
patterns, the timing of harvest and conditions during harvest; volatility of production 
costs; governmental regulation of the agriculture and manufacturing industries, 
including environmental regulation; actions taken by governmental authorities, 
including increases in taxes and changes in government regulations and incentive 
programs; risks inherent in marketing operations; credit risk; the availability of credit 
for customers; seasonality and industry cyclicality; potential delays or changes in 
plans with respect to capital expenditures; the cost and availability of sufficient 
financial resources to fund the Company’s capital expenditures; the availability 
of credit for customers, incorrect assessments of the value of acquisitions and 
failure of the Company to realize the anticipated benefits of acquisitions; volatility 
in the stock markets including the market price of the Common Shares and in 
market valuations; competition for, among other things, customers, supplies, 
acquisitions, capital and skilled personnel; the availability of capital on acceptable 
terms; dependence on suppliers; changes in labour costs and the labour market; 
and climate change risks. These risks and uncertainties are not the only risks and 
uncertainties we face. Additional risks and uncertainties not currently known to us 
or that we currently consider immaterial also may impair operations. If any of these 
risks actually occur, our business, results of operations and financial condition, and 
the amount of cash available for dividends could be materially adversely affected.

CHANGES IN ACCOUNTING STANDARDS AND FUTURE   
ACCOUNTING CHANGES

New accounting policies

Investments in associates

An associate is an entity over which the Company has significant influence. 
Significant influence is the power to participate in the financial and operating policy 
decisions of the investee but is not control or joint control over those policies. 

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

3131

 
 
 
 
 
 
 
 
S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

32

 
 
 
 
 
 
 
 
S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

3333

 
 
 
 
 
 
 
 
The considerations made in determining significant influence are similar to those 
necessary to determine control over subsidiaries.

Adoption of new accounting standards

AGI’s investment in its associate is accounted for using the equity method. Under 
the equity method, the investment in an associate is initially recognized at cost. 
The carrying amount of the investment is adjusted to recognize changes in the 
Company’s share of net assets of the associate since the acquisition date. Goodwill 
relating to the associate is included in the carrying amount of the investment and is 
not tested for impairment separately.

The consolidated statements of income reflect the Company’s share of the results 
of operations of the associate. Any change in OCI of the associate is presented as 
part of AGI’s OCI. In addition, when there has been a change recognized directly 
in the equity of the associate, the Company recognizes its share of any changes, 
when applicable, in the consolidated statements of changes in shareholders’ 
equity. Unrealized gains and losses resulting from transactions between AGI and 
the associate are eliminated to the extent of the interest in the associate. The 
aggregate of the Company’s share of profit or loss of an associate is shown on the 
face of the consolidated statements of income and represents profit or loss after 
tax and non-controlling interests in the subsidiaries of the associate.

The financial statements of the associate are prepared for the same reporting 
period as the Company. When necessary, adjustments are made to bring the 
accounting policies in line with those of AGI.

After application of the equity method, the Company determines whether it is 
necessary to recognize an impairment loss on its investment in its associate. At 
each reporting date, the Company determines whether there is objective evidence 
that the investment in the associate is impaired. If there is such evidence, the 
Company calculates the amount of impairment as the difference between the 
recoverable amount of the associate and its carrying value, and then recognizes the 
loss within share of associate’s net income (loss) in the consolidated statements of 
income.

Upon loss of significant influence over the associate, the Company measures and 
recognizes any retained investment at its fair value. Any difference between the 
carrying amount of the associate upon loss of significant influence and the fair 
value of the retained investment and proceeds from disposal is recognized in profit 
or loss.

IFRS 16, Leases [“IFRS 16”]

The Company has applied IFRS 16 using the modified retrospective approach, and 
therefore the comparative information has not been restated and continues to be 
reported under IAS 17, Leases, [“IAS 17”] and IFRIC 4, Determining whether an 
Arrangement contains a Lease [“IFRIC 4”].

For contracts entered into before January 1, 2019, the Company determined 
whether the arrangement was or contained a lease based on the assessment of 
whether:

•  Fulfilment of the arrangement was dependent on the use of a specific asset or 

assets; and

•  The arrangement had conveyed a right to use the asset.

The Company elected to use the transition practical expedient to not reassess 
whether a contract is, or contains, a lease at January 1, 2019. Instead, the 
Company applied the standard only to contracts that were previously identified as 
leases applying IAS 17 and IFRIC 4 at the date of initial application. The Company 
has also elected not to recognize right-of-use assets and lease liabilities for short-
term leases [12 months or less] and leases of low-value assets. The Company 
recognizes the lease payments associated with these leases as an expense on a 
straight-line basis over the lease term.

As a result of adoption of IFRS 16, the Company recorded a right-of-use asset and 
a lease liability of $9,071 as at January 1, 2019 on the consolidated statements of 
financial position. On adoption of IFRS 16, AGI used the incremental borrowing rate 
as required by the standard.

The lease liabilities as at January 1, 2019 can be reconciled to the operating lease 
commitments as at December 31, 2018 as follows:

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

34

 
 
 
 
 
 
 
 
Operating lease commitments as at December 31, 2018

Weighted average incremental borrowing rate as at January 1, 2019

Discounted operating lease commitments at January 1, 2019 

Less:

Commitments relating to short-term and low-value leases

Lease liabilities as at January 1, 2019

$

11,059

5.02%

10,841

(1,770)

9,071

IAS 19, Employee Benefits [“IAS 19”]

The Company adopted the amendments to IAS 19 with a date of application of 
January 1, 2019. The amendments to IAS 19 address the accounting when a 
plan amendment, curtailment or settlement occurs during a reporting period. The 
amendments specify that when a plan amendment, curtailment or settlement 
occurs during the annual reporting period, an entity is required to:

•  Determine current service cost for the remainder of the period after the plan 

amendment, curtailment or settlement, using the actuarial assumptions used to 
remeasure the net defined benefit liability (asset) reflecting the benefits offered 
under the plan and the plan assets after that event.

•  Determine net interest for the remainder of the period after the plan 

amendment, curtailment or settlement using the net defined benefit liability 
(asset) reflecting the benefits offered under the plan and the plan assets after 
that event and the discount rate used to remeasure that net defined benefit 
liability (asset).

The amendments also clarify that an entity first determines any past service cost, 
or a gain or loss on settlement, without considering the effect of the asset ceiling. 
This amount is recognized in profit or loss. An entity then determines the effect of 
the asset ceiling after the plan amendment, curtailment or settlement. Any change 
in that effect, excluding amounts included in the net interest, is recognized in other 
comprehensive income.

These amendments are applied prospectively to any future plan amendments, 
curtailments, or settlements of the Company; as at December 31, 2019, there were 
no such amendments.

IFRIC 23 – Uncertainty Over Income Tax Treatments

The Company adopted IFRIC 23 with a date of application of January 1, 2019. IFRIC 
23 sets out how to determine the accounting tax position when there is uncertainty 
over income tax treatments. The interpretation requires an entity to:

•  Determine whether uncertain tax positions are assessed separately or as a 

group; and

•  Assess whether it is probable that a tax authority will accept an uncertain tax 
treatment used, or proposed to be used, by an entity in its income tax filings:

•  If yes, the entity should determine its accounting tax position consistently 
with the tax treatment used or planned to be used in its income tax filings.

•  If no, the entity should reflect the effect of uncertainty in determining its 

accounting tax position.

The Company’s adoption of IFRIC 23 did not have a significant impact on the 
Company’s consolidated financial statements.

Standards issued but not yet effective

Amendments to IFRS 3, Business Combinations [“IFRS 3”]

The IASB issued amendments to the definition of a business in IFRS 3 to help 
entities determine whether an acquired set of activities and assets is a business or 
not. They clarify the minimum requirements for a business, remove the assessment 
of whether market participants are capable of replacing any missing elements, 
add guidance to help entities assess whether an acquired process is substantive, 
narrow the definitions of a business and of outputs, and introduce an optional fair 
value concentration test.

The amendments must be applied to transactions that are either business 
combinations or asset acquisitions for which the acquisition date is on or after the 
beginning of the first annual reporting period beginning on January 1, 2020 with 
earlier application permitted. Consequently, transactions that occurred in prior 
periods do not need to be reassessed. The Company’s assessment did not identify 
significant classification, recognition or measurement differences. The Company 
will adopt the amendments to IFRS 3 as at January 1, 2020.

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

3535

 
 
 
 
 
 
 
 
DISCLOSURE CONTROLS AND PROCEDURES AND INTERNAL 
CONTROLS

Disclosure controls and procedures are designed to provide reasonable assurance 
that all relevant information is gathered and reported to senior management, 
including AGI’s Chief Executive Officer and Chief Financial Officer, on a timely basis 
so that appropriate decisions can be made regarding public disclosure.

Management of AGI is responsible for designing internal controls over financial 
reporting for the Company as defined under National Instrument 52-109 issued by 
the Canadian Securities Administrators. Management has designed such internal 
controls over financial reporting, or caused them to be designed under their 
supervision, to provide reasonable assurance regarding the reliability of financial 
reporting and the preparation of the financial statements for external purposes in 
accordance with IFRS.

Subsequent to December 31, 2018, AGI acquired Improtech, IntelliFarms and 
Milltec. See “Basis of Presentation - Acquisitions”. Management has not completed 
its review of internal controls over financial reporting or disclosure controls and 
procedures for these acquired businesses. Since the acquisitions occurred within 
365 days of the end of the reporting period, management has limited the scope 
of design, and subsequent evaluation, of disclosure controls and procedures 
and internal controls over financial reporting to exclude controls, policies and 
procedures of these acquisitions, as permitted under Section 3.3 of National 
Instrument 52-109 - Certification of Disclosure in Issuer’s Annual and Interim 
Filings. For the period covered by this MD&A, management has undertaken specific 
procedures to satisfy itself with respect to the accuracy and completeness of the 
financial information of Improtech, IntelliFarms and Milltec. The following is the 
summary financial information pertaining to Improtech, IntelliFarms and Milltec 
that was included in AGI’s consolidated financial statements for the year ended 
December 31, 2019:

[THOUSANDS  OF  DOLLARS]

Revenue [1]

Loss [1]

Current assets [1][2]

Non-current assets [1][2]

Current liabilities [1][2]

Non-current liabilities [1][2]

(1)  Net of intercompany
(2)  Statement of financial position as at December 31 2019

Improtech/IntelliFarms/Milltec
$

60,046

(13,070)

44,793

149,229

34,379

31,070

There have been no material changes in AGI’s internal controls over financial 
reporting that occurred in the three-month period ended December 31, 2019, that 
have materially affected, or are reasonably likely to materially affect, the Company’s 
internal controls over financial reporting.

NON-IFRS MEASURES

In analyzing our results, we supplement our use of financial measures that are 
calculated and presented in accordance with IFRS with a number of non-IFRS 
financial measures including “trade sales”, “EBITDA”, “Adjusted EBITDA”, “gross 
margin”, “funds from operations”, “payout ratio”, “adjusted profit”, and “diluted 
adjusted profit per share”. A non-IFRS financial measure is a numerical measure of 
a company’s historical performance, financial position or cash flow that excludes 
[includes] amounts, or is subject to adjustments that have the effect of excluding 
[including] amounts, that are included [excluded] in the most directly comparable 
measures calculated and presented in accordance with IFRS. Non-IFRS financial 
measures are not standardized; therefore, it may not be possible to compare these 
financial measures with other companies’ non-IFRS financial measures having 
the same or similar businesses. We strongly encourage investors to review our 
consolidated financial statements and publicly filed reports in their entirety and not 
to rely on any single financial measure.

We use these non-IFRS financial measures in addition to, and in conjunction with, 
results presented in accordance with IFRS. These non-IFRS financial measures 
reflect an additional way of viewing aspects of our operations that, when viewed 
with our IFRS results and the accompanying reconciliations to corresponding IFRS 
financial measures, may provide a more complete understanding of factors and 
trends affecting our business.

In this MD&A, we discuss the non-IFRS financial measures, including the reasons 
that we believe that these measures provide useful information regarding our 
financial condition, results of operations, cash flows and financial position, as 
applicable, and, to the extent material, the additional purposes, if any, for which 
these measures are used. Reconciliations of non-IFRS financial measures to the 
most directly comparable IFRS financial measures are contained in this MD&A.

Management believes that the Company’s financial results may provide a more 
complete understanding of factors and trends affecting our business and be more 

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

36

 
 
 
 
 
 
 
 
meaningful to management, investors, analysts and other interested parties when 
certain aspects of our financial results are adjusted for the gain (loss) on foreign 
exchange and other operating expenses and income. These measurements are 
non-IFRS measurements. Management uses the non-IFRS adjusted financial 
results and non-IFRS financial measures to measure and evaluate the performance 
of the business and when discussing results with the Board of Directors, analysts, 
investors, banks and other interested parties.

References to “EBITDA” are to profit before income taxes, finance costs, 
depreciation, amortization and share of associate’s net loss. References to 
“adjusted EBITDA” are to EBITDA before the gain or loss on foreign exchange, non-
cash share based compensation expenses, gain or loss on financial instruments, 
M&A expenses, other transaction and transitional costs, gain or loss on the 
sale of property, plant & equipment, gain or loss on disposal of assets held for 
sale and fair value of inventory from acquisitions, equipment rework costs and 
impairment. Management believes that, in addition to profit or loss, EBITDA and 
adjusted EBITDA are useful supplemental measures in evaluating the Company’s 
performance. Management cautions investors that EBITDA and adjusted EBITDA 
should not replace profit or loss as indicators of performance, or cash flows from 
operating, investing, and financing activities as a measure of the Company’s 
liquidity and cash flows. See “Operating Results - EBITDA and Adjusted EBITDA” 
for the reconciliation of EBITDA and Adjusted EBITDA to profit before income taxes.

References to “trade sales” are to sales net of the gain or loss on foreign 
exchange. Management cautions investors that trade sales should not replace 
sales as an indicator of performance. See “Operating Results - Trade Sales” for the 
reconciliation of trade sales to sales.

References to “gross margin” are to trade sales less cost of inventories, and 
thereby exclude depreciation, amortization, fair value of inventory from acquisitions 
and equipment rework from cost of sales. Management believes that gross 
margin provides a useful supplemental measure in evaluating its performance. See 
“Operating Results– Gross Margin” for the calculation of gross margin.

References to “funds from operations” are to adjusted EBITDA less IFRS 15 
adjustment, interest expense, non-cash interest, cash taxes and maintenance 
capital expenditures. Management believes that, in addition to cash provided by 
(used in) operating activities, funds from operations provide a useful supplemental 
measure in evaluating its performance. References to “payout ratio” are to 

dividends declared as a percentage of funds from operations. See “Funds from 
Operations and Payout Ratio” for the calculation of funds from operations and 
payout ratio.

References to “adjusted profit” and “diluted adjusted profit per share” are to profit 
for the period and diluted profit per share for the period adjusted for the gain or 
loss on foreign exchange, fair value of inventory from acquisitions, M&A expenses 
or recoveries, other transaction and transitional costs, gain or loss on financial 
instruments, gain or loss on sale of property, plant and equipment impairment 
charges, cost of equipment rework and share of associate’s net loss. See “Detailed 
Operating Results – Diluted profit (loss) per share and diluted adjusted profit per 
share” for the reconciliation of diluted profit per share and diluted adjusted profit 
per share to profit.

In addition, the financial information in this MD&A relating to Milltec’s sales and 
EBITDA for periods prior to its acquisition by AGI was derived from Milltec’s 
financial statements, which are prepared in accordance with generally accepted 
accounting principles in India, which differ in some material respects from IFRS, 
and accordingly may not be comparable to the financial statements of AGI or other 
Canadian public companies.

FORWARD-LOOKING INFORMATION

This MD&A contains forward-looking statements and information [collectively, 
“forward-looking information”] within the meaning of applicable securities laws 
that reflect our expectations regarding the future growth, results of operations, 
performance, business prospects, and opportunities of the Company. All 
information and statements contained herein that are not clearly historical in 
nature constitute forward-looking information, and the words “anticipate”, “believe”, 
“continue”, “could”, “expects”, “intend”, “plans”, “postulates”, “predict”, “will” or 
similar expressions suggesting future conditions or events or the negative of these 
terms are generally intended to identify forward-looking information. Forward-
looking information involves known or unknown risks, uncertainties and other 
factors that may cause actual results or events to differ materially from those 
anticipated in such forward-looking information. In addition, this MD&A may 
contain forward-looking information attributed to third party industry sources. 
Undue reliance should not be placed on forward-looking information, as there can 
be no assurance that the plans, intentions or expectations upon which it is based 

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

3737

 
 
 
 
 
 
 
 
will occur. In particular, the forward-looking information in this MD&A includes 
information relating to our business and strategy, including our outlook for our 
financial and operating performance including our expectations for our future 
financial results including sales, EBITDA and adjusted EBITDA, industry demand 
and market conditions, the anticipated impacts of the coronavirus (COVID-19) 
outbreak on our business, operations and financial results; and with respect to our 
ability to achieve the expected benefits of recent acquisitions and the contribution 
therefrom including from purchasing and personnel synergies and margin 
improvement initiatives. Such forward-looking information reflects our current 
beliefs and is based on information currently available to us, including certain 
key expectations and assumptions concerning: the anticipated impacts of the 
coronavirus (COVID-19) outbreak on our business, operations and financial results; 
anticipated grain production in our market areas; financial performance; the financial 
and operating attributes of recently acquired businesses and the anticipated future 
performance thereof and contributions therefrom; business prospects; strategies; 
product and input pricing; regulatory developments; tax laws; the sufficiency of 
budgeted capital expenditures in carrying out planned activities; political events; 
currency exchange and interest rates; the cost of materials; labour and services; 
the value of businesses and assets and liabilities assumed pursuant to recent 
acquisitions; the impact of competition; the general stability of the economic and 
regulatory environment in which the Company operates; the timely receipt of any 
required regulatory and third party approvals; the ability of the Company to obtain 
and retain qualified staff and services in a timely and cost efficient manner; the 
timing and payment of dividends; the ability of the Company to obtain financing 
on acceptable terms; the regulatory framework in the jurisdictions in which the 
Company operates; and the ability of the Company to successfully market its 
products and services. Forward-looking information involves significant risks and 
uncertainties. A number of factors could cause actual results to differ materially 
from results discussed in the forward-looking information, including the effects 
of global outbreaks of pandemics or contagious diseases or the fear of such 
outbreaks, such as the recent coronavirus (COVID-19) pandemic, including the 
effects on the Company’s operations, personnel, and supply chain, the demand 
for its products and services, its ability to expand and produce in new geographic 
markets or the timing of such expansion efforts, and on overall economic conditions 
and customer confidence and spending levels, changes in international, national 
and local macroeconomic and business conditions, as well as sociopolitical 
conditions in certain local or regional markets, weather patterns, crop planting, 
crop yields, crop conditions, the timing of harvest and conditions during harvest, 

the ability of management to execute the Company’s business plan, seasonality, 
industry cyclicality, volatility of production costs, agricultural commodity prices, the 
cost and availability of capital, currency exchange and interest rates, the availability 
of credit for customers, competition, AGI’s failure to achieve the expected benefits 
of recent acquisitions including to realize anticipated synergies and margin 
improvements; and changes in trade relations between the countries in which 
the Company does business including between Canada and the United States. 
These risks and uncertainties are described under “Risks and Uncertainties” in this 
MD&A, our annual MD&A and in our most recently filed Annual Information Form, 
all of which are available under the Company’s profile on SEDAR [www.sedar.com]. 
These factors should be considered carefully, and readers should not place undue 
reliance on the Company’s forward-looking information. We cannot assure readers 
that actual results will be consistent with this forward-looking information. Readers 
are further cautioned that the preparation of financial statements in accordance 
with IFRS requires management to make certain judgments and estimates that 
affect the reported amounts of assets, liabilities, revenues and expenses and the 
disclosure of contingent liabilities. These estimates may change, having either a 
negative or positive effect on profit, as further information becomes available and 
as the economic environment changes. The forward-looking information contained 
herein is expressly qualified in its entirety by this cautionary statement. The 
forward-looking information included in this MD&A is made as of the date of this 
MD&A and AGI undertakes no obligation to publicly update such forward-looking 
information to reflect new information, subsequent events or otherwise unless so 
required by applicable securities laws.

ADDITIONAL INFORMATION

Additional information relating to AGI, including AGI’s most recent Annual 
Information Form, is available under the Company’s profile on SEDAR  
[www.sedar.com].

S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

38

 
 
 
 
 
 
 
 
S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

3939

NURTURE THE SOIL WITH SCIENCE

 
 
 
 
 
 
 
 
S

I

S
Y
L
A
N
A

N
O

I

S
S
U
C
S

I

D

S

’

T
N
E
M
E
G
A
N
A
M

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

40

 
 
 
 
 
 
 
 
S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

4141

 
 
 
 
 
 
 
 
CONSOLIDATED FINANCIAL 
STATEMENTS

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

42
42

 
 
 
 
 
 
 
 
INDEPENDENT AUDITOR ’S REPORT

To the Shareholders of 
Ag Growth International Inc.

Opinion

We have audited the consolidated financial statements of Ag Growth International 
Inc. and its subsidiaries [the ”Group”], which comprise the consolidated statements 
of financial position as at December 31, 2019 and 2018, and the consolidated 
statements of income, consolidated statements of comprehensive income (loss), 
consolidated statements of changes in shareholders’ equity and consolidated 
statements of cash flows for the years then ended, and notes to the consolidated 
financial statements, including a summary of significant accounting policies.

In our opinion, the accompanying consolidated financial statements present 
fairly, in all material respects the consolidated financial position of the Group as at 
December 31, 2019 and 2018, and its consolidated financial performance and its 
consolidated cash flows for the years then ended in accordance with International 
Financial Reporting Standards [“IFRS”].

Basis for opinion

We conducted our audit in accordance with Canadian generally accepted auditing 
standards. Our responsibilities under those standards are further described in the 
Auditor’s responsibilities for the audit of the consolidated financial statements 
section of our report. We are independent of the Group in accordance with the 
ethical requirements that are relevant to our audit of the consolidated financial 
statements in Canada, and we have fulfilled our other ethical responsibilities in 
accordance with these requirements. We believe that the audit evidence we have 
obtained is sufficient and appropriate to provide a basis for our opinion.

Other information

Our opinion on the consolidated financial statements does not cover the other 
information and we do not express any form of assurance conclusion thereon.

In connection with our audit of the consolidated financial statements, our 
responsibility is to read the other information, and in doing so, consider whether 
the other information is materially inconsistent with the consolidated financial 
statements or our knowledge obtained in the audit or otherwise appears to be 
materially misstated.

We obtained Management’s Discussion and Analysis prior to the date of this 
auditor’s report. If, based on the work we have performed, we conclude that there 
is a material misstatement of this other information, we are required to report that 
fact in this auditor’s report. We have nothing to report in this regard.

The Annual Report is expected to be made available to us after the date of the 
auditor’s report. If based on the work we will perform on this other information, we 
conclude there is a material misstatement of other information, we are required to 
report that fact to those charged with governance.

Responsibilities of management and those charged with governance for 
the consolidated financial statements

Management is responsible for the preparation and fair presentation of the 
consolidated financial statements in accordance with IFRS, and for such internal 
control as management determines is necessary to enable the preparation of 
consolidated financial statements that are free from material misstatement, 
whether due to fraud or error.

In preparing the consolidated financial statements, management is responsible 
for assessing the Group’s ability to continue as a going concern, disclosing, as 
applicable, matters related to going concern and using the going concern basis of 
accounting unless management either intends to liquidate the Group or to cease 
operations, or has no realistic alternative but to do so.

Management is responsible for the other information. The other information 
comprises:

Those charged with governance are responsible for overseeing the Group’s financial 
reporting process.

•  Management’s Discussion and Analysis

•  The information other than the consolidated financial statements and our 

auditor’s report thereon, in the Annual Report

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

4343

 
 
 
 
 
 
 
 
Auditor’s responsibilities for the audit of the consolidated financial 
statements

auditor’s report. However, future events or conditions may cause the Group to 
cease to continue as a going concern.

Our objectives are to obtain reasonable assurance about whether the consolidated 
financial statements as a whole are free from material misstatement, whether 
due to fraud or error, and to issue an auditor’s report that includes our opinion. 
Reasonable assurance is a high level of assurance, but is not a guarantee that an 
audit conducted in accordance with Canadian generally accepted auditing standards 
will always detect a material misstatement when it exists. Misstatements can arise 
from fraud or error and are considered material if, individually or in the aggregate, 
they could reasonably be expected to influence the economic decisions of users 
taken on the basis of these consolidated financial statements.

As part of an audit in accordance with Canadian generally accepted auditing 
standards, we exercise professional judgment and maintain professional skepticism 
throughout the audit. We also:

•  Identify and assess the risks of material misstatement of the consolidated 

financial statements, whether due to fraud or error, design and perform audit 
procedures responsive to those risks, and obtain audit evidence that is sufficient 
and appropriate to provide a basis for our opinion. The risk of not detecting a 
material misstatement resulting from fraud is higher than for one resulting 
from error, as fraud may involve collusion, forgery, intentional omissions, 
misrepresentations, or the override of internal control.

•  Obtain an understanding of internal control relevant to the audit in order to 

design audit procedures that are appropriate in the circumstances, but not for 
the purpose of expressing an opinion on the effectiveness of the Group’s internal 
control.

•  Evaluate the appropriateness of accounting policies used and the reasonableness 

of accounting estimates and related disclosures made by management.

•  Conclude on the appropriateness of management’s use of the going concern 

basis of accounting and, based on the audit evidence obtained, whether 
a material uncertainty exists related to events or conditions that may cast 
significant doubt on the Group’s ability to continue as a going concern. If we 
conclude that a material uncertainty exists, we are required to draw attention 
in our auditor’s report to the related disclosures in the consolidated financial 
statements or, if such disclosures are inadequate, to modify our opinion. Our 
conclusions are based on the audit evidence obtained up to the date of our 

•  Evaluate the overall presentation, structure, and content of the consolidated 

financial statements, including the disclosures, and whether the consolidated 
financial statements represent the underlying transactions and events in a 
manner that achieves fair presentation.

•  Obtain sufficient appropriate audit evidence regarding the financial information 
of the entities or business activities within the Group to express an opinion on 
the consolidated financial statements. We are responsible for the direction, 
supervision and performance of the Group audit. We remain solely responsible 
for our audit opinion.

We communicate with those charged with governance regarding, among other 
matters, the planned scope and timing of the audit and significant audit findings, 
including any significant deficiencies in internal control that we identify during our 
audit.

We also provide those charged with governance with a statement that we have 
complied with relevant ethical requirements regarding independence, and to 
communicate with them all relationships and other matters that may reasonably be 
thought to bear on our independence, and where applicable, related safeguards.

The engagement partner on the audit resulting in this independent auditor’s report 
is Tanis Petreny.

Winnipeg, Canada 
March 24, 2020

Chartered Professional Accountants

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

44

 
 
 
 
 
 
 
 
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Income taxes payable

[IN THOUSANDS O F CANADIAN  DO LL ARS]

Assets [note 20]

Current assets

Cash and cash equivalents [note 29]

Cash held in trust and restricted cash [notes 6 and 7]

Accounts receivable [note 8]

Inventory [note 9]

Prepaid expenses and other assets

Current portion of note receivable

Derivative instruments [note 30]

Income taxes recoverable

Non-current assets

Property, plant and equipment, net [note 10]

Right-of-use assets, net [note 11]

Goodwill [note 12]

Intangible assets, net [note 13]

Investment in associate [note 15[b]]

Equity investment [note 15[a]]

Non-current accounts receivable [note 8]

Note receivable

Deferred tax asset [note 27]

Assets held for sale [note 16]

Total assets

Liabilities and shareholders’ equity

Current liabilities

Current portion of convertible unsecured subordinated debentures [note 21]

74,298

50,708

AS AT DECEMBER 31

2019
$

2018
$

48,421

33,610

5,416

2,955

162,543

134,239

174,356

190,887

34,333

26,031

97

5,865

7,425

85

7,649

4,344

438,456

399,800

363,678

332,645

9,353

—

351,573

256,619

264,858

233,199

17,312

—

—

900

16,182

8,122

525

—

650

455

1,023,481

832,590

1,043

1,169

Current portion of due to vendor [note 6]

Current portion of contingent consideration [note 6]

Current portion of obligations under finance lease

Current portion of lease liability [note 19]

Current portion of long-term debt [note 20]

Provisions [note 18]

Non-current liabilities

Other financial liabilities [note 26]

Due to vendor [note 6]

Contingent consideration [note 6]

Optionally convertible redeemable preferred shares [note 6]

Obligations under finance lease

Lease liability [note 19]

Long-term debt [note 20]

Convertible unsecured subordinated debentures [note 21]

Senior unsecured subordinated debentures [note 22]

Deferred tax liability [note 27]

Total liabilities

Shareholders’ equity [note 23]

Common shares

Accumulated other comprehensive income

Equity component of convertible debentures

Contributed surplus

1,462,980

1,233,559

Deficit

Total shareholders’ equity

Total liabilities and shareholders’ equity

2,010

4,541

5,270

—

2,562

693

4,286

7,973

4,552

65

—

289

17,539

7,685

255,606

228,676

484

3,829

—

26,320

—

6,787

85

1,376

1,834

—

165

—

392,435

271,132

164,535

234,140

165,474

—

74,115

61,952

833,979

570,684

1,089,585

799,360

455,857

450,645

22,375

57,324

6,707

8,203

27,113

26,045

(138,657)

(108,018)

373,395

434,199

1,462,980

1,233,559

Accounts payable and accrued liabilities [note 17]

105,378

101,504

See accompanying notes

Customer deposits

Dividends payable

39,583

47,941

3,732

3,673

On behalf of the Board of Directors:

B IL L LA MBERT 
Director

DAVID  A . WHITE, CA, ICD.D 
Director

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

4545

 
 
 
 
 
 
 
 
CONSOLIDATED STATEMENTS OF INCOME

CONSOLIDATED STATEMENTS OF COMPREHENSIVE   
INCOME (LOSS)

[IN THOUSANDS O F  CANADIAN  DO LL ARS,   
EXCE PT PER  SHARE AM OUNTS]

YEARS ENDED DECEMBER 31

2019
$

2018
$

[IN THOUSANDS  OF  CANADIAN  DOLLARS ]

Sales

995,787

931,664

Profit for the year

Cost of goods sold [note 25[d]]

728,047

663,505

Other comprehensive (loss) income

267,740

268,159

Items that may be reclassified subsequently to profit or loss

YEARS ENDED DECEMBER 31

2019
$

14,633

—

—

—

(34,080)

(34,080)

(900)

43

(12)

(869)

2018
$

26,618

1,025

(2,785)

477

28,799

27,516

—

233

(63)

170

Change in fair value of derivatives designated as cash flow hedges

Gains on derivatives designated as cash flow hedges recognized  
in net earnings in the year

Income tax effect on cash flow hedges

Exchange differences on translation of foreign operations

Items that will not be reclassified to profit or loss

Change in the fair value of equity investment

Actuarial gains on defined benefit plan

Income tax effect on defined benefit plan

Other comprehensive income (loss) for the year

Total comprehensive income (loss) for the year

(34,949)

(20,316)

27,686

54,304

See accompanying notes

Gross profit

Expenses (income)

Selling, general and administrative [note 25[e]]

211,113

175,914

Other operating income [note 25[a]]

Impairment charge [notes 10 and 16]

Finance costs [note 25[c]]

Finance expense (income) [note 25[b]]

Share of associate’s net loss [note 15[b]]

Profit before income taxes

Income tax expense (recovery) [note 27]

Current

Deferred

Profit for the year

Profit per share [note 28]

Basic

Diluted

See accompanying notes

(2,238)

233

44,793

(6,917)

2,352

(21)

232

37,067

16,403

—

249,336

229,595

18,404

38,564

5,521

(1,750)

3,771

14,633

0.79

0.77

10,517

1,429

11,946

26,618

1.58

1.56

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

46

 
 
 
 
 
 
 
 
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

[IN THOUSANDS O F CANADIAN  DO LL ARS]

As at January 1, 2019

Profit for the year

Other comprehensive income (loss)

Share-based payment transactions  
[notes 23[a]] and 23[b]]

Dividends paid to shareholders [note 23[d]]

Dividends on share-based compensation  
awards [note 23[d]]

Conversion of convertible unsecured  
subordinated debentures [note 21]

Redemption of convertible unsecured  
subordinated debentures [note 21]

Common
Shares
$

450,645

—

—

5,187

—

—

25

—

Equity  
component of 
 convertible  
debentures
$

Contributed 
surplus
$

Deficit
$

Foreign 
currency 
reserve
$

Equity 
investment
$

Defined 
benefit 
plan reserve
$

Total 
shareholders’ 
equity
$

8,203

26,045

(108,018)

57,417

—

—

—

—

—

—

—

—

(82)

—

—

—

(1,496)

1,150

—

—

14,633

—

—

—

(44,705)

(567)

—

—

(34,080)

(900)

—

—

—

—

—

—

—

—

—

—

(93)

434,199

—

31

—

—

—

—

—

14,633

(34,949)

5,105

(44,705)

(567)

25

(346)

As at December 31, 2019

455,857

6,707

27,113

(138,657)

23,337

(900)

(62)

373,395

See accompanying notes

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

4747

 
 
 
 
 
 
 
 
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

[IN THOUSANDS O F  CANADIAN  DO LL ARS]

As at January 1, 2018

Profit for the year

Other comprehensive income (loss)

Share-based payment transactions
[notes 23[a]] and 23[b]]

Dividend reinvestment plan [note 23[d]]

Dividends to shareholders [note 23[d]]

Dividends on share-based compensation  
awards [note 23[d]]

Common
Shares
$

323,199

—

—

5,820

1,384

—

—

Common share issuance [note 23[a]]

111,564

Equity  
component of 
 convertible  
debentures
$

Contributed 
surplus
$

Deficit
$

Cash flow  
hedge  
reserve
$

Foreign 
currency 
reserve
$

Defined 
benefit 
plan reserve
$

Total 
shareholders’ 
equity
$

9,903

20,956

(92,842)

1,283

28,618

(263)

290,854

26,618

—

—

(1,283)

28,799

—

—

—

—

—

—

—

—

—

1,956

—

—

—

—

—

—

—

—

—

(40,650)

(1,144)

—

—

—

—

—

170

—

—

—

—

—

—

—

—

26,618

27,686

7,776

1,384

(40,650)

(1,144)

111,564

1,433

8,678

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

Issuance of convertible unsecured
subordinated debentures [note 21]

Conversion of convertible unsecured
subordinated debentures [note 21]

Redemption of convertible unsecured
subordinated debentures [note 21]

—

8,678

1,433

—

—

(3,133)

3,133

As at December 31, 2018

450,645

8,203

26,045

(108,018)

See accompanying notes

57,417

(93)

434,199

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

48

 
 
 
 
 
 
 
 
CONSOLIDATED STATEMENTS OF CASH FLOWS

[IN THOUSANDS O F CANADIAN  DO LL ARS]

Operating activities

Profit before income taxes

Add (deduct) items not affecting cash

Depreciation of property, plant and equipment

Depreciation of right-of-use assets

Amortization of intangible assets

Loss on sale of property, plant and equipment

Gain on disposal of assets held for sale [note 16]

Impairment charge [notes 10 and 16]

Share of associate’s net loss

Gain on redemption of convertible debenture

Non-cash component of interest expense

Non-cash movement in derivative instruments

Non-cash investment tax credits

Share-based compensation expense

Employer contribution to defined benefit plan

Defined benefit plan expense

Contingent consideration

Equipment provided to vendor

YEARS ENDED DECEMBER 31

Investing activities

2019
$

2018
$

Acquisition of property, plant and equipment

Acquisitions, net of cash acquired [note 6]

18,404

38,564

Investment in associate

Transfer from restricted cash

22,431

3,027

22,730

260

—

233

2,352

(55)

6,485

1,793

(226)

5,968

(27)

131

7,267

—

19,200

—

13,831

193

(8)

232

—

—

6,206

2,061

—

8,004

—

135

4,284

(115)

27,771

Proceeds from sale of property, plant and equipment

Proceeds from sale of assets held for sale [note 16]

Development and purchase of intangible assets

Transaction costs paid and payable

Cash used in investing activities

Financing activities

Repayment of obligation under lease liabilities

Repayment of obligation under finance lease

Change in obligation under finance lease

Change in interest accrued

Issuance of senior unsecured subordinated debentures,  
net of issuance costs

Issuance of convertible unsecured subordinated debentures,  
net of issuance costs

Redemption of convertible unsecured subordinated  
debentures [note 21]

Common share issuance, net of issuance costs

Translation loss (gain) on foreign exchange

(16,262)

Net change in non-cash working capital balances related  
to operations [note 29]

Non-current accounts receivable

Long-term payables

Settlement of EIAP obligation

Income taxes paid

Cash provided by operating activities

74,511

120,358

Dividends paid in cash [note 23[d]]

(13,585)

(63,017)

Cash provided by financing activities

(8,060)

—

(2,553)

(9,894)

40,419

Net increase (decrease) in cash and cash equivalents  
during the year

Cash and cash equivalents, beginning of year

Cash and cash equivalents, end of year

(3,942)

(280)

(1,953)

(9,975)

41,191

Supplemental cash flow information

Interest paid

See accompanying notes

(48,539)

(36,549)

(112,619)

(50,266)

(19,720)

(3,274)

792

—

(13,257)

(26,517)

—

(784)

952

2,427

(7,397)

2,982

(223,134)

(88,635)

(2,674)

—

—

464

—

(1,064)

192

(7,522)

165,402

—

—

82,293

(51,786)

(77,477)

—

110,670

(44,646)

(39,266)

197,526

17,073

14,811

(30,371)

33,610

48,421

63,981

33,610

37,442

36,393

Issuance of long-term debt, net of issuance costs [note 20[b]]

203,329

165,098

Repayment of long-term debt

(72,563)

(215,851)

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

4949

 
 
 
 
 
 
 
 
AUTOMATE FOR EFFICIENCY

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

50

 
 
 
 
 
 
 
 
S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

515151

 
 
 
 
 
 
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

[in thousands of Canadian dollars, except where otherwise noted  
and per share data] 

December 31, 2019

1. Organization

The consolidated financial statements of Ag Growth International Inc. [“AGI” or the 
“Company”] for the year ended December 31, 2019 were authorized for issuance 
in accordance with a resolution of the directors on March 24, 2020. AGI is a listed 
company incorporated and domiciled in Canada, whose shares are publicly traded 
on the Toronto Stock Exchange. The registered office is located at 198 Commerce 
Drive, Winnipeg, Manitoba, Canada.

2. Operations

AGI is a provider of solutions for the global food infrastructure, including seed, 
fertilizer, grain, rice, feed, and food processing systems. AGI has manufacturing 
facilities in Canada, the United States, the United Kingdom, Brazil, Italy, France, and 
India and distributes its product globally.

Included in these consolidated financial statements are the accounts of AGI and all 
its subsidiaries and incorporated companies [together, Ag Growth International Inc. 
and its subsidiaries are referred to as “AGI” or the “Company”].

3. Summary of significant accounting policies

Statement of compliance

These consolidated financial statements have been prepared in accordance with 
International Financial Reporting Standards [“IFRS”] as issued by the International 
Accounting Standards Board [“IASB”].

Basis of preparation

The consolidated financial statements are presented in Canadian dollars, which is 
also the functional currency of the parent company, Ag Growth International Inc. 
All values are rounded to the nearest thousand. They are prepared on the historical 
cost basis, except for derivative financial instruments, assets held for sale, equity 
investments, and contingent consideration resulting from business combinations, 
which are measured at fair value.

The accounting policies set out below have been applied consistently to all periods 
presented in these consolidated financial statements.

Principles of consolidation

The consolidated financial statements include the accounts of Ag Growth 
International Inc. and its subsidiaries, Ag Growth Holdings Corp., AGI Alpha 
Holdings Corp., AGI Bravo Holdings Corp., AGI Charlie Holdings Corp., AGI 
Solutions Inc., AGI France Agricultural Equipment S.A.S., AGI Agricultural Equipment 
Proprietary Limited, Ag Growth International Australia PTY Ltd., Westfield 
Distributing (North Dakota) Inc., Hansen Manufacturing Corp. [“Hi Roller”], 
Improtech Ltd., Union Iron Inc. [“Union Iron”], Airlanco Inc. [“Airlanco”], Tramco, 
Inc. [“Tramco”], Tramco Europe Limited, Euro-Tramco B.V., AGI Netherlands B.V., 
Ag Growth Suomi Oy, Ag Growth Scandinavia, AGI Comercio de Equipamentos E 
Montagens Ltda, AGI EMEA S.R.L., AGI Brasil Industria e Comercio S.A., Mitchell 
Mill Systems USA Inc., Yargus Manufacturing, Inc., Global Industries, Inc., CMC 
Industrial Electronics Ltd., CMC Industrial Electronics USA, Inc. Junge Control 
Inc., Danmare Group Inc. and its affiliate Danmare, Inc. [collectively, “Danmare”], 
Sabe S.A.S., Z-AGI Agricultural Equipment (India) Private Limited, Milltec Machinery 
Limited, and AGI Suretrack LLC as at December 31, 2019. Subsidiaries are fully 
consolidated from the date of acquisition, it being the date on which AGI obtains 
control, and continue to be consolidated until the date that such control ceases. The 
financial statements of the subsidiaries are prepared for the same reporting period 
as the Company, using consistent accounting policies. All intercompany balances, 
income and expenses and unrealized gains and losses resulting from intercompany 
transactions are eliminated in full.

Business combinations and goodwill

Business combinations are accounted for using the acquisition method. The 
cost of an acquisition is measured as the fair value of the assets given, equity 
instruments and liabilities incurred or assumed at the date of exchange. Acquisition 
costs for business combinations are expensed and included in selling, general and 
administrative expenses. Identifiable assets acquired and liabilities and contingent 
liabilities assumed in a business combination are measured initially at fair values at 
the date of acquisition.

Goodwill is initially measured at cost, being the excess of the cost of the business 
combination over AGI’s share in the net fair value of the acquiree’s identifiable 
assets, liabilities and contingent liabilities. Any negative difference is recognized 

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

52

 
 
 
 
 
 
 
 
 
directly in the consolidated statements of income. If the fair values of the assets, 
liabilities and contingent liabilities can only be calculated on a provisional basis, 
the business combination is recognized using provisional values. Any adjustments 
resulting from the completion of the measurement process are recognized within 
12 months of the date of acquisition [“measurement period”].

statements of income are translated at the monthly rates of exchange. 
The exchange differences arising on the translation are recognized in other 
comprehensive income [“OCI”]. On disposal of a foreign operation, the component 
of OCI relating to that particular foreign operation is reclassified to the consolidated 
statements of income when the gain or loss on disposal is recognized.

After initial recognition, goodwill is measured at cost less any accumulated 
impairment losses. For the purpose of impairment testing, goodwill acquired in a 
business combination is, from the acquisition date, allocated to each of AGI’s cash-
generating units or groups of cash-generating units [“CGUs”] that are expected 
to benefit from the synergies of the combination, irrespective of whether other 
assets and liabilities of the acquiree are assigned to those CGUs. Where goodwill 
forms part of a CGU or group of CGUs and part of the operating unit is disposed 
of, the goodwill associated with the operation disposed of is included in the 
carrying amount of the operation when determining the gain or loss on disposal of 
operation. If the Company reorganizes its reporting structure in a way that changes 
the composition of one or more CGUs or group of CGUs to which goodwill has 
been allocated, the goodwill is reallocated to the units affected. Goodwill disposed 
of or reallocated in these cases is measured based on the relative values of the 
operation disposed of and the portion of the CGU retained, or the relative fair value 
of the part of a CGU allocated to a new CGU compared to the part remaining in the 
old organizational structure.

Foreign currency translation

Each entity in AGI determines its own functional currency, and items included in the 
financial statements of each entity are measured using that functional currency.

Transactions in foreign currencies are initially recorded by AGI entities at their 
respective functional currency rates prevailing at the date of the transaction.

Monetary items are translated at the functional currency spot rate as of the 
reporting date. Exchange differences from monetary items are recognized in the 
consolidated statements of income. Non-monetary items that are not carried 
at fair value are translated using the exchange rates as at the dates of the initial 
transaction. Non-monetary items measured at fair value in a foreign currency are 
translated using the exchange rates at the date when the fair value is determined.

The assets and liabilities of foreign operations are translated into Canadian dollars 
at the rate of exchange prevailing at the reporting date and their consolidated 

Any goodwill arising on the acquisition of a foreign operation and any fair value 
adjustments to the carrying amounts of assets and liabilities arising on the 
acquisition are treated as assets and liabilities of the foreign operation and 
translated at the rate of exchange prevailing at the reporting date.

Cash and cash equivalents

All highly liquid temporary cash investments with an original maturity of three 
months or less when purchased are considered to be cash equivalents. For the 
purpose of the consolidated statements of cash flows, cash and cash equivalents 
consist of cash, net of outstanding bank overdrafts.

Inventory

Inventory comprises raw materials and finished goods. Inventory is valued at the 
lower of cost and net realizable value, at average cost. For finished goods, costs 
include all direct costs incurred in production, including direct labour and materials, 
freight, directly attributable manufacturing overhead costs based on normal 
operating capacity and property, plant and equipment depreciation.

Inventories are written down to net realizable value when the cost of inventories is 
estimated to be unrecoverable due to obsolescence, damage or declining selling 
prices. Net realizable value is the estimated selling price in the ordinary course of 
business, less estimated costs of completion and the estimated costs necessary 
to make the sale. When the circumstances that previously caused inventories to 
be written down below cost no longer exist, or when there is clear evidence of 
an increase in selling prices, the amount of the write-down previously recorded is 
reversed.

Property, plant and equipment

Property, plant and equipment are stated at cost, net of any accumulated 
depreciation and any impairment losses determined. Cost includes the purchase 
price, any costs directly attributable to bringing the asset to the location and 

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

5353

 
 
 
 
 
 
 
 
condition necessary and, where relevant, the present value of all dismantling and 
removal costs. Where major components of property, plant and equipment have 
different useful lives, the components are recognized and depreciated separately. 
AGI recognizes in the carrying amount of an item of property, plant and equipment 
the cost of replacing part of such an item when the cost is incurred, and if it 
is probable that the future economic benefits embodied with the item can be 
reliably measured. All other repair and maintenance costs are recognized in the 
consolidated statements of income as an expense when incurred.

Depreciation is calculated on a straight-line basis over the estimated useful lives of 
the assets as follows:

Buildings and building components  
Manufacturing equipment  
Computer hardware  
Leasehold improvements  
Furniture and fixtures  
Vehicles    

20 – 60 years 
10 – 20 years 
5 years 
Over the lease period 
5 – 10 years 
4 – 16 years

An item of property, plant and equipment and any significant part initially 
recognized, is derecognized upon disposal or when no future economic benefits 
are expected from its use or disposal. Any gain or loss arising on derecognition of 
the asset is included in the consolidated statements of income when the asset is 
derecognized.

The assets’ useful lives and methods of depreciation of assets are reviewed at 
each financial year-end, and adjusted prospectively, if appropriate. No depreciation 
is taken on construction in progress until the asset is placed in use. Amounts 
representing direct costs incurred for major overhauls are capitalized and 
depreciated over the estimated useful lives of the different components replaced.

Leases

Company assesses whether:

•  The contract involves the use of an identified asset, which may be specified 

explicitly or implicitly, and should be physically distinct or represent substantially 
all of the capacity of a physically distinct asset. If the supplier has a substantive 
substitution right, then the asset is not identified;

•  The Company has the right to obtain substantially all of the economic benefits 

from use of the asset throughout the period of use; and

•  The Company has the right to direct the use of the asset. The Company has this 
right when it has the decision-making rights that are most relevant to changing 
how and for what purpose the asset is used.

At inception or on reassessment of a contract that contains a lease component, 
the consideration in the contract is allocated to each lease component on the basis 
of their relative stand-alone prices. For leases of land and buildings, the lease and 
non-lease components are accounted for as a single lease component as permitted 
within IFRS 16.

The Company recognizes a right-of-use asset and a lease liability at the lease 
commencement date. The right-of-use asset is initially measured at cost, which 
comprises the initial amount of the lease liability adjusted for any lease payments 
made at or before the commencement date, plus any initial direct costs incurred 
and an estimate of costs to dismantle and remove the underlying asset or to 
restore the underlying asset or the site on which it is located, less any lease 
incentives received.

The right-of-use asset is subsequently depreciated using the straight-line method 
from the commencement date to the earlier of the useful life of the right-of-use 
asset or the end of the lease term. The estimated useful lives of right-of-use assets 
are determined on the same basis as those of property, plant, and equipment.

Effective January 1, 2019, the Company adopted IFRS 16 and the following are the 
policies for leases:

At inception of a contract, AGI assesses whether a contract is, or contains, a lease. 
A contract is, or contains, a lease if the contract conveys the right to control the use 
of an identified asset for a period of time in exchange for consideration. To assess 
whether a contract conveys the right to control the use of an identified asset, the 

The lease liability is initially measured at the present value of the lease payments 
that are not paid at the commencement date, discounted using the interest rate 
implicit in the lease or, if that rate cannot be readily determined, the Company’s 
incremental borrowing rate.

After the commencement date, the amount of lease liabilities is increased to 
reflect the accretion of interest and reduced for the lease payments made. It is 

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

54

 
 
 
 
 
 
 
 
 
 
 
 
 
 
remeasured when there is a change in future lease payments arising from a change 
in rates, the amount expected to be payable under a residual value guarantee, 
or the Company’s assessment of whether it will exercise a purchase, extension 
or termination option. Upon remeasurement of a lease liability, a corresponding 
adjustment is made to the carrying amount of the right-of-use asset or is recorded 
in profit or loss if the carrying amount of the right-of-use asset has been reduced to 
zero.

Borrowing costs

Borrowing costs directly attributable to the acquisition, construction or production 
of an asset that necessarily takes a substantial period of time, which AGI considers 
to be 12 months or more, to get ready for its intended use or sale are capitalized as 
part of the cost of the respective assets. All other borrowing costs are expensed in 
the period they occur.

For short-term leases [12 months or less] and leases of low-value assets, the 
Company recognizes the lease payments associated with these leases as an 
expense on a straight-line basis over the lease term.

This policy is applied to contracts entered into, or changed, on or after January 1, 
2019.

Prior to January 1, 2019, the Company’s policies under IAS 17 were as follows:

The determination of whether an arrangement is, or contains, a lease is based on 
whether fulfilment of the arrangement is dependent on the use of a specific asset 
or assets, or the arrangement conveys a right to use the asset.

Finance leases, which transfer to AGI substantially all the risks and benefits 
incidental to ownership of the leased item, are capitalized at the commencement of 
the lease at the fair value of the leased property or, if lower, at the present value of 
the minimum lease payments. Lease payments are apportioned between finance 
charges and reduction of the lease liability so as to achieve a constant rate of 
interest on the remaining balance of the liability. Finance charges are recognized in 
finance costs in the consolidated statements of income (loss).

Leased assets are depreciated over the useful life of the asset. However, if there is 
no reasonable certainty that AGI will obtain ownership by the end of the lease term, 
the asset is depreciated over the shorter of the estimated useful life of the asset 
and the lease term.

Operating lease payments are recognized as an expense in selling, general and 
administrative expense in the consolidated statements of income on a straight-line 
basis over the lease term.

Intangible assets

Intangible assets acquired separately are measured on initial recognition at cost. 
The cost of intangible assets acquired in a business combination is its fair value at 
the date of acquisition. Following initial recognition, intangible assets are carried at 
cost less any accumulated amortization and any accumulated impairment losses. 
The useful lives of intangible assets are assessed as either finite or indefinite. 
Intangible assets with finite useful lives are amortized over the useful economic 
life and assessed for impairment whenever there is an indication that the intangible 
asset may be impaired. The amortization method and amortization period of an 
intangible asset with a finite useful life are reviewed at least annually. Changes in 
the expected useful life or the expected pattern of consumption of future economic 
benefits embodied in the asset are accounted for by changing the amortization 
period or method, as appropriate, and are treated as changes in accounting 
estimates. The amortization expense on intangible assets with finite lives is 
recognized in the consolidated statements of income in the expense category 
consistent with the function of the intangible assets.

Intangible assets with indefinite useful lives, which include brand names, are not 
amortized, but are tested for impairment annually, either individually or at the CGU 
level. The assessment of indefinite life is reviewed annually to determine whether 
the indefinite life continues to be supportable. If not, the change in useful life from 
indefinite to finite is made on a prospective basis.

Internally generated intangible assets are capitalized when the product or 
process is technically and commercially feasible and AGI has sufficient resources 
to complete development. The cost of an internally generated intangible asset 
comprises all directly attributable costs necessary to create, produce and prepare 
the asset to be capable of operating in the manner intended by management. 
Expenditures incurred to develop new demos and prototypes are recorded at cost 
as internally generated intangible assets. Amortization of the internally generated 
intangible assets begins when the development is complete and the asset is 
available for use and it is amortized over the period of expected future benefit. 

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

5555

 
 
 
 
 
 
 
 
Amortization is recorded in cost of goods sold. During the period of development, 
the asset is tested for impairment at least annually.

Finite-life intangible assets are amortized on a straight-line basis over the estimated 
useful lives of the related assets as follows:

Patents  
Distribution networks and customer relationships    
Development projects  
Order backlog  
Non-compete agreement  
Software   

4 – 10 years 
8 – 25 years 
3 – 15 years 
3 – 6 months 
7 years 
5 – 8 years

Gains or losses arising from derecognition of an intangible asset are measured 
as the difference between the net disposal proceeds and the carrying amount of 
the asset, and are recognized in the consolidated statements of income when the 
asset is derecognized.

Investments in associates

An associate is an entity over which the Company has significant influence. 
Significant influence is the power to participate in the financial and operating policy 
decisions of the investee but is not control or joint control over those policies. 
The considerations made in determining significant influence are similar to those 
necessary to determine control over subsidiaries.

AGI’s investment in its associate is accounted for using the equity method. Under 
the equity method, the investment in an associate is initially recognized at cost. 
The carrying amount of the investment is adjusted to recognize changes in the 
Company’s share of net assets of the associate since the acquisition date. Goodwill 
relating to the associate is included in the carrying amount of the investment and is 
not tested for impairment separately.

The consolidated statements of income reflect the Company’s share of the results 
of operations of the associate. Any change in OCI of the associate is presented as 
part of AGI’s OCI. In addition, when there has been a change recognized directly 
in the equity of the associate, the Company recognizes its share of any changes, 
when applicable, in the consolidated statements of changes in shareholders’ 
equity. Unrealized gains and losses resulting from transactions between AGI and 
the associate are eliminated to the extent of the interest in the associate. The 

aggregate of the Company’s share of profit or loss of an associate is shown on the 
face of the consolidated statements of income and represents profit or loss after 
tax and non-controlling interests in the subsidiaries of the associate.

The financial statements of the associate are prepared for the same reporting 
period as the Company. When necessary, adjustments are made to bring the 
accounting policies in line with those of AGI.

After application of the equity method, the Company determines whether it is 
necessary to recognize an impairment loss on its investment in its associate. At 
each reporting date, the Company determines whether there is objective evidence 
that the investment in the associate is impaired. If there is such evidence, the 
Company calculates the amount of impairment as the difference between the 
recoverable amount of the associate and its carrying value, and then recognizes the 
loss within share of associate’s net income (loss) in the consolidated statements of 
income.

Upon loss of significant influence over the associate, the Company measures and 
recognizes any retained investment at its fair value. Any difference between the 
carrying amount of the associate upon loss of significant influence and the fair 
value of the retained investment and proceeds from disposal is recognized in profit 
or loss.

Impairment of non-financial assets

AGI assesses at each reporting date whether there is an indication that an asset 
may be impaired. If such an indication exists, or when annual testing for an asset is 
required, AGI estimates the asset’s recoverable amount. The recoverable amount of 
goodwill as well as intangible assets not yet available for use is estimated at least 
annually on December 31. The recoverable amount is the higher of an asset’s or 
CGU group’s fair value less costs to sell and its value in use.

Value in use is determined by discounting estimated future cash flows using a 
pre-tax discount rate that reflects the current market assessment of the time 
value of money and the specific risks of the asset. In determining fair value less 
costs to sell, recent market transactions are taken into account, if available. If no 
such transactions can be identified, an appropriate valuation model is used. The 
recoverable amount of assets that do not generate independent cash flows is 
determined based on the CGU group to which the asset belongs.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

56

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

5757

MANAGE WITH
CERTAINTY

 
 
 
 
 
 
 
 
S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

5858

 
 
 
 
 
 
 
 
AGI bases its impairment calculation on detailed budgets and forecast calculations 
that are prepared separately for each of AGI’s CGU groups to which the individual 
assets are allocated. These budgets and forecast calculations generally cover a 
period of five years. For periods after five years, a terminal value approach is used.

An impairment loss is recognized in the consolidated statements of income if an 
asset’s carrying amount or that of the CGU group to which it is allocated is higher 
than its recoverable amount. Impairment losses of a CGU group are first charged 
against the carrying value of the goodwill balance included in the CGU group and 
then against the value of the other assets, in proportion to their carrying amount. 
In the consolidated statements of income, the impairment losses are recognized in 
those expense categories consistent with the function of the impaired asset.

Company’s business model for managing the financial assets and the contractual 
cash flow characteristics of the financial assets. Certain derivatives are designated 
as hedging instruments and hedge accounting is applied, as appropriate.

All financial instruments are recognized initially at fair value plus, in the case 
of instruments not at FVTPL, directly attributable transaction costs. Financial 
instruments are recognized on the trade date, which is the date on which AGI 
commits to purchase or sell the asset. Accounts receivable that do not contain a 
significant financing component or for which the Company has applied the practical 
expedient are measured at the transaction price determined under IFRS 15.

Amortized cost

For assets other than goodwill, an assessment is made at each reporting date 
as to whether there is any indication that previously recognized impairment 
losses may no longer exist or may have decreased. If such indication exists, AGI 
estimates the asset’s or CGU group’s recoverable amount. A previously recognized 
impairment loss is reversed only if there has been a change in the assumptions 
used to determine the asset’s recoverable amount since the last impairment loss 
was recognized. The reversal is limited so that the carrying amount of the asset 
does not exceed its recoverable amount, nor exceed the carrying amount that 
would have been determined, net of depreciation, had no impairment loss been 
recognized for the asset or CGU group in prior years. Such a reversal is recognized 
in the consolidated statements of income.

Financial assets are measured at amortized cost if [i] the financial asset is held 
within a business model whose objective is to hold financial assets in order to 
collect contractual cash flows, and [ii] the contractual terms of the financial asset 
give rise on specified dates to cash flows that are solely payments of principal 
and interest on the principal of amount outstanding. Assets in this category 
include cash and cash equivalents, cash held in trust and restricted cash, accounts 
receivable and note receivable and are measured at amortized cost using the 
effective interest method less any impairment. The effective interest amortization 
is included in finance costs in the consolidated statements of income. The losses 
arising from impairment are recognized in the consolidated statements of income 
in finance costs.

Goodwill is tested for impairment annually as at December 31 and when 
circumstances indicate that the carrying value may be impaired. Impairment is 
determined for goodwill by assessing the recoverable amount of each CGU group 
to which the goodwill relates. Where the recoverable amount of the CGU group is 
less than its carrying amount, an impairment loss is recognized. Impairment losses 
relating to goodwill cannot be reversed in future periods.

Intangible assets with indefinite useful lives are tested for impairment annually as 
at December 31, either individually or at the CGU group level, as appropriate, and 
when circumstances indicate that the carrying value may be impaired.

Financial instruments

Financial assets

AGI classifies its financial assets as [i] amortized cost, [ii] financial assets at fair 
value through profit or loss [“FVTPL”] or [iii] fair value through other comprehensive 
income [“FVTOCI”]. Appropriate classification of financial assets is based on the 

Fair value through other comprehensive income (debt securities)

Debt securities are measured at FVTOCI if [i] the financial asset is held within a 
business model whose object is achieved by both collecting contractual cash flows 
and selling financial assets and [ii] the contractual terms of the financial assets 
give rise on specified dates to cash flows that are solely payments of principal and 
interest on the principal amount outstanding. The Company does not hold any debt 
securities measured at FVTOCI.

Fair value through other comprehensive income (equity investments)

Upon initial recognition, the Company can elect to classify irrevocably its equity 
investments as equity instruments designated at FVTOCI when they meet the 
definition of equity under IAS 32, Financial Instruments: Presentation and are not 
held for trading. The classification is determined on an instrument-by-instrument 
basis.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

5959

 
 
 
 
 
 
 
 
Gains and losses on these financial assets are never recycled to profit or loss. 
Dividends are recognized as other income in the consolidated statements of 
income when the right of payment has been established, except when the 
Company benefits from such proceeds as a recovery of part of the cost of the 
financial asset, in which case, such gains are recorded in OCI. Equity instruments 
designated at FVTOCI are not subject to impairment assessment. The Company 
elected to classify irrevocably its equity investment under this category.

Financial assets at fair value through profit or loss

Financial assets are measured at FVTPL unless they are measured at amortized 
cost or at FVTOCI. Assets in this category include financial assets designated upon 
initial recognition at FVTPL and derivative instruments entered into that are not 
designated as hedging instruments in hedge relationships as defined by IFRS 9. 
Financial assets at FVTPL are carried in the consolidated statements of financial 
position at fair value, with changes in the fair value recognized in finance income or 
finance costs in the consolidated statements of income.

An embedded derivative is a component of a hybrid contract that also includes 
a non-derivative host, with the effect that some of the cash of the combined 
instrument varies in a way similar to a stand-alone derivative. Derivatives embedded 
in a financial asset within the scope of IFRS 9 are assessed in their entirety, and the 
asset as whole is measured at FVTPL. Derivatives embedded in host contracts are 
accounted for as separate derivatives and recorded at fair value if the host asset is 
not within the scope of IFRS 9 [e.g., lease contracts]. These embedded derivatives 
are measured at fair value with changes in fair value recognized in the consolidated 
statements of income. Reassessment only occurs if there is a change in the terms 
of the contract that significantly modifies the cash flows that would otherwise be 
required.

Impairment

The Company recognizes an allowance for expected credit losses [“ECLs”] for 
debt instruments not held at fair value through profit or loss. ECLs are based on the 
difference between the contractual cash flows due in accordance with the contract 
and all the cash flows that the Company expects to receive, discounted at an 
approximation of the original effective interest rate.

Under the general approach, ECLs are recognized in two stages: [i] For credit 
exposures for which there has not been a significant increase in credit risk since 

initial recognition, ECLs are provided for credit losses that result from default 
events that are possible within the next 12-months. [ii] For those credit exposures 
for which there has been a significant increase in credit risk since initial recognition, 
a loss allowance is required for credit losses expected over the remaining life of the 
exposure, irrespective of the timing of the default [a lifetime ECL].

For accounts receivable, AGI applies a simplified approach in calculating ECLs. 
Therefore, the Company does not track changes in credit risk, but instead 
recognizes a loss allowance based on lifetime ECLs at each reporting date. The 
Company has established a provision matrix that is based on its historical credit 
loss experience, adjusted for forward-looking factors specific to the debtors and the 
economic environment.

The Company considers a financial asset in default when internal or external 
information indicates that the Company is unlikely to receive the outstanding 
contractual amounts in full before taking into account any credit enhancements 
held by the Company. A financial asset is written off when there is no reasonable 
expectation of recovering the contractual cash flows.

Financial liabilities

Financial liabilities are measured at amortized cost, using the effective interest rate 
method, except for financial liabilities designated at initial recognition at FVTPL and 
those required to be FVTPL. Liabilities measured at amortized cost include accounts 
payable and accrued liabilities, dividends payable, due to vendor, long-term debt, 
and convertible unsecured subordinated debentures. Long-term debt, convertible 
unsecured subordinated debentures, and senior unsecured subordinated 
debentures are initially measured at fair value, which is the consideration received, 
net of transaction costs incurred, net of the equity component, if any. Transaction 
costs related to those instruments are included in the value of the instruments and 
amortized using the effective interest rate method. The effective interest expense 
is included in finance costs in the consolidated statements of income. Financial 
liabilities measured at FVTPL include contingent consideration resulting from 
business combinations and derivative financial instruments entered into by the 
Company that are not designated as hedging instruments in hedge relationships as 
defined by IFRS 9.

AGI has not designated any financial liabilities upon initial recognition as FVTPL.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

60

 
 
 
 
 
 
 
 
Derecognition

A financial asset is derecognized when the contractual rights to receive cash flows 
from the asset have expired or when AGI has transferred its rights to receive cash 
flows from the asset.

A financial liability is derecognized when the obligation under the liability is 
discharged or cancelled or expires.

When an existing financial liability is replaced by another from the same lender on 
substantially different terms, or the terms of an existing liability are substantially 
modified, such an exchange or modification is treated as a derecognition of the 
original liability and the recognition of a new liability, and the difference in the 
respective carrying amounts is recognized in the consolidated statements of 
income.

Derivative financial instruments and hedge accounting

AGI uses derivative financial instruments such as forward currency contracts, 
interest rate swaps and equity swaps to hedge its foreign currency risk, interest 
rate risk and market risk. Such derivative financial instruments are initially 
recognized at fair value on the date on which a derivative contract is entered into 
and are subsequently remeasured at fair value. Derivatives are carried as financial 
assets when the fair value is positive and as financial liabilities when the fair value 
is negative.

AGI analyses all its contracts, of both a financial and non-financial nature, to identify 
the existence of any “embedded” derivatives. Any gains or losses arising from 
changes in the fair value of derivatives are recorded directly in the consolidated 
statements of income, except for the effective portion of cash flow hedges, which 
is recognized in OCI.

For the purpose of hedge accounting, hedges are classified as cash flow hedges 
when hedging exposure to variability in cash flows that is either attributable 
to a particular risk associated with a recognized asset or liability or a highly 
probable forecast transaction or the foreign currency risk in an unrecognized firm 
commitment.

The Company applies IFRS 9 for hedge accounting, whereby at the inception of a 
hedge relationship, AGI formally designates and documents the hedge relationship 

to which AGI wishes to apply hedge accounting and the risk management objective 
and strategy for undertaking the hedge. The documentation includes identification 
of the hedging instrument, the hedged item, the nature of the risk being hedged 
and how the Company will assess whether the hedging relationship meets the 
hedge effectiveness requirements (including the analysis of sources of hedge 
ineffectiveness and how the hedge ratio is determined).

A hedging relationship qualifies for hedge accounting if it meets all of the following 
effectiveness requirements:

•  There is “an economic relationship” between the hedged item and the hedging 

instrument.

•  The effect of credit risk does not “dominate the value changes” that result from 

that economic relationship.

•  The hedge ratio of the hedging relationship is the same as that resulting from the 
quantity of the hedged item that the Company actually hedges and the quantity 
of the hedging instrument that Company actually uses to hedge that quantity of 
hedged item.

Hedges that meet the strict criteria for hedge accounting are accounted for as 
follows:

Cash flow hedges

The effective portion of the gain or loss on the hedging instrument is recognized 
directly as other comprehensive income in the cash flow hedge reserve, while 
any ineffective portion is recognized immediately in the consolidated statements 
of income in other operating income or expenses. Amounts recognized as other 
comprehensive income are transferred to the consolidated statements of income 
when the hedged transaction affects profit or loss, such as when the hedged 
financial income or financial expense is recognized or when a forecast sale occurs.

If the forecast transaction or firm commitment is no longer expected to occur, 
the cumulative gain or loss previously recognized in equity is transferred to the 
consolidated statements of income. If the hedging instrument expires or is sold, 
terminated or exercised without replacement or rollover, or if its designation as 
a hedge is revoked, any cumulative gain or loss previously recognized in other 
comprehensive income remains in other comprehensive income until the forecast 
transaction or firm commitment affects profit or loss.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

6161

 
 
 
 
 
 
 
 
Offsetting of financial instruments

Profit per share

Financial assets and financial liabilities are offset and the net amount reported in 
the consolidated statements of financial position if, and only if, there is a currently 
enforceable legal right to offset the recognized amounts and there is an intention to 
settle on a net basis, or to realize the assets and settle the liabilities simultaneously.

The computation of profit per share is based on the weighted average number 
of shares outstanding during the period. Diluted profit per share is computed in 
a similar way to basic profit per share except that the weighted average shares 
outstanding are increased to include additional shares assuming the exercise of 
share options, share appreciation rights and convertible debt options, if dilutive.

Fair value of financial instruments

Fair value is the estimated amount that AGI would pay or receive to dispose of 
these contracts in an arm’s length transaction between knowledgeable, willing 
parties who are under no compulsion to act. The fair value of financial instruments 
that are traded in active markets at each reporting date is determined by reference 
to quoted market prices, without any deduction for transaction costs.

For financial instruments not traded in an active market, the fair value is determined 
using appropriate valuation techniques that are recognized by market participants. 
Such techniques may include using recent arm’s length market transactions, 
reference to the current fair value of another instrument that is substantially the 
same, discounted cash flow analysis or other valuation models.

Provisions

Provisions are recognized when AGI has a present obligation, legal or constructive, 
as a result of a past event, it is probable that an outflow of resources embodying 
economic benefits will be required to settle the obligation and a reliable 
estimate can be made of the amount of the obligation. Where AGI expects 
some or all of a provision to be reimbursed, for example under an insurance 
contract, the reimbursement is recognized as a separate asset but only when 
the reimbursement is virtually certain. The expense relating to any provision is 
presented in the consolidated statements of income, net of any reimbursement. If 
the effect of the time value of money is material, provisions are discounted using a 
current pre-tax rate that reflects, where appropriate, the risks specific to the liability. 
Where discounting is used, the increase in the provision due to the passage of time 
is recognized as a finance cost.

Warranty provisions

Provisions for warranty-related costs relate to assurance-type warranties and are 
recognized when the product is sold or service provided. Initial recognition is based 
on historical experience. The initial estimate of warranty-related costs is revised at 
each reporting period.

Revenue recognition

Sale of goods

Revenue from the sale of goods is primarily recognized at a point in time when 
the Company satisfies a performance obligation and control of the goods is 
transferred from seller to buyer. A performance obligation is a good or a series 
of goods that are distinct. A contract with various distinct goods is considered to 
have multiple performance obligations for which revenue is recognized as each 
performance obligation is satisfied. If a promised good is not distinct, the good is 
combined with other promised goods until a bundle of goods is distinct, resulting 
in accounting for all the goods promised in a contract as a single performance 
obligation. In determining satisfaction of the performance obligation and point of 
revenue recognition, the Company considers the terms of the underlying contracts 
including, but not limited to, shipping terms, transfer of title and risk of loss, and 
acceptance/performance testing. All costs incurred or to be incurred in connection 
with the sale, including assurance-type warranty costs and sales incentives, are 
charged to cost of sales or as a deduction from revenue at the time revenue is 
recognized. The Company does not provide service-type warranties.

Revenue from contracts with customers is recognized at an amount that reflects 
the consideration to which the Company is entitled to in exchange for those goods. 
The Company considers whether there are other promises in the contract that are 
separate performance obligations to which a portion of the transaction price needs 
to be allocated.

If the consideration in a contract includes a variable amount, the Company 
estimates the amount of consideration to which it will be entitled in exchange for 
transferring the goods to the customer. The variable consideration is estimated 
at contract inception and constrained until it is highly probable that a significant 
revenue reversal in the amount of cumulative revenue recognized will not occur 
when the associated uncertainty with the variable consideration is subsequently 
resolved.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

62

 
 
 
 
 
 
 
 
The Company applies the practical expedient for advances received from 
customers. That is, the promised amount of consideration is not adjusted for the 
effects of a significant financing component if the period between the transfer of 
the promised good or service and the payment is one year or less.

AGI applies bill and hold sales accounting in specific situations provided all the 
following conditions are met as of the reporting date: [i] there is a substantive 
reason for the arrangement; [ii] the goods are separately identified as belonging 
to the customer; [iii] AGI is no longer able to use the goods or direct the goods to 
another customer; and [iv] the goods are currently ready for physical transfer to the 
customer.

The sale of certain turn-key projects under the customer’s control can span over 
three to six months but collectively represents an insignificant portion of AGI’s 
total revenues. Revenue on these projects is recognized over-time progressively 
based on the percentage completion method by reference to costs incurred as a 
percentage of the total estimated costs. Payment terms are usually based on set 
milestones as outlined in the contract. Typically amounts are received in advance 
of work performed and are recorded as customer deposits. Contract assets 
representing revenue recognized prior to being invoiced are not material. Any 
foreseeable losses on such projects are recognized immediately in profit or loss as 
identified.

Contract liabilities include customer deposits, which represent cash received 
from the customer in advance of the delivery of goods or work being performed. 
Contract liabilities are subsequently recognized in revenue when AGI performs 
under contracts, which typically occurs within 12 months or less. AGI has elected to 
use the practical expedient to not disclose the Company’s remaining performance 
obligations as those obligations are part of contracts that have an original expected 
duration of less than one year.

The Company has also elected to apply the practical expedient of expensing the 
incremental costs of obtaining a contract when incurred as the amortization period 
of the asset that would be recognized is one year or less.

Income taxes

AGI and its subsidiaries are generally taxable under the statutes of their country of 
incorporation.

Current income tax assets and liabilities for the current and prior period are 
measured at the amount expected to be recovered from or paid to the taxation 
authorities. The tax rates and tax laws used to compute the amount are those that 
are enacted or substantively enacted at the reporting date in the countries where 
AGI operates and generates taxable income. Current income tax relating to items 
recognized directly in equity is recognized in equity and not in the consolidated 
statements of income. Management periodically evaluates positions taken in the 
tax returns with respect to situations in which applicable tax regulations are subject 
to interpretation and establishes provisions where appropriate.

AGI follows the liability method of accounting for deferred taxes. Under this 
method, income tax liabilities and assets are recognized for the estimated tax 
consequences attributable to the temporary differences between the carrying value 
of the assets and liabilities on the consolidated statements of financial position and 
their respective tax bases.

Deferred tax liabilities are recognized for all taxable temporary differences, except:

•  Where the deferred tax liability arises from the initial recognition of goodwill or of 
an asset or liability in a transaction that is not a business combination and, at the 
time of the transaction, affects neither the accounting profit nor the taxable profit 
or loss.

•  In respect of taxable temporary differences associated with investments in 

subsidiaries and associates, where the timing of the reversal of the temporary 
differences can be controlled and it is probable that the temporary differences 
will not reverse in the foreseeable future. 

Deferred tax assets are recognized for all deductible temporary differences and 
carryforward of unused tax losses, to the extent that it is probable that taxable 
profit will be available against which the deductible temporary differences and the 
carryforward of unused tax losses can be utilized, except:

•  When the deferred tax asset relating to the deductible temporary difference 

arises from the initial recognition of an asset or liability in a transaction that is not 
a business combination and, at the time of the transaction, affects neither the 
accounting profit nor taxable profit or loss.

•  In respect of deductible temporary differences associated with investments in 

subsidiaries and associates, deferred tax assets are recognized only to the extent 

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

6363

 
 
 
 
 
 
 
 
S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

6464

 
 
 
 
 
 
 
 
KEEP YOUR DRYER IN CHECK

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

6565

 
 
 
 
 
 
 
 
that it is probable that the temporary differences will reverse in the foreseeable 
future and taxable profit will be available against which the temporary differences 
can be utilized.

The carrying amount of deferred tax assets is reviewed at each reporting date and 
reduced to the extent that it is no longer probable that sufficient taxable profit will 
be available to allow all or part of the deferred tax asset to be utilized. Unrecognized 
deferred tax assets are reassessed at each reporting date and are recognized to 
the extent that it has become probable that future taxable profits will allow the 
deferred tax asset to be recovered. Deferred tax assets and liabilities are measured 
at the tax rates that are expected to apply in the year when the asset is realized or 
the liability is settled, based on tax rates [and tax laws] that have been enacted or 
substantively enacted at the reporting date.

Deferred tax items are recognized in correlation to the underlying transaction either 
in the consolidated statements of income, other comprehensive income or directly 
in equity.

Deferred tax assets and deferred tax liabilities are offset if a legally enforceable 
right exists to offset current tax assets against current income tax liabilities and the 
deferred taxes relate to the same taxable entity and the same taxation authority.

Tax benefits acquired as part of a business combination, but not satisfying the 
criteria for separate recognition at that date, would be recognized subsequently if 
information about facts and circumstances changed. The adjustment would either 
be treated as a reduction to goodwill if it occurred during the measurement period 
or in profit or loss, when it occurs subsequent to the measurement period.

Sales tax

Share-based compensation plans

Employees of AGI may receive remuneration in the form of share-based payment 
transactions, whereby employees render services and receive consideration in the 
form of equity instruments [equity-settled transactions or share award incentive 
plan and directors’ deferred compensation plan]. In situations where equity 
instruments are issued and some or all of the goods or services received by the 
entity as consideration cannot be specifically identified, the unidentified goods or 
services received are measured as the difference between the fair value of the 
share-based payment transaction and the fair value of any identifiable goods or 
services received at the grant date and are capitalized or expensed as appropriate.

Equity-settled transactions

The cost of equity-settled transactions is determined using the grant date fair value 
and is recognized, together with a corresponding increase in other capital reserves, 
in equity, over the period in which the performance and/or service conditions are 
fulfilled.

The cumulative expense recognized for equity-settled transactions at each reporting 
date until the vesting period reflects the extent to which the vesting period has 
expired and AGI’s best estimate of the number of the shares that will ultimately 
vest. The expense or credit recognized for a period represents the movement in 
cumulative expense recognized as at the beginning and end of that period and is 
recognized in the consolidated statements of income in the respective function 
line. When options and other share-based compensation awards are exercised or 
exchanged, the amounts previously credited to contributed surplus are reversed 
and credited to shareholders’ equity. The amount of cash, if any, received from 
participants is also credited to shareholders’ equity.

Revenue, expenses and assets are recognized net of the amount of sales tax, 
except where the sales tax incurred on a purchase of assets or services is not 
recoverable from the taxation authority, in which case the sales tax is recognized 
as part of the cost of acquisition of the asset or as part of the expense item as 
applicable and where receivables and payables are stated with the amount of sales 
tax included.

Where the terms of an equity-settled transaction award are modified, the minimum 
expense recognized is the expense as if the terms had not been modified, if 
the original terms of the award are met. An additional expense is recognized for 
any modification that increases the total fair value of the share-based payment 
transaction, or is otherwise beneficial to the employee as measured at the date of 
modification.

The net amount of sales tax recoverable from, or payable to, the taxation authority 
is included as part of receivables or payables in the consolidated statements of 
financial position.

Where an equity-settled award is cancelled, it is treated as if it vested on the date 
of cancellation and any expense not yet recognized for the award [being the total 
expense as calculated at the grant date] is recognized immediately. This includes 

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

66

 
 
 
 
 
 
 
 
any award where vesting conditions within the control of either the Company or 
the employee are not met. However, if a new award is substituted for the cancelled 
award, and designated as a replacement award on the date that it is granted, the 
cancelled and new awards are treated as if they were a modification of the original 
award.

The dilutive effect of outstanding options is reflected as additional share dilution in 
the computation of diluted earnings per share.

Employee benefits

Certain employees are covered by defined benefit pension plans, and certain 
former employees are also entitled to other post-employment benefits such as 
life insurance. The Company’s defined benefit plan asset (obligation) is actuarially 
calculated by a qualified actuary at the end of each annual reporting period using 
the projected unit credit method and management’s best estimates of the discount 
rate, the rate of compensation increase, retirement rates, termination rates and 
mortality rates. The discount rate used to value the defined benefit obligation for 
accounting purposes is based on the yield on a portfolio of high-quality corporate 
bonds denominated in the same currency with cash flows that match the terms of 
the defined benefit plan obligations. Past service costs (credits) arising from plan 
amendments are recognized in operating income in the year that they arise. The 
actuarially determined net interest costs on the net defined benefit plan obligation 
are recognized in interest cost for the defined benefit plan. Actual post-employment 
benefit costs incurred may differ materially from management estimates.

The fair values of plan assets are deducted from the defined benefit plan 
obligations to arrive at the net defined benefit plan asset (obligation). When the 
plan has a net defined benefit asset, the recognized asset is limited to the present 
value of economic benefits available in the form of future refunds from the plan or 
reductions in future contributions to the plan [the “asset ceiling”]. If it is anticipated 
that the Company will not be able to recover the value of the net defined benefit 
asset, after considering minimum funding requirements for future service, the 
net defined benefit asset is reduced to the amount of the asset ceiling. When 
the payment in the future of minimum funding requirements related to past 
service would result in a net defined benefit surplus or an increase in a surplus, 
the minimum funding requirements are recognized as a liability to the extent 
that the surplus would not be fully available as a refund or a reduction in future 
contributions.

Re-measurements including actuarial gains and losses and the impact of any 
minimum funding requirements are recognized through other comprehensive 
income.

Current employee wages and benefits are expensed as incurred.

Post-retirement benefit plans

AGI contributes to retirement savings plans subject to maximum limits per 
employee. AGI accounts for such defined contributions as an expense in the period 
in which the contributions are required to be made.

Research and development expenses

Research expenses, net of related tax credits, are charged to the consolidated 
statements of income in the period they are incurred. Development costs are 
charged to operations in the period of the expenditure unless they satisfy the 
condition for recognition as an internally generated intangible asset.

Government grants

Government grants are recognized at fair value where there is reasonable 
assurance that the grant will be received and all attaching conditions will be 
complied with. Where the grants relate to an asset, the fair value is credited to the 
cost of the asset and is released to the consolidated statements of income over 
the expected useful life in a consistent manner with the depreciation method for 
the relevant assets.

Investment tax credits

Federal and provincial investment tax credits are accounted for as a reduction of 
the cost of the related assets or expenditures in the year in which the credits are 
earned and when there is reasonable assurance that the credits can be used to 
recover taxes.

Adoption of new accounting policies

IFRS 16, Leases [“IFRS 16”]

The Company has applied IFRS 16 using the modified retrospective approach, and 
therefore the comparative information has not been restated and continues to be 

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

6767

 
 
 
 
 
 
 
 
reported under IAS 17, Leases, [“IAS 17”] and IFRIC 4, Determining whether an 
Arrangement contains a Lease [“IFRIC 4”].

IAS 19, Employee Benefits [“IAS 19”]

For contracts entered into before January 1, 2019, the Company determined 
whether the arrangement was or contained a lease based on the assessment of 
whether:

•  Fulfilment of the arrangement was dependent on the use of a specific asset or 

assets; and

•  The arrangement had conveyed a right to use the asset.

The Company elected to use the transition practical expedient to not reassess 
whether a contract is, or contains, a lease at January 1, 2019. Instead, the 
Company applied the standard only to contracts that were previously identified as 
leases applying IAS 17 and IFRIC 4 at the date of initial application. The Company 
has also elected not to recognize right-of-use assets and lease liabilities for short-
term leases [12 months or less] and leases of low-value assets. The Company 
recognizes the lease payments associated with these leases as an expense on a 
straight-line basis over the lease term.

As a result of adoption of IFRS 16, the Company recorded a right-of-use asset and 
a lease liability of $9,071 as at January 1, 2019 on the consolidated statements of 
financial position. On adoption of IFRS 16, AGI used the incremental borrowing rate 
as required by the standard.

The lease liabilities as at January 1, 2019 can be reconciled to the operating lease 
commitments as at December 31, 2018 as follows:

Operating lease commitments as at December 31, 2018

Weighted average incremental borrowing rate as at January 1, 2019

Discounted operating lease commitments at January 1, 2019

Less:

Commitments relating to short-term and low-value leases

Lease liabilities as at January 1, 2019

$

11,059

5.02%

10,841

(1,770)

9,071

The Company adopted the amendments to IAS 19 with a date of application of 
January 1, 2019. The amendments to IAS 19 address the accounting when a 
plan amendment, curtailment or settlement occurs during a reporting period. The 
amendments specify that when a plan amendment, curtailment or settlement 
occurs during the annual reporting period, an entity is required to:

•  Determine current service cost for the remainder of the period after the plan 

amendment, curtailment or settlement, using the actuarial assumptions used to 
remeasure the net defined benefit liability (asset) reflecting the benefits offered 
under the plan and the plan assets after that event.

•  Determine net interest for the remainder of the period after the plan 

amendment, curtailment or settlement using the net defined benefit liability 
(asset) reflecting the benefits offered under the plan and the plan assets after 
that event and the discount rate used to remeasure that net defined benefit 
liability (asset).

The amendments also clarify that an entity first determines any past service cost, 
or a gain or loss on settlement, without considering the effect of the asset ceiling. 
This amount is recognized in profit or loss. An entity then determines the effect of 
the asset ceiling after the plan amendment, curtailment or settlement. Any change 
in that effect, excluding amounts included in the net interest, is recognized in other 
comprehensive income.

These amendments are applied prospectively to any future plan amendments, 
curtailments, or settlements of the Company; as at December 31, 2019, there were 
no such amendments.

IFRIC 23, Uncertainty Over Income Tax Treatments [“IFRIC 23”]

The Company adopted IFRIC 23 with a date of application of January 1, 2019. IFRIC 
23 sets out how to determine the accounting tax position when there is uncertainty 
over income tax treatments. The interpretation requires an entity to:

•  Determine whether uncertain tax positions are assessed separately or as a 

group; and

•  Assess whether it is probable that a tax authority will accept an uncertain tax 
treatment used, or proposed to be used, by an entity in its income tax filings:

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

68

 
 
 
 
 
 
 
 
•  If yes, the entity should determine its accounting tax position consistently 
with the tax treatment used or planned to be used in its income tax filings.

•  If no, the entity should reflect the effect of uncertainty in determining its 

accounting tax position.

The Company’s adoption of IFRIC 23 did not have a significant impact on the 
Company’s consolidated financial statements.

4. Significant accounting judgments, estimates and assumptions

The preparation of the consolidated financial statements requires management to 
make judgments, estimates and assumptions that affect the reported amounts of 
assets, liabilities, income, expenses and the disclosure of contingent liabilities. The 
estimates and related assumptions are based on previous experience and other 
factors considered reasonable under the circumstances, the results of which form 
the basis of making the assumptions about carrying values of assets and liabilities 
that are not readily apparent from other sources. However, uncertainty about 
these assumptions and estimates could result in outcomes that require a material 
adjustment to the carrying amount of the asset or liability affected in future periods.

The estimates and underlying assumptions are reviewed on an ongoing basis. 
Revisions to accounting estimates are recognized in the period in which the 
estimate is revised if the revision affects only that period, or in the period of the 
revision and future periods if the revision affects both current and future periods. 
The key assumptions concerning the future and other key sources of estimation 
uncertainty at the reporting date that have a significant risk of causing a material 
adjustment to the carrying amounts of assets and liabilities within the next financial 
year are described below.

Impairment of financial assets

Assessments about the recoverability of financial assets, including accounts 
receivable, require significant judgment in determining whether there is objective 
evidence that a loss event has occurred and estimates of the amount and timing 
of future cash flows. The Company maintains an allowance for doubtful accounts 
for estimated losses resulting from the inability to collect on its trade receivables. 
A portion of the Company’s sales are generated in overseas markets, including 
in emerging markets such as countries in Eastern Europe, South America, and 
Asia. Emerging markets are subject to various additional risks, including currency 

exchange rate fluctuations, economic conditions and foreign business practices. 
One or more of these factors could have a material effect on the future collectability 
of such receivables.

In assessing whether objective evidence of impairment exists at each reporting 
date, the Company uses a provision matrix to measure expected credit losses. 
The provision rates are based on days past due for groupings of various customer 
segments with similar loss patterns [i.e., by geographical region, product type, 
customer type and rating, and coverage by letters of credit or other forms of credit 
insurance]. The calculation reflects the probability-weighted outcome, the time 
value of money and reasonable and supportable information that is available at 
the reporting date about past events, current conditions and forecasts of future 
economic conditions. The maximum exposure to credit risk at the reporting date 
is the carrying value of each class of financial assets disclosed in note 30[b]. The 
letters of credit and other forms of credit insurance are considered integral part of 
trade receivables and considered in the calculation of impairment. The Company 
evaluates the concentration of risk with respect to trade receivables and contract 
assets as low, as its customers are located in several jurisdictions and operate in 
largely independent markets.

Future collections of accounts receivable that differ from the Company’s current 
estimates would affect the results of the Company’s operations in future periods as 
well as the Company’s trade receivables and general and administrative expenses, 
and amounts may be material.

Impairment of non-financial assets

AGI’s impairment test is based on value-in-use calculations that use a discounted 
cash flow model. The cash flows are derived from the forecast for the next five 
years and do not include restructuring activities to which AGI has not yet committed 
or significant future investments that will enhance the asset’s performance of the 
CGU being tested. These calculations require the use of estimates and forecasts 
of future cash flows. Qualitative factors, including market presence and trends, 
strength of customer relationships, strength of local management, strength of debt 
and capital markets, and degree of variability in cash flows, as well as other factors, 
are considered when making assumptions with regard to future cash flows and the 
appropriate discount rate. The recoverable amount is most sensitive to the discount 
rate, as well as the forecasted margins and growth rate used for extrapolation 
purposes. A change in any of the significant assumptions or estimates used to 

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

6969

 
 
 
 
 
 
 
 
evaluate goodwill and other non-financial assets could result in a material change to 
the results of operations. The key assumptions used to determine the recoverable 
amount for the different CGUs are further explained in note 14.

CGUs are defined as the lowest grouping of integrated assets that generate 
identifiable cash inflows that are largely independent of the cash inflows of 
other assets or groups of assets. The classification of assets into CGUs requires 
significant judgment and interpretations with respect to the integration between 
assets, the nature of products, the way in which management allocates resources 
and other relevant factors.

Development costs

Development costs are capitalized in accordance with the accounting policy 
described in note 3. Initial capitalization of costs is based on management’s 
judgment that technical and economic feasibility is confirmed, usually when 
a project has reached a defined milestone according to an established project 
management model.

Useful lives of key property, plant and equipment and intangible assets

The depreciation method and useful lives reflect the pattern in which management 
expects the asset’s future economic benefits to be consumed by AGI. Refer to note 
3 for the estimated useful lives.

Fair value of financial instruments

Where the fair value of financial assets and financial liabilities recorded in the 
consolidated statements of financial position, including the determination of the 
fair value of the Company’s equity investment cannot be derived from active 
markets, it is determined using valuation techniques including the discounted 
cash flow models. The inputs to these models are taken from observable markets 
where possible, but where this is not feasible, a degree of judgment is required 
in establishing fair values. The judgments include considerations of inputs such 
as liquidity risk, credit risk and volatility. Changes in assumptions about these 
factors could affect the reported fair value of financial instruments. Contingent 
considerations resulting from business combinations are valued at fair value at the 
acquisition date as part of the business combination and subsequently fair valued 
as described in business combinations below.

Share-based payments

AGI measures the cost of equity-settled share-based payment transactions with 
employees by reference to the fair value of equity instruments at the grant date, 
whereas the fair value of cash-settled share-based payments is remeasured at 
every reporting date. Estimating fair value for share-based payments requires 
determining the most appropriate valuation model for a grant of these instruments, 
which is dependent on the terms and conditions of the grant.

Income taxes

Uncertainties exist with respect to the interpretation of complex tax regulations, 
changes in tax laws and the amount and timing of future taxable income. Given 
the wide range of international business relationships and the long-term nature and 
complexity of existing contractual agreements, differences arising between the 
actual results and the assumptions made, or future changes to such assumptions, 
could necessitate future adjustments to taxable income and expenses already 
recorded. AGI establishes provisions, based on reasonable estimates, for possible 
consequences of audits by the tax authorities of the respective countries in which 
it operates. The amount of such provisions is based on various factors, such as 
experience of previous tax audits and differing interpretations of tax regulations by 
the taxable entity and the responsible tax authority.

Such differences of interpretation may arise on a wide variety of issues, depending 
on the conditions prevailing in the respective company’s domicile. As AGI assesses 
the probability for litigation and subsequent cash outflow with respect to taxes 
as remote, no contingent liability has been recognized. Deferred tax assets 
are recognized for all unused tax losses to the extent that it is probable that 
taxable profit will be available against which the losses can be utilized. Significant 
management judgment is required to determine the amount of deferred tax assets 
that can be recognized, based upon the likely timing and the level of future taxable 
profits together with future tax planning strategies.

Business combinations

For acquisition accounting purposes, all identifiable assets, liabilities and contingent 
liabilities acquired in a business combination are recognized at fair value at the 
date of acquisition. Estimates are used to calculate the fair value of these assets 
and liabilities as at the date of acquisition. Contingent consideration resulting from 
business combinations is valued at fair value at the acquisition date as part of the 
business combination. Where the contingent consideration is recognized, it is 

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

70

 
 
 
 
 
 
 
 
Purchase price

Cash acquired

Working capital adjustment

Contingent consideration

Total purchase price

Post-combination expense

Purchase consideration

$

9,000

126

85

1,000

10,211

(3,000)

7,211

Terms of the purchase agreement included $6.0 million payable upon closing and 
$3.0 million payable in annual instalments, contingent on certain conditions. The 
$3.0 million is expected to be expensed over the three-year period. In addition, 
contingent consideration of $1.0 million was payable based on an earnings target. 
In April 2018, the purchase agreement was amended such that payment of the 
first annual instalment of $1.0 million and contingent consideration of $1.0 million 
was guaranteed. Related to certain terms of the purchase agreement, $1,797 
was expensed during the year ended December 31, 2018. During the year ended 
December 31, 2019, $875 was expensed, of which $1,050 was paid.

The purchase has been accounted for by the acquisition method, with the results of 
Danmare included in the Company’s net earnings from the date of acquisition.

subsequently remeasured to fair value at each reporting date. The determination 
of the fair value is based on discounted cash flows. The key assumptions take into 
consideration the probability of meeting each performance target and the discount 
factor.

5. Standards issued but not yet effective

Standards issued, but not yet effective up to the date of issuance of the Company’s 
consolidated financial statements are listed below. This listing is of standards and 
interpretations issued that the Company reasonably expects to be applicable at a 
future date. The Company intends to adopt those standards when they become 
effective.

Amendments to IFRS 3, Business Combinations [“IFRS 3”]

The IASB issued amendments to the definition of a business in IFRS 3 to help 
entities determine whether an acquired set of activities and assets is a business or 
not. They clarify the minimum requirements for a business, remove the assessment 
of whether market participants are capable of replacing any missing elements, 
add guidance to help entities assess whether an acquired process is substantive, 
narrow the definitions of a business and of outputs, and introduce an optional fair 
value concentration test.

The amendments must be applied to transactions that are either business 
combinations or asset acquisitions for which the acquisition date is on or after the 
beginning of the first annual reporting period beginning on January 1, 2020 with 
earlier application permitted. Consequently, transactions that occurred in prior 
periods do not need to be reassessed. The Company’s assessment did not identify 
significant classification, recognition or measurement differences. The Company 
will adopt the amendments to IFRS 3 as at January 1, 2020.

6. Business combinations

[a] Danmare Group Inc. and Danmare, Inc.

Effective February 22, 2018, the Company acquired 100% of the outstanding shares 
of Danmare Group Inc. and its affiliate Danmare, Inc. [collectively, “Danmare”]. 
Based in Canada and the U.S., Danmare provides engineering solutions and project 
management services to the food industry. The acquisition further evolves AGI’s 
ability to provide complete solutions to a broad customer base.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

7171

 
 
 
 
 
 
 
 
The following table summarizes the fair values of the identifiable assets and 
liabilities as at the date of acquisition:

Cash

Accounts receivable

Prepaid expenses and other assets

Income taxes recoverable

Property, plant and equipment

Intangible assets

Brand name

Distribution network

Customer backlog

Goodwill

Deferred tax liability

Accounts payable and accrued liabilities

Customer deposits

Purchase consideration

$

126

1,112

40

56

237

490

2,690

250

3,651

(918)

(278)

(245)

7,211

The goodwill of $3,651 comprises the value of the assembled workforce and other 
expected synergies arising from the acquisition.

The fair value of the accounts receivable acquired is $1,112. This consists of the 
gross contractual value of $1,162 less the estimated amount not expected to be 
collected of $50.

The components of the purchase consideration are as follows:

During the year ended December 31, 2018, the cash held in trust and the amounts 
due to vendor were paid and the allocation of the purchase price to acquired assets 
and liabilities was finalized. During the year ended December 31, 2019, $1,050 of 
post-combination expense was paid to the vendor.

Transaction costs related to the Danmare acquisition in the year ended December 
31, 2019 were $40 [2018 – $154] and are included in selling, general and 
administrative expenses.

[b] Sabe Group of Companies

Effective July 26, 2018, the Company acquired 100% of the outstanding shares of 
Cobalt Investissement and its wholly owned subsidiaries Sabe, Sabe Distribution, 
Agro Maintenance Système (AMS), Sabis and Société D’Études Techniques 
D’Installation (Setir) [collectively, “Sabe”]. Based in France, Sabe offers design, 
manufacturing, installation and commissioning of turnkey solutions to the food 
industry. The acquisition further evolves AGI’s ability to provide complete solutions 
to a broad customer base.

Purchase price

Cash acquired

Working capital adjustment

Contingent consideration

Employee loans

Long-term debt

Total purchase price

Post-combination expense

Purchase consideration

$

24,464

3,708

820

2,709

18

(738)

30,981

(4,436)

26,545

Cash paid

Cash held in trust

Due to vendor

Purchase consideration

$

6,000

525

686

7,211

The $4.4 million of post-combination expense is expected to be expensed over 
a three-year period. During the year ended December 31, 2019, $1,920 [2018 – 
$1,375] related to certain terms of the purchase agreement was expensed, of 
which $1,430 was paid during the year ended December 31, 2019. During the year, 
the earn-out period expired, and the earnings target was not met. As a result, the 
contingent consideration of $2.7 million was derecognized and a gain was recorded 
in transaction costs in the consolidated statements of income.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

72

 
 
 
 
 
 
 
 
The purchase has been accounted for by the acquisition method, with the results of 
Sabe included in the Company’s net earnings from the date of acquisition.

The components of the purchase consideration are as follows:

The following table summarizes the fair values of the identifiable assets and 
liabilities as at the date of acquisition:

Cash paid

Due to vendor

Cash

Accounts receivable

Inventory

Prepaid expenses and other assets

Property, plant and equipment

Intangible assets

Trade name

Customer relationships

Customer backlog

Goodwill

Accounts payable and accrued liabilities

Customer deposits

Income taxes payable

Deferred tax liability

Long-term payables

Long-term debt

Purchase consideration

$

3,708

2,090

749

135

4,233

5,234

6,493

837

14,131

(4,920)

(585)

(123)

(4,695)

(4)

(738)

26,545

The fair value of the accounts receivable acquired is $2,090. This consists of the 
gross contractual value of $2,332 less the estimated amount not expected to be 
collected of $242.

The goodwill of $14,131 comprises the value of the assembled workforce and other 
expected synergies arising from the acquisition. During the measurement period, 
further deferred tax liabilities existing at acquisition were identified, resulting in a 
$1,337 increase in deferred tax liability and an offsetting increase in goodwill, in the 
year ended December 31, 2019.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

7373

$

23,432

404

2,709

26,545

Contingent consideration derecognized in the year

Purchase consideration

Transaction costs related to the Sabe acquisition in the year ended December 
31, 2019 were $209 [2018 – $523] and are included in selling, general and 
administrative expenses. During the year ended December 31, 2019, the allocation 
of the purchase price to acquired assets and liabilities was finalized.

[c] Improtech Ltd.

Effective January 18, 2019, the Company acquired 100% of the outstanding 
shares of Improtech Ltd [“Improtech”]. Improtech is a professional engineering 
services firm specializing in providing engineering design, project management and 
integration of new machinery and processes within the food and beverage industry. 
The acquisition further evolves AGI’s ability to provide complete solutions to a broad 
customer base.

Purchase price

Cash acquired

Working capital adjustment

Pre-paid tax instalments

Total purchase price

Post-combination expense

Purchase consideration

$

3,000

438

479

124

4,041

(2,000)

2,041

The $2 million of post-combination expense is expected to be expensed over 
a three-year period, contingent on certain conditions. During the year ended 
December 31, 2019, $1,222 [2018 – nil] related to certain terms of the purchase 
agreement was expensed.

The purchase has been accounted for by the acquisition method, with the results of 
Improtech included in the Company’s net earnings from the date of acquisition.

 
 
 
 
 
 
 
 
S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

0
2
0
2

74

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

74
74

SELL WITH CONFIDENCE

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MARKET WITH CONFIDENCE

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

75
75

 
 
 
 
 
 
 
 
The following table summarizes the provisional fair values of the identifiable assets 
and liabilities as at the date of acquisition:

Cash

Accounts receivable

Prepaid expenses and other assets

Property, plant and equipment

Right-of-use assets

Intangible assets

Customer relationships

Goodwill

Accounts payable and accrued liabilities

Customer deposits

Lease liability

Deferred tax liability

Purchase consideration

$

438

1,422

149

17

131

748

316

(600)

(249)

(131)

(200)

2,041

The goodwill of $316 comprises the value of the assembled workforce and other 
expected synergies arising from the acquisition.

The fair value of the accounts receivable acquired is $1,422. This consists of the 
gross contractual value of $1,447 less the estimated amount not expected to be 
collected of $25.

From the date of acquisition, Improtech contributed to the results $2,041 of 
revenue and $1,277 of net loss. If the acquisition had taken place as at January 1, 
2019, revenue in 2019 would not have materially changed.

The components of the purchase consideration are as follows:

Cash paid

Due to vendor

Purchase consideration

$

1,000

1,041

2,041

During the year ended December 31, 2019, the amount due to vendor was paid in 
full and the allocation of the purchase price to acquired assets and liabilities was 
finalized.

Transaction costs related to the Improtech acquisition in the year ended December 
31, 2019 were $107 [2018 – $54] and are included in selling, general and 
administrative expenses.

[d] IntelliFarms LLC

Effective March 5, 2019, the Company acquired 100% of the LLC interests of 
IntelliFarms LLC [“IntelliFarms”]. IntelliFarms is a provider of hardware and 
software solutions that benefit grain growers, processors, and other participants in 
the agriculture market. IntelliFarms was founded in 2001 and is headquartered in 
Archie, Missouri.

Purchase price

Cash acquired

Working capital adjustment

Contingent consideration

Customer deposits

Total purchase price

Post-combination expense

Purchase consideration

$

19,350

53

87

5,105

(1,566)

23,029

(7,340)

15,689

The $7.3 million of post-combination expense is expected to be expensed over 
a three-year period, contingent on certain conditions. During the year ended 
December 31, 2019, $3,041 [2018 – nil] related to certain terms of the purchase 
agreement was expensed. In addition, contingent consideration of $5.1 million is 
payable based on an earnings target.

The purchase has been accounted for by the acquisition method, with the results of 
IntelliFarms included in the Company’s net earnings from the date of acquisition.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

76

 
 
 
 
 
 
 
 
The following table summarizes the fair values of the identifiable assets and 
liabilities as at the date of acquisition:

Cash

Accounts receivable

Inventory

Prepaid expenses and other assets

Property, plant and equipment

Right-of-use assets

Intangible assets

Trade name

Customer relationships

Customer backlog

Software

Goodwill

Accounts payable and accrued liabilities

Customer deposits

Lease liability

Long-term debt

Purchase consideration

$

53

225

1,235

61

803

289

1,768

1,603

380

3,336

13,358

(4,153)

(2,740)

(65)

(464)

15,689

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

7777

The goodwill of $13,358 comprises the value of the assembled workforce and other 
expected synergies arising from the acquisition. During the measurement period, 
further information regarding the working capital adjustment as part of the purchase 
consideration was identified, resulting in a $218 increase in working capital with an 
offsetting increase in goodwill. Further information regarding inventory, intangible 
assets and accounts payable and accrued liabilities was also identified, resulting 
in a $315 decrease in inventory, $1,469 increase in intangible assets, and $1,041 
increase in accounts payable and accrued liabilities, with an offsetting increase in 
goodwill.

The fair value of the accounts receivable acquired is $225. This consists of the 
gross contractual value of $359 less the estimated amount not expected to be 
collected of $134.

From the date of acquisition, IntelliFarms contributed to the results $12,522 of 
revenue and $8,131 of net loss. Revenue and net loss that occurred as though 

the acquisition date for the business had been as of the beginning of the annual 
reporting period are impracticable to disclose due to IntelliFarms historically 
reporting under differing reporting standards and differing year-end.

The components of the purchase consideration are as follows:

Cash paid

Due from vendor

Contingent consideration

Purchase consideration

$

12,010

(1,426)

5,105

15,689

Transaction costs related to the IntelliFarms acquisition in the year ended 
December 31, 2019 were $162 [2018 – nil] and are included in selling, general and 
administrative expenses.

During the year ended December 31, 2019, the allocation of the purchase price to 
acquired assets and liabilities was finalized.

[e] Milltec Machinery Limited

Effective March 28, 2019, the Company acquired 100% of the outstanding shares 
of Milltec Machinery Limited [“Milltec”]. Based in India, Milltec is a market leading 
manufacturer of rice milling and processing equipment. The acquisition further 
evolves AGI’s ability to provide complete solutions to a broad customer base.

Purchase price

Cash acquired

Working capital adjustment

Due to vendor

Optionally convertible redeemable preferred shares [“OCRPS”]

Purchase consideration

$

113,079

6,746

32

4,917

26,494

151,268

The due to vendor and OCRPS redemption value of $31.4 million is payable based 
on earnings targets from 2019 through 2024.

 
 
 
 
 
 
 
 
The purchase has been accounted for by the acquisition method, with the results of 
Milltec included in the Company’s net earnings from the date of acquisition. The fair 
value of the assets acquired and the liabilities assumed has been determined on a 
provisional basis utilizing information available at the time the consolidated financial 
statements were prepared. Additional information is being gathered to finalize 
these provisional measurements particularly with respect to intangible assets, 
goodwill and deferred taxes. Accordingly, the measurement of assets acquired and 
liabilities assumed may change upon finalization of the Company’s valuation and 
completion of the purchase price allocation, both of which are expected to occur no 
later than one year from the acquisition date.

The goodwill of $92,297 comprises the value of the assembled workforce and other 
expected synergies arising from the acquisition. During the measurement period, 
further analysis of revenue recognition resulted in the reversal of certain sales 
and related costs. As a result, accounts receivable decreased by $946, inventory 
increased by $846, accounts payable and accrued liabilities decreased by $98 and 
intangible assets increased by $197. In addition, the fair value of property, plant, 
and equipment acquired increased by $129, income taxes decreased by $240 from 
a payable to a recoverable position, and deferred tax liability increased by $12,450. 
All other adjustments net to $54. These changes resulted in an overall increase of 
$10,720 to goodwill.

The following table summarizes the provisional fair values of the identifiable assets 
and liabilities as at the date of acquisition:

Cash

Restricted cash

Accounts receivable

Inventory

Prepaid expenses and other assets

Income taxes recoverable

Property, plant and equipment

Right-of-use assets

Intangible assets

Trade name

Customer relationships

Customer backlog

Goodwill

Accounts payable and accrued liabilities

Other liabilities

Customer deposits

Lease liability

Deferred tax liability

Long-term payables

Purchase consideration

$

6,746

1,425

11,796

8,809

4,489

87

20,456

24

12,764

23,599

3,835

92,297

(16,347)

(172)

(2,533)

(24)

(15,693)

(290)

151,268

The fair value of the accounts receivable acquired is $11,796. This consists of the 
gross contractual value of $12,281 less the estimated amount not expected to be 
collected of $485.

From the date of acquisition, Milltec contributed to the results $45,484 of revenue 
and $3,091 of net loss. Revenue and net income that occurred as though the 
acquisition date for the business had been as of the beginning of the annual 
reporting period are impracticable to disclose due to Milltec historically reporting 
with a differing year-end.

The components of the purchase consideration are as follows:

Cash paid

Due to vendor

Optionally convertible redeemable preferred shares

Purchase consideration

$

106,845

17,929

26,494

151,268

As part of the acquisition, a subsidiary of the Company issued 1,050 Series A1 
and 700 Series A2 non-voting OCRPS at a price per share of INR 1,000. The Series 
A1 and A2 OCRPS have a cumulative preferential dividend rate of 0.00001% and 
must be redeemed by the nineteenth anniversary of their issuance. The OCRPS 
represent contingent consideration included within the acquisition agreement, and 
the future value of the OCRPS, to a maximum of INR 1,750 million [$34.4 million 
CAD], will be based on the achievement of certain earning targets over the period 
of April 1, 2020 to March 31, 2024, as set forth in the terms and conditions of the 
OCRPS agreement. The OCRPS can be redeemed by the Company for cash, or the 

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

78

 
 
 
 
 
 
 
 
Company has the option to convert the OCRPS for shares and direct an affiliate of 
the Company to purchase the shares for cash. As such, the preferred shares are 
recorded as a financial liability at fair value through profit and loss.

Non-current accounts receivable is the present value of asset-backed receivables. 
These receivables are backed by customers’ crop pledge and/or property, plant and 
equipment.

Transaction costs related to the Milltec acquisition in the year ended December 
31, 2019 were $2,148 [2018 – $735] and are included in selling, general and 
administrative expenses.

Trade receivables assessed to be impaired are included as an allowance in 
selling, general and administrative expenses in the period of the assessment. The 
movement in the Company’s allowance for doubtful accounts for the years ended 
December 31, 2019 and December 31, 2018 was as follows:

Balance, beginning of year

Additional provision recognized

Amounts written off during the year as uncollectible

Exchange differences

Balance, end of year

9. Inventory

Raw materials

Finished goods

2019
$

1,531

298

(27)

(44)

1,758

2018
$

1,846

143

(457)

(1)

1,531

2019
$

85,017

89,339

2018
$

102,244

88,643

174,356

190,887

7. Restricted cash

As at December 31, 2019, restricted cash of $5,416 consists of cash on hand 
related to certain contractual obligations.

As at December 31, 2018, restricted cash of $827 consists of cash on hand related 
to advance payment guarantees included in sales contracts with customers.

8. Accounts receivable

As is typical in the agriculture sector, AGI may offer extended terms on its accounts 
receivable to match the cash flow cycle of its customer. The following table sets 
forth details of the age of trade accounts receivable that are not overdue, as well as 
an analysis of overdue amounts and the related allowance for doubtful accounts:

Total current accounts receivable

Less allowance for doubtful accounts

Non-current accounts receivable

Total accounts receivable, net

Of which

Neither impaired nor past due

Not impaired and past the due date as follows

Within 30 days

31 to 60 days

61 to 90 days

Over 90 days

Allowance for doubtful accounts

Total accounts receivable, net

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

7979

2019
$

2018
$

164,301

135,770

(1,758)

(1,531)

162,543

134,239

16,182

8,122

178,725

142,361

132,022

110,469

18,200

14,858

5,877

8,051

16,333

(1,758)

4,167

3,922

10,476

(1,531)

178,725

142,361

 
 
 
 
 
 
 
 
S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

80

 
 
 
 
 
 
 
 
10. Property, plant and equipment

Cost

Balance, January 1, 2019

Additions

Acquisitions

Transfer to right-of-use assets [note 11]

Disposals

Impairment

Exchange differences

Balance, December 31, 2019

Depreciation

Balance, January 1, 2019

Depreciation

Transfer to right-of-use assets [note 11]

Disposals

Exchange differences

Balance, December 31, 2019

Land
$

Grounds
$

Buildings
$

Leasehold 
 improvements
$

Furniture 
and fixtures
$

Vehicles
$

Computer
hardware
$

Manufacturing 
equipment
$

Construction  
in progress
$

Total
$

22,411

503

13,754

—

—

(187)

(1,720)

34,761

—

—

—

—

—

—

6,350

1,055

—

—

(31)

—

(188)

7,186

167,486

5,840

2,854

—

(3)

—

(6,941)

169,236

5,688

4,067

45

—

(96)

—

(602)

9,102

3,632

17,327

703

235

—

6,278

578

(70)

(111)

(1,197)

—

—

(204)

(2,605)

4,255

20,311

1,303

15,967

1,478

1,649

466

—

(7)

(63)

4,891

—

—

(439)

573

—

(23)

(8)

400

—

(51)

(80)

7,083

2,079

(21)

(705)

(1,501)

7,443

2,513

214

—

(31)

—

(114)

10,025

4,522

1,163

—

(30)

(41)

169,489

27,496

3,596

(259)

(956)

—

(3,991)

195,375

48,329

12,859

(28)

(557)

70

1,699

20,419

2,020

1,918

6,935

5,614

60,673

13,150

412,976

84

—

—

—

—

48,539

21,276

(329)

(2,425)

(187)

(529)

(16,894)

12,705

462,956

—

—

—

—

—

—

80,331

22,431

(49)

(1,373)

(2,062)

99,278

Net book value, January 1, 2019

Net book value, December 31, 2019

22,411

34,761

5,047

5,487

151,519

148,817

4,210

7,082

1,983

2,337

10,244

13,376

2,921

4,411

121,160

134,702

13,150

332,645

12,705

363,678

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

8181

 
 
 
 
 
 
 
 
Land
$

Grounds
$

Buildings
$

Leasehold 
 improvements
$

Furniture 
and fixtures
$

Vehicles
$

Computer
hardware
$

Manufacturing 
equipment
$

Construction  
in progress
$

Total
$

Cost

Balance, January 1, 2018

21,722

Additions

Acquisitions

Classification as held for sale

Disposals

Impairment

Exchange differences

—

81

—

—

—

608

4,717

1,552

—

—

(47)

—

128

150,742

9,239

2,254

(805)

—

(226)

6,282

3,778

1,857

100

—

(154)

—

107

3,230

14,000

298

3,965

66

—

121

—

(32)

(1,063)

—

70

—

304

Balance, December 31, 2018

22,411

6,350

167,486

5,688

3,632

17,327

Depreciation

Balance, January 1, 2018

Depreciation

Classification as held for sale

Disposals

Exchange differences

Balance, December 31, 2018

—

—

—

—

—

—

932

325

—

(1)

47

11,059

4,396

(19)

—

531

1,128

354

—

(8)

4

1,326

313

—

(30)

40

1,303

15,967

1,478

1,649

5,882

1,618

—

(506)

89

7,083

Net book value, January 1, 2018

Net book value, December 31, 2018

21,722

22,411

3,785

5,047

139,683

151,519

2,650

4,210

1,904

1,983

8,118

10,244

5,948

1,351

130

—

(119)

—

133

7,443

3,515

1,004

—

(116)

119

4,522

2,433

2,921

139,520

21,193

364,850

26,065

1,718

—

(1,005)

—

3,191

(7,778)

36,549

—

—

(32)

—

4,470

(805)

(2,452)

(226)

(233)

10,590

169,489

13,150

412,976

36,465

11,190

—

(646)

1,320

48,329

103,055

121,160

—

—

—

—

—

—

60,307

19,200

(19)

(1,307)

2,150

80,331

21,193

304,543

13,150

332,645

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

82

 
 
 
 
 
 
 
 
AGI regularly assesses its long-lived assets for impairment. As at December 
31, 2019 and 2018, the recoverable amount of each CGU exceeded the carrying 
amounts of the assets allocated to the respective units.

Capitalized borrowing costs

No borrowing costs were capitalized in 2019 or 2018.

11. Right-of-use assets

Balance, beginning of year

Additions

Acquisitions

Depreciation

Buildings
$

Furniture 
and fixtures
$

Vehicles
$

Manufacturing 
equipment
$

6,745

2,601

420

387

175

—

5891

140

24

1,3501

52

—

Total
$

9,071

2,968

444

(2,147)

(128)

(293)

(459)

(3,027)

Exchange differences

Balance, end of year

(23)

7,596

(13)

421

(17)

443

(50)

893

(103)

9,353

1 Includes $280 transferred from property, plant and equipment for leases previously classified as finance leases under 
IAS 17 and IFRIC 4.

12. Goodwill

Balance, beginning of year

Acquisitions [note 6]

Exchange differences

Balance, end of year

2019
$

2018
$

256,619

234,669

107,308

(12,354)

16,423

5,527

351,573

256,619

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

8383

 
 
 
 
 
 
 
 
13. Intangible assets

Cost

Distribution networks and  
customer relationships
$

Brand
names
$

Patents
$

Software
$

Order backlog
$

Non-compete 
agreement
$

Development 
projects
$

Balance, January 1, 2019

153,863

124,579

3,023

Internal development

Acquisitions

Exchange differences

Balance, December 31, 2019

Amortization

Balance, January 1, 2019

Amortization

Exchange differences

Balance, December 31, 2019

Net book value, January 1, 2019

Net book value, December 31, 2019

—

25,950

(4,649)

175,164

63,304

13,436

(1,533)

75,207

90,559

99,957

Distribution networks and  
customer relationships
$

—

14,533

(3,302)

135,810

—

—

—

—

124,579

135,810

Brand
names
$

106

—

(61)

6,725

2,488

3,335

(345)

9,768

—

4,215

(564)

3,068

12,203

13,419

2,157

153

(92)

2,218

866

850

3,522

1,445

(191)

4,776

3,203

7,427

9,623

4,248

(454)

13,417

145

2

114

—

—

—

114

79

16

—

95

35

19

15,502

10,663

—

1,110

27,275

1,690

3,432

1,360

6,482

13,812

20,793

Patents
$

Software
$

Order backlog
$

Non-compete 
agreement
$

Development 
projects
$

Cost

Balance, January 1, 2018

140,767

115,852

2,828

Internal development

Acquisitions

Exchange differences

—

9,183

3,913

—

5,724

3,003

94

—

101

Balance, December 31, 2018

153,863

124,579

3,023

Amortization 

Balance, January 1, 2018

Amortization

Exchange differences

Balance, December 31, 2018

Net book value, January 1, 2018

Net book value, December 31, 2018

50,878

10,428

1,998

63,304

89,889

90,559

—

—

—

—

115,852

124,579

1,915

141

101

2,157

913

866

4,791

1,689

—

245

6,725

2,451

890

181

3,522

2,340

3,203

8,270

—

1,087

411

9,768

7,751

1,455

417

9,623

519

145

114

—

—

—

114

63

16

—

79

51

35

9,863

5,614

—

25

15,502

313,574

1,271

901

(482)

1,690

8,592

13,812

64,329

13,831

2,215

80,375

218,156

233,199

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

84

Total
$

313,574

13,257

48,033

(7,811)

367,053

80,375

22,730

(910)

102,195

233,199

264,858

Total
$

282,485

7,397

15,994

7,698

 
 
 
 
 
 
 
 
The Company is continuously working on research and development projects. 
Development costs capitalized include the development of new products and the 
development of new applications of existing products and prototypes. Research 
costs and development costs that are not eligible for capitalization have been 
expensed and are recognized in selling, general and administrative expenses.

Intangible assets include patents acquired through business combinations, which 
have a remaining life between 2 and 8 years. All brand names with a carrying 
amount of $135,810 [2018 – $124,579] have been classified as indefinite-life 
intangible assets, as the Company expects to maintain these brand names and 
currently no end point of the useful lives of these brand names can be determined. 
The Company assesses the assumption of an indefinite useful life at least annually. 
For definite-life intangible assets, the Company assesses whether there are 
indicators of impairment at subsequent reporting dates as a triggering event for 
performing an impairment test.

Intangible assets and research and development expenses for the year ended 
December 31, 2019 are net of combined federal and provincial scientific research 
and experimental development [“SR&ED”] tax credits in the amounts of $68 and 
$133, respectively. A number of specific criteria must be met in order to qualify for 
federal and provincial SR&ED investment tax credits. As at December 31, 2019, the 
Company had federal investment tax credit carryforwards in the amount of nil [2018 
– nil], federal SR&ED investment tax credit carryforwards in the amount of $1,038 
[2018 – $947], provincial SR&ED investment tax credit carryforwards in the amount 
of $786 [2018 – $696] and provincial manufacturing or processing tax credits in the 
amount of $658 [2018 – $658]; these began expiring in 2015.

Other significant intangible assets are goodwill [note 12] and the distribution 
network and customer relationships of the Company. The distribution network and 
customer relationships were acquired in past business combinations and reflect 
the Company’s dealer network in North America and its international customer 
base. The remaining amortization period for the distribution network and customer 
relationships ranges from 2 to 20 years.

The Company had no contractual commitments for the acquisition of intangible 
assets as of the reporting date.

14. Impairment testing

The Company performs its annual goodwill impairment test as at December 31. The 
recoverable amount of the Company’s group of CGUs has been determined based 
on value in use for the year ended December 31, 2019, using cash flow projections 
covering a five-year period. The Company performs its indefinite-life intangible 
assets impairment test as at December 31, which are tested at the individual CGU 
level.

The pre-tax discount rates applied to the cash flow projections for Farm and 
Commercial are 11.1% and 10.9% [2018 – 11.3% and 11.1%] and cash flows beyond 
the five-year period are extrapolated using a 3% growth rate [2018 – 3%], which 
is management’s estimate of long-term inflation and productivity growth in the 
industry and geographies in which it operates.

The Company’s group of CGUs, goodwill and indefinite-life intangible assets 
allocated thereto are as follows, which represents how goodwill is monitored by 
management.

Farm

Goodwill

Intangible assets with indefinite lives

Commercial

Goodwill

Intangible assets with indefinite lives

Total

Goodwill

Intangible assets with indefinite lives

2019
$

2018
$

145,378

132,469

79,501

78,206

206,195

124,150

56,309

46,373

351,573

135,810

256,619

124,579

The values of significant indefinite-life intangible assets are held by Westfield and 
Westeel; the values of which are $19,000 and $43,300, respectively.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

8585

 
 
 
 
 
 
 
 
Key assumptions used in valuation calculations

The calculation of value in use or fair value less cost to sell for all the CGUs or 
group of CGUs is most sensitive to the following assumptions:

•  Gross margins;

•  Discount rates;

•  Market share during the budget period; and

•  Growth rate used to extrapolate cash flows beyond the budget period.

deposit to AGI for future purchases of grain handling and storage equipment to 
support their farming operations, and AGI was to become a strategic supplier to 
Investco. AGI recorded a $1.1 million charge to reflect management’s estimate of 
the fair value of its investment in Investco in 2014. In 2019, AGI concluded that 
it is unlikely to recover its investment in Investco based on externally available 
information and observable conditions, and as a result, recorded a decrease of 
$0.9 million in the fair value of the equity investment in OCI, which represented the 
remaining value of Investco.

Gross margins

[b] Investment in associate

Forecasted gross margins are based on actual gross margins achieved in the 
years preceding the forecast period. Margins are kept constant over the forecast 
period and the terminal period, unless management has started an efficiency 
improvement process.

Carrying value, beginning of period

Additions in the year

Share of net loss for the period before adjustments

Discount rates

Discount rates reflect the current market assessment of the risks specific to each 
CGU or group of CGUs. The discount rate was estimated based on the weighted 
average cost of capital for the industry. This rate was further adjusted to reflect the 
market assessment of any risk specific to the CGU or group of CGUs for which 
future estimates of cash flows have not been adjusted.

Market share assumptions

These assumptions are important because, as well as using industry data for 
growth rates [as noted below], management assesses how the CGU’s or group of 
CGUs’ position, relative to its competitors, might change over the forecast period.

Growth rate estimates

Rates are based on published research and are primarily derived from the long-
term Consumer Price Index expectations for the markets in which AGI operates. 
Management considers the Consumer Price Index to be a conservative indicator of 
the long-term growth expectations for the agricultural industry.

15. Equity investment

[a] Equity investment at fair value through OCI

In fiscal 2009, AGI invested $2 million in a privately held Canadian farming company 
[“Investco”]. In conjunction with AGI’s investment, Investco made a $2 million 

Amortization of fair value adjustments

Share of net loss for the period

Share of other comprehensive income

Carrying value, end of period

On July 16, 2019, the Company acquired an equity interest in Farmobile Inc. 
[“Farmobile”], a privately owned agriculture technology company, headquartered 
in Leawood, Kansas. The consideration given for the equity interest in Farmobile 
amounted to $19,720. In addition, the Company incurred $140 of transaction costs 
which were capitalized with the investment.

The equity interest acquired in Farmobile represents an investment subject to 
significant influence, which is accounted for using the equity method from the 
date of acquisition, July 16, 2019. The investment was initially recorded at cost and 
adjustments were made to include the Company’s share of Farmobile’s net loss. 
The Company’s share of net loss was adjusted to reflect the amortization of the 
fair value adjustments related to the Company’s share of the net identifiable assets 
of Farmobile acquired and the tax impact. The Company’s share of net loss since 
acquisition of $2,352 has been recorded in the consolidated statements of income.

Farmobile is a start-up company and its revenue is nominal at present. The 
Company’s share of net loss since acquisition is $2,352.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

86

2019
$

—

19,720

(1,598)

(754)

(2,352)

(56)

17,312

 
 
 
 
 
 
 
 
Farmobile’s balance sheet

Current assets

Non-current assets

Current liabilities

Non-current liabilities

Equity

The Company’s share of Farmobile

Share of equity

Goodwill

Fair value adjustment and amortization of intangible assets

2019
$

19,359

3,542

(1,706)

(8)

21,187

8,051

12,696

(3,435)

17,312

16. Assets held for sale

Assets held for sale include a building in Illinois and land, grounds, and building in 
Brazil. These land, grounds, and buildings met the definition of assets held for sale 
and were recorded at the lower of cost and fair value less cost to sell. During the 
year ended December 31, 2019, the Company recorded impairment losses totaling 
$46. As at December 31, 2019, the carrying amount of the assets held for sale is 
$1,043.

17. Accounts payable and accrued liabilities

Trade payables

Other payables

Personnel-related accrued liabilities

Accrued outstanding service invoices

2019
$

51,753

25,280

26,523

1,822

2018
$

49,415

19,770

30,224

2,095

105,378

101,504

Trade payables and other payables are non-interest bearing and are normally settled 
on 30- or 60-day terms. Personnel-related accrued liabilities include primarily 
vacation accruals, bonus accruals and overtime benefits. For explanations on the 
Company’s credit risk management processes, refer to note 30.

18. Provisions

Provisions consist of the Company’s warranty provision. A provision is recognized 
for expected claims on products sold based on past experience of the level of 
repairs and returns. It is expected that most of these costs will be incurred in the 
next financial year. Assumptions used to calculate the provision for warranties were 
based on current sales levels and current information available about returns.

Balance, beginning of year

Additional provisions recognized

Amounts written off

Acquisitions

Balance, end of year

19. Lease liability

Current

Non-current

Lease liability

2019
$

7,685

18,007

2018
$

5,909

7,907

(10,870)

(6,244)

2,717

17,539

113

7,685

Incremental 
borrowing rate
%

Maturity

2.7 – 29.3

2020

2.7 – 29.3

2021 – 2029

2019
$

2,562

6,787

9,349

The Company has various lease contracts that have not yet commenced as at 
December 31, 2019. The future lease payments for the non-cancellable lease 
contracts are $485 within one year, $4,601 within five years and $3,742 thereafter.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

8787

 
 
 
 
 
 
 
 
MAKE BETTER BUSINESS DECISIONS

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

88

 
 
 
 
 
 
 
 
8989

20. Long-term debt

Interest rate
%

Maturity

3.7 – 6.8

nil

nil

4.4

3.7

4.1 – 6.9

4.0 – 4.3

2023

2025

2025

2025

2026

2023

2023

Current portion of long-term debt

Canadian swing line

Equipment financing

Non-current portion of long-term debt

Equipment financing

Series B secured notes

Series C secured notes  
[U.S. dollar denominated]

Canadian Revolver

U.S. Revolver

Less deferred financing costs

Long-term debt

[a] Bank indebtedness

2019
$

345

348

693

2018
$

—

289

289

773

25,000

809

25,000

32,470

34,105

140,511

196,379

395,133

(2,698)

392,435

393,128

69,203

144,877

273,994

(2,862)

271,132

271,421

AGI has a swing line of $40.0 million and U.S. $10.0 million. The facilities bear 
interest at prime plus 0.45% to prime plus 1.5% per annum based on performance 
calculations. As at December 31, 2019, there was $345 [2018 – nil] outstanding 
under the swing line.

Collateral for the swing line ranks pari passu with the Series B and C secured notes 
and includes a general security agreement over all assets, first position collateral 
mortgages on land and buildings, assignments of rents and leases and security 
agreements for patents and trademarks.

[b] Long-term debt

AGI’s revolver facilities of $175 million and U.S. $215 million are inclusive of 
amounts that may be allocated to the Company’s swing line and can be drawn in 
Canadian or U.S. funds. The facilities bear interest at BA or LIBOR plus 1.45% to BA 
or LIBOR plus 2.5% and prime plus 0.45% to prime plus 1.5% per annum based 
on performance calculations. The combined effective interest rate for the year 
ended December 31, 2019 on AGI’s revolver facilities was 5.11%. As at December 
31, 2019, there was $337 million [2018 – $214 million] outstanding under these 
facilities. Interest on a portion of the revolver line has been fixed at 3.8% through 

an interest rate swap contract [note 30]. Collateral for the revolving line ranks pari 
passu and includes a general security agreement over all assets, first position 
collateral mortgages on land and buildings, assignments of rents and leases and 
security agreements for patents and trademarks.

The Series B secured notes were issued on May 22, 2015. The non-amortizing 
notes bear interest at 4.4% payable quarterly and mature on May 22, 2025. 
Collateral for the Series B secured notes and term loans ranks pari passu and 
includes a general security agreement over all assets, first position collateral 
mortgages on land and buildings, assignments of rents and leases and security 
agreements for patents and trademarks.

The Series C secured notes were issued on October 29, 2016. The non-amortizing 
notes bear interest at 3.7% payable quarterly and mature on October 29, 2026. 
The Series C secured notes are denominated in U.S. dollars. Collateral for the 
Series C secured notes and term loans ranks pari passu and includes a general 
security agreement over all assets, first position collateral mortgages on land and 
buildings, assignments of rents and leases and security agreements for patents 
and trademarks.

[c] Covenants

AGI is subject to certain financial covenants in its credit facility agreements that 
must be maintained to avoid acceleration of the termination of the agreement. 
The financial covenants require AGI to maintain a debt to earnings before interest, 
taxes, depreciation and amortization [“EBITDA”] ratio of less than 3.25, the 
calculation of which excludes the convertible unsecured subordinated debentures 
from debt, and to provide debt service coverage of a minimum of 1.0. In the event 
of an acquisition in respect of which the aggregate consideration is $75,000 or 
greater, the minimum debt to EBITDA ratio increases to 3.75 in the financial quarter 
in which the acquisition occurs and the three succeeding financial quarters, to 
3.50 for the immediately succeeding quarter and subsequently will revert to 3.25. 
As at December 31, 2019 and December 31, 2018, AGI was in compliance with all 
financial covenants.

On March 20, 2020, the Company amended and extended the Credit Facility [note 
30]. As a result, the financial covenant that requires AGI to maintain a debt to 
EBITDA ratio of less than 3.25 has been raised to 3.75 as at December 31, 2019 
and for fiscal 2020 and 3.25 thereafter. In addition, in the event of an acquisition 
by AGI for aggregate consideration of $75,000 or greater, in fiscal 2020 or in 
subsequent years, the debt to EBITDA ratio requirement increases to 3.75 or less 
for the financial quarter and the three following financial quarters in which the 
acquisition occurred.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

90

 
 
 
 
 
 
 
 
21. Convertible unsecured subordinated debentures

Current portion of convertible unsecured subordinated debentures

Non-current portion of convertible unsecured subordinated debentures

Principal amount

Equity component

Accretion

Financing fees, net of amortization

Convertible unsecured subordinated debentures

2019
$

74,298

172,475

(6,351)

2,827

(4,416)

164,535

238,833

2018
$

50,708

247,500

(9,629)

3,536

(7,267)

234,140

284,848

Year issued

2015

2017

2018

Aggregate  
principal amount
$

75,000

86,225

86,250

Coupon

5.00%

4.85%

4.50%

Conversion price
$

Conversion rate(1)

60.00

83.45

88.15

16.6667

11.9832

11.3443

Number of  
common shares  
reserved for issuance  
upon conversion

Maturity date

Redeemable 
at par (2)(3)

1,250,000

1,033,551

978,446

31-Dec-20

30-Jun-22

31-Dec-22

01-Jan-20

30-Jun-21

01-Jan-22

(1)  During the year ended December 31, 2019, a holder of the 2017 Debentures converted $25,000 into common shares. No conversion options were exercised during the year ended December 31, 2018.

(2)  At the option of the Company, at par plus accrued and unpaid interest.

(3)  In the twelve-month period prior to the date on which the Company may, at its option, redeem any series of convertible debentures at par plus accrued and unpaid interest, such convertible debentures may be redeemed, in whole or in part, at the  
      option of the Company at a price equal to their principal amount plus accrued and unpaid interest, provided that the volume weighted average trading price of the common shares [“Common Shares”] of the Company during the 20 consecutive  
      trading days ending on the fifth trading day preceding the date on which the notice of redemption is given is not less than 125% of the conversion price.

On redemption or at maturity, the Company may, at its option, elect to satisfy its obligation to pay the principal amount of the Debentures by issuing and delivering common 
shares. The Company may also elect to satisfy its obligation to pay interest on the Debentures by delivering sufficient common shares. The Company does not expect to 
exercise the option to satisfy its obligations to pay the principal amount or interest by delivering common shares. The number of shares issued will be determined based on 
market prices at the time of issuance.

On April 2, 2019, the Company redeemed its 5.25% convertible unsecured subordinated debentures due December 31, 2019 [“2014 Debentures”] in accordance with the 
terms of the supplemental trust indenture dated December 1, 2014. Upon redemption, AGI paid to the holders of the 2014 Debentures the redemption price of $52,435 
equal to the outstanding principal amount of the 2014 Debentures redeemed including accrued and unpaid interest up to but excluding the redemption date, less taxes 
deducted or withheld.

Consequently, during the year ended December 31, 2019, the Company expensed the remaining unamortized balance of $425 of deferred fees related to the 2014 
Debentures. The expense was recorded to finance costs in the consolidated statements of income. Upon redemption, a gain of $55 was recorded to gain on financial 
instruments and the equity component of the 2014 Debentures was reclassified to contributed surplus.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

9191

 
 
 
 
 
 
 
 
On January 2, 2020, the Company redeemed its 5.00% convertible unsecured 
subordinated debentures due December 31, 2020 [“2015 Debentures”] in 
accordance with the terms of the supplemental trust indenture dated September 
29, 2015. Upon redemption, AGI paid to the holders of the 2015 Debentures the 
redemption price of $75,031 equal to the outstanding principal amount of the 2015 
Debentures redeemed including accrued and unpaid interest up to but excluding 
the redemption date, less taxes deducted or withheld.

Consequently, during the year ended December 31, 2019, the Company expensed 
the remaining unamortized balance of $723 of deferred fees related to the 2015 
Debentures. The expense was recorded to finance costs in the consolidated 
statements of income.

The Company presents and discloses its financial instruments in accordance with 
the substance of its contractual arrangement. Accordingly, upon issuance of the 
Debentures, the Company recorded the liability, which is the aggregate principal 
amount less related offering costs, and the estimated fair value of the holder’s 
conversion option as follows:

During the year ended December 31, 2019, the Company recorded accretion, 
non-cash interest expense relating to financing costs, and interest expense on the 
coupon of:

Year issued

2014

2015

2017

2018

2019

Non-cash interest 
expense
$

137

681

689

759

Accretion
$

117

663

806

398

Interest expense
$

649

3,750

4,182

3,881

During the year ended December 31, 2018, the Company recorded accretion, 
non-cash interest expense relating to financing costs, and interest expense on the 
coupon of:

Year issued

2015

2017

2018

Aggregate principal 
amount
$

Offering costs
$

Equity component
$

Year issued

75,000

86,250

86,250

3,509

3,673

3,957

3,277

4,290

2,063

2014

2015

2017

2018

Accretion
$

452

626

761

366

The liability component is accreted using the effective interest rate method. The 
equity component of $6,707 [2018 – $8,203] on the consolidated statements of 
financial position is net of income taxes of $2,471 [2018 – $3,028] and its pro rata 
share of financing costs of $452 [2018 – $563].

22. Senior unsecured subordinated debentures

Principal amount

Financing fees, net of amortization

Senior unsecured subordinated debentures

2018

Non-cash interest 
expense
$

Interest expense
$

527

641

650

692

2,717

3,750

4,183

3,881

2019
$

172,500

(7,026)

165,474

On March 19, 2019, the Company closed the offering of $75 million aggregate 
principal amount of senior subordinated unsecured debentures [the “2019 March 
Debentures”] at a price of $1,000 per Debenture [the “Offering”]. On March 26, 

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

92

 
 
 
 
 
 
 
 
2019, AGI closed the over-allotment option of $11.25 million aggregate principal 
amount of Debentures at the same price. The net proceeds of the Offering of 
$82,100, net of fees, were used to fund the redemption of the Company’s 2014 
Debentures, to repay existing indebtedness and for general corporate purposes.

23. Equity

[a] Common shares

On November 19, 2019, the Company closed the offering of $75 million aggregate 
principal amount of senior subordinated unsecured debentures [the “2019 
November Debentures”] at a price of $1,000 per Debenture [the “Offering”]. 
On November 22, 2019, AGI closed the over-allotment option of $11.25 million 
aggregate principal amount of Debentures at the same price. The net proceeds 
of the Offering initially were used to repay a portion of the Company’s revolving 
bank debt and then redrawn to fund the redemption of the outstanding 2015 
Debentures. AGI redeemed in full the Company’s 5.00% Convertible Unsecured 
Debentures due December 31, 2020 [the “2015 Debentures”] on January 2, 2020.

Aggregate 
principal amount
$

Year issued

2019 March

2019 November

86,250

86,250

5.40%

5.25%

30-Jun-24

31-Dec-24

30-Jun-22(1)

31-Dec-22(2)

Coupon

Maturity date

Redeemable(3)

Convertible unsecured subordinated debentures

Authorized
Unlimited number of voting common shares without par value

Issued
18,658,479 common shares

Balance, January 1, 2018

Dividend reinvestment shares issued from treasury [note 23[d]]

Settlement of EIAP obligation

Issuance of common shares

Balance, December 31, 2018

Settlement of EIAP obligation

Convertible unsecured subordinated debentures [note 21]

Balance, December 31, 2019

[b] Contributed surplus

Balance, beginning of year

Equity-settled director compensation [note 24[b]]

Dividends on EIAP

Obligation under EIAP [note 24[a]]

Settlement of EIAP obligation

Convertible unsecured subordinated debentures [note 21]

Balance, end of year

Shares
#

16,160,916

26,132

144,451

Amount
$

323,199

1,384

5,820

1,874,500

111,564

157,781

8,678

18,363,780

450,645

294,400

299

5,187

25

18,658,479

455,857

2019
$

26,045

497

567

5,471

(6,617)

1,150

27,113

2018
$

20,956

419

1,144

8,135

(7,742)

3,133

26,045

(1)  On and after June 30, 2022 and prior to June 30, 2023, the 2019 Debentures may be redeemed at the Company’s  
      option at a price equal to 102.70% of their principal amount plus accrued and unpaid interest. On or after June 30,  
      2023, the 2019 Debentures will be redeemable at the Company’s option at a price equal to their principal amount plus  
      accrued and unpaid interest.

(2)  On and after December 31, 2022 and prior to December 31, 2023, the Debentures may be redeemed at the  
      Company’s option at a price equal to 102.625% of their principal amount plus accrued and unpaid interest. On or  
      after December 31, 2023, the Debentures will be redeemable at the Company’s option at a price equal to their  
      principal amount plus accrued and unpaid interest.

(3)  The Company will have the option to satisfy its obligation to repay the principal amount of the Debentures due at  
      redemption or maturity by issuing and delivering that number of freely tradeable common shares in accordance with  
      the terms of the Indenture.

The debentures will not be convertible into common shares of the Company at the 
option of the holders at any time.

During the year ended December 31, 2019, the Company recorded non-cash 
interest expense of $561 relating to financing costs, and interest expense on the 
coupon of $4,164.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

9393

 
 
 
 
 
 
 
 
[c] Accumulated other comprehensive income

[e] Shareholder protection rights plan

Accumulated other comprehensive income comprises of the following:

Cash flow hedge reserve

The cash flow hedge reserve contains the effective portion of the cash flow hedge 
relationships incurred as at the reporting date.

Foreign currency translation reserve

The foreign currency translation reserve is used to record exchange differences 
arising from the translation of the financial statements of foreign subsidiaries. It is 
also used to record the effect of hedging net investments in foreign operations.

Defined benefit plan reserve

The defined benefit plan reserve is used to record changes in the pension liability 
including actuarial gains and losses and the impact of any minimum funding 
requirements.

[d] Dividends paid and proposed

In the year ended December 31, 2019, the Company declared dividends of $44,705 
or $2.40 per common share [2018 – $40,650 or $2.40 per common share] and 
dividends on share compensation awards of $567 [2018 – $1,144]. In the year 
ended December 31, 2019, dividends paid to shareholders were financed $44,646 
[2018 – $39,266] from cash on hand and nil [2018 – $1,384] by the dividend 
reinvestment plan [the “DRIP”].

In 2018, the Company suspended the active operation of its DRIP. Accordingly, 
dividends payable to shareholders will not be reinvested through the DRIP, and 
shareholders who were enrolled in the program will automatically receive dividend 
payments in the form of cash.

AGI’s dividend policy is to pay cash dividends on or about the 15th of each month 
to shareholders of record on the last business day of the previous month. The 
Company’s current monthly dividend rate is $0.20 per common share. Subsequent 
to December 31, 2019, the Company declared dividends of $0.20 per common 
share with record dates of January 31 and February 28.

On December 20, 2010, the Company’s Board of Directors adopted a Shareholders’ 
Protection Rights Plan [the “Rights Plan”]. Specifically, the Board of Directors has 
implemented the Rights Plan by authorizing the issuance of one right [a “Right”] 
in respect of each common share [the “Common Shares”] of the Company. If a 
person or a Company, acting jointly or in concert, acquires [other than pursuant to 
an exemption available under the Rights Plan] beneficial ownership of 20% or more 
of the Common Shares, Rights [other than those held by such acquiring person, 
which will become void] will separate from the Common Shares and permit the 
holder thereof to purchase that number of Common Shares having an aggregate 
market price [as determined in accordance with the Rights Plan] on the date of 
consummation or occurrence of such acquisition of Common Shares equal to four 
times the exercise price of the Rights for an amount in cash equal to the exercise 
price. The exercise price of the Rights pursuant to the Rights Plan is $150 per Right.

[f] Preferred shares

On May 14, 2014, the shareholders of AGI approved the creation of two new 
classes of preferred shares, each issuable in one or more series without par 
value and each with such rights, restrictions, designations and provisions as the 
Company’s Board of Directors may, at any time from time to time, determine, 
subject to an aggregate maximum number of authorized preferred shares. In 
particular, no preferred shares of either class may be issued if:

[i]      The aggregate number of preferred shares that would then be outstanding  
         would exceed 50% of the aggregate number of common shares then  
         outstanding; or

[ii]     The maximum aggregate number of common shares into which all of the  
         preferred shares then outstanding could be converted in accordance with  
         their terms, would exceed 20% of the aggregate number of common shares  
         then outstanding; or

[iii]     The aggregate number of votes, which the holders of all preferred shares  
         then outstanding would be entitled to cast at any meeting of the shareholders  
         of the Company [other than meetings at which only holders of preferred  
         shares are entitled to vote], would exceed 20% of the aggregate number of  
         votes, which the holders of all common shares then outstanding would be  
         entitled to cast at any such meeting.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

94

 
 
 
 
 
 
 
 
As at December 31, 2019 and December 31, 2018, no preferred shares were issued 
or outstanding.

A summary of the status of the options under the EIAP is presented below:

24. Share-based compensation plans

[a] Equity incentive award plan [“EIAP”]

Outstanding, January 1, 2018

On May 11, 2012, the shareholders of AGI approved an Equity Incentive Award Plan 
[the “EIAP”], which authorizes the Board to grant Restricted Awards [“Restricted 
Awards”] and Performance Awards [“Performance Awards”] [collectively, the 
“Awards”] to persons who are officers, employees or consultants of the Company 
and its affiliates. Awards may not be granted to non-management Directors.

On May 5, 2016, the shareholders of AGI approved an amendment to the EIAP 
to increase the number of common shares available for issuance to 1,215,000. 
At the discretion of the Board, the EIAP provides for cumulative adjustments to 
the number of common shares to be issued pursuant to, or the value of, Awards 
on each date that dividends are paid on the common shares. The EIAP provides 
for accelerated vesting in the event of a change in control, retirement, death or 
termination without cause.

Each Restricted Award will entitle the holder to be issued the number of common 
shares designated in the Restricted Award. The Company has an obligation to settle 
any amount payable in respect of a Restricted Award by common shares issued 
from treasury of the Company.

Each Performance Award requires the Company to deliver to the holder at the 
Company’s discretion either the number of common shares designated in the 
Performance Award multiplied by a Payout Multiplier or the equivalent amount 
in cash. The Payout Multiplier is determined based on an assessment of the 
achievement of pre-defined measures in respect of the applicable period. The 
Payout Multiplier may not exceed 200%. As at December 31, 2019, 600,852 [2018 
– 406,006] Restricted Awards and 663,408 [2018 – 440,672] Performance Awards 
have been granted. The Company has accounted for the EIAP as an equity-settled 
plan. The fair values of the Restricted Awards and the Performance Awards were 
based on the share price as at the grant date and the assumption that there will be 
no forfeitures. During the year ended December 31, 2019, AGI expensed $5,471 for 
the EIAP [2018 – $7,585].

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

9595

Granted

Vested

Forfeited

Balance, December 31, 2018

Granted

Vested

Forfeited

Balance, December 31, 2019

EIAP

Restricted Awards
#

Performance Awards
#

156,479

68,585

(70,918)

(15,166)

138,980

194,846

(80,918)

(8,500)

244,408

213,175

33,883

(73,281)

(17,000)

156,777

222,736

(249,762)

(20,254)

109,497

There is no exercise price on the EIAP awards.

[b] Directors’ deferred compensation plan [“DDCP”]

Under the DDCP, every Director receives a fixed base retainer fee, an attendance 
fee for meetings and a committee chair fee, if applicable, and a predetermined 
minimum of the total compensation must be taken in common shares. A Director 
will not be entitled to receive the common shares he or she has been granted 
until a period of three years has passed since the date of grant or until the Director 
ceases to be a Director, whichever is earlier. The Directors’ common shares are 
fixed based on the fees eligible to him or her for the respective period and his 
or her decision to elect for cash payments for dividends related to the common 
shares; therefore, the Director’s remuneration under the DDCP vests directly in 
the respective service period. The three-year period [or any shorter period until a 
Director ceases to be a Director] qualifies only as a waiting period to receive the 
vested common shares.

For the year ended December 31, 2019, an expense of $497 [2018 – $419] was 
recorded for the share grants, and a corresponding amount has been recorded to 
contributed surplus. The share grants were measured with the contractual agreed 
amount of service fees for the respective period.

The total number of common shares issuable pursuant to the DDCP shall not 
exceed 120,000, subject to adjustment in lieu of dividends, if applicable. For the 
year ended December 31, 2019, 9,793 [2018 – 7,820] common shares were granted 

 
 
 
 
 
 
 
 
under the DDCP, and as at December 31, 2019, a total of 87,946 [2018 – 78,153] 
common shares had been granted under the DDCP and 18,436 [2018 – 18,436] 
common shares had been issued.

[c] Summary of expenses recognized under share-based payment plans

For the year ended December 31, 2019, an expense of $5,968 [2018 – $8,004] was 
recognized for employee and Director services rendered.

25. Other expenses (income)

[a] Other operating expense (income)

Loss on sale of property, plant and equipment

Gain on disposal of assets held for sale

Loss on financial instruments [note 30]

Other

[b] Finance expense (income)

Interest income from banks

Loss (gain) on foreign exchange

[c] Finance costs

Interest on overdrafts and other finance costs

Interest on lease liabilities

2019
$

260

—

1,503

(4,001)

(2,238)

(235)

(6,682)

(6,917)

1,626

357

2018
$

193

(8)

2,061

(2,267)

(21)

(202)

16,605

16,403

617

—

Interest, including non-cash interest, on debts and borrowings

20,272

17,097

Interest, including non-cash interest, on senior and convertible 
unsecured subordinated debentures [note 21]

[d] Cost of goods sold

Depreciation of property, plant and equipment

Depreciation of right-of-use assets

Amortization of intangible assets

Warranty provision

Cost of inventory recognized as an expense

22,538

19,353

44,793

37,067

20,275

1,133

5,913

7,137

17,535

—

2,503

1,776

693,589

641,691

728,047

663,505

[e] Selling, general and administrative expenses

Depreciation of property, plant and equipment

Depreciation of right-of-use assets

Amortization of intangible assets

Minimum lease payments recognized as an operating lease 
expense

Transaction costs

Selling, general and administrative

[f] Employee benefits expense

Wages and salaries

Share-based compensation expense [note 24]

Pension costs

2,156

1,894

1,665

—

16,817

11,328

449

13,150

3,347

8,865

176,647

150,709

211,113

175,914

246,103

216,911

5,968

6,430

8,004

5,336

258,501

230,251

Included in cost of goods sold

164,057

148,342

Included in selling, general and administrative expenses

94,444

81,909

258,501

230,251

26. Retirement benefit plans

AGI contributes to group retirement savings plans subject to maximum limits 
per employee. The expense recorded during the year ended December 31, 2019 
was $6,430 [2018 – $5,336]. AGI expects to contribute $6,715 for the year ending 
December 31, 2020.

The Company has a defined benefit plan providing pension benefits to certain of 
its union employees and former employees. The Company operates the defined 
benefit pension plan in Canada. The plan is a flat-dollar defined benefit pension plan, 
which provides clearly defined benefits to members based on negotiated benefit 
rates and years of credited service. Responsibility for the governance of the plan 
and overseeing the plan including investment policy and performance lies with the 
Pension and Investment Committee. Effective May 16, 2017, new enrolments in 
the defined benefit pension plan were closed. All benefits earned by employees 
up to that date remain in place. As such, the Company continues to manage any 
residual obligation for past service consistent with the plan text and applicable 
legislation and will continue to account for the residual obligations based on IAS 
19. In addition, effective May 17, 2017, the group of affected employees will receive 
retirement contributions from the Company on a defined contribution basis when 

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

96

 
 
 
 
 
 
 
 
S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

9797

 
 
 
 
 
 
 
 
S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

98

 
 
 
 
 
 
 
 
they qualify as enrollees in the new plan.

The Company’s pension committee and appointed and experienced, independent 
professional experts such as investment managers and actuaries assist in the 
management of the plan.

The Company’s defined benefit pension plan will measure the respective accrued 
benefit obligation and the fair value of plan assets at December 31 of each year. 
Actuarial valuations are performed annually or triennially as required. The Company’s 
registered defined benefit plan was last valued on December 31, 2019. The present 
value of the defined obligation, and the related current service cost and past 
service cost, was measured using the Unit Credit Method.

The liabilities were revalued at December 31, 2019. We have used the same 
methods and assumptions used at December 31, 2018 for the purpose of 
estimating the liabilities at December 31, 2019. The following assumptions were 
used to determine the periodic pension expense and the net present value of the 
accrued pension obligations:

Expected long-term rate of return on plan assets

Discount rate on benefit costs

Discount rate on accrued pension and post-employment obligations

Rate of compensation increases

2019
%

3.10

3.10

3.10

n/a

2018
%

3.90

3.90

3.90

n/a

The weighted average duration of the defined benefit obligation as of December 31, 
2019 is 15.8 years [2018 – 14.8 years]. Compensation increases were not included 
in the valuation of the accrued pension obligation because the accrued benefit is 
not a function of salary. All members receive a fixed benefit rate monthly for each 
year of credited service. This same benefit rate is received by all plan members 
regardless of salary level.

The following table outlines the key assumptions for 2019 and the sensitivity of 
changes in each of these assumptions on the defined benefit plan obligation. The 
sensitivity analysis is hypothetical and should be used with caution. The sensitivities 
of each key assumption have been calculated independently of any changes in 
other key assumptions. Actual experience may result in changes in a number of 

key assumptions simultaneously. Changes in one factor may result in changes in 
another, which could amplify or reduce the impact of such assumptions.

Impact of 0.5% increase/decrease in discount  
rate assumption

Impact of 1-year increase/decrease in life  
expectancy assumption

Increase in  
assumption
$

Decrease in  
assumption
$

(990,776)

1,112,290

399,629

(407,618)

The net expense of $131 [2018 – $135] for the year is included in cost of goods 
sold.

Information about the Company’s defined benefit pension plan, in aggregate, is as 
follows:

Plan assets

Fair value of plan assets, beginning of year

12,641

13,794

2019
$

2018
$

Interest income on plan assets

Actual return on plan assets

Employer contributions

Benefits paid

483

1,572

27

(754)

459

(836)

—

(776)

Fair value of plan assets, end of year

13,969

12,641

Accrued benefit obligation

Accrued benefit obligation, beginning of year

12,727

13,976

Current service cost

Interest cost

Actuarial losses (gains) from changes in financial assumptions

Actuarial gains from experience adjustments

Benefits paid

Accrued benefit obligation, end of year

Net accrued benefit liability

125

489

1,533

(5)

(754)

14,115

(146)

124

470

(956)

(112)

(776)

12,726

(85)

The net accrued benefit liability of $146 [2018 – $85] is included in non-current other 
liabilities.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

9999

 
 
 
 
 
 
 
 
The major categories of plan assets for each category are as follows:

Canadian equity securities

U.S. equity securities

International equity securities

Fixed-income securities

                         2019

                    2018

$

4,204

2,431

2,445

4,889

%

30.1

17.4

17.5

35.0

$

3,843

2,301

2,187

4,310

%

30.4

18.2

17.3

34.1

13,969

100.0

12,641

100.0

Management’s assessment of the expected returns is based on historical return 
trends and analysts’ predictions of the market for the asset over the life of the 
related obligation. The actual return on plan assets was a gain (loss) of $1,572 [2018 
– $(836)].

All equity and debt securities are valued based on quoted prices in active markets 
for identical assets or liabilities or based on inputs other than quoted prices in active 
markets that are observable for the asset or liability, either directly [i.e., as prices] or 
indirectly [i.e., derived from prices].

The Company’s asset allocation reflects a balance of fixed-income investments, 
which are sensitive to interest rates, and equities, which are expected to provide 
higher returns and inflation-sensitive returns over the long term. The Company’s 
targeted asset allocations are actively monitored and adjusted to align the asset 
mix with the liability profile of the plan.

bond yields; if plan assets under-perform this yield, this will create a deficit. The 
plan holds a significant proportion of equities, which are expected to outperform 
corporate bonds in the long term while contributing volatility and risk in the short 
term.

However, the Company believes that due to the long-term nature of the plan 
liabilities and the strength of the supporting group, a level of continuing equity 
investment is an appropriate element of the Company’s long-term strategy to 
manage the plan efficiently.

Change in fixed-income security yields

A decrease in corporate fixed-income security yields will increase plan liabilities, 
although this will be partially offset by an increase in the value of the plan’s fixed-
income security holdings. 

Life expectancy

The plan’s obligation is to provide benefits for the life of the member, so increases 
in life expectancy will result in an increase in the plan’s liability.

27. Income taxes

The major components of income tax expense for the years ended December 31, 
2019 and 2018 are as follows:

Consolidated statements of income

The Company expects to make contributions of nil [2019 – $27] to the defined 
benefit plan in 2020. The actual amount paid may vary from the estimate based on 
actuarial valuations being completed, investment performance, volatility in discount 
rates, regulatory requirements and other factors.

Current income tax expense

Current income tax expense

Deferred tax expense (recovery)

Through its defined benefit plan, the Company is exposed to a number of risks, the 
most significant of which are detailed below:

Income tax expense reported in the consolidated  
statements of income

3,771

11,946

Origination and reversal of temporary differences

(1,750)

1,429

Asset volatility

The plan liability is calculated using a discount rate set with reference to corporate 

2019
$

2018
$

5,521

10,517

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

100

 
 
 
 
 
 
 
 
Consolidated statements of comprehensive income

Deferred tax related to items charged or credited directly  
to other comprehensive income during the year

Unrealized gain on derivatives

Defined benefit plan reserve

Exchange differences on translation of foreign operations

Income tax charged (credited) directly to other  
comprehensive income

2019
$

2018
$

—

12

(1,479)

(1,467)

(477)

63

736

322

India

04

The reconciliation between tax expense and the product of accounting profit 
multiplied by the Company’s domestic tax rate for the years ended December 31, 
2019 and 2018 is as follows:

Profit before income taxes

At the Company’s statutory income tax rate of 27% [2018 – 27%]

Tax rate changes

Additional deductions allowed in a foreign jurisdiction

Tax losses not recognized as a deferred tax asset

Foreign rate differential

Non-deductible EIAP expense

State income tax, net of federal tax benefit

Unrealized foreign exchange loss (gain)

IFRS 15 transition adjustment

Change in uncertain tax position

Permanent differences and others

At the effective income tax rate 20.49% [2018 – 30.98%]

2019
$

18,404

4,969

(2,736)

5

2,087

(1,751)

132

388

(1,444)

—

—

2,121

3,771

2018
$

38,564

10,412

587

(398)

2,887

(3,011)

152

996

2,159

(412)

(2,305)

879

11,946

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

101101

 
 
 
 
 
 
 
 
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are presented below:

Consolidated statements of financial position

Consolidated statements of income

Inventory

Property, plant and equipment

Intangible assets

Deferred financing costs

Accruals and long-term provisions

Tax loss carryforwards

Investment tax credits

Canadian exploration expenses

Capitalized development expenditures

Convertible debentures

Derivative instruments

EIAP liability

Equity swap

Exchange difference on translation of foreign operations

Deferred tax expense (recovery)

Deferred tax liabilities, net

Reflected in the consolidated statements of financial position as follows

Deferred tax asset

Deferred tax liability

Deferred tax liabilities, net

2019
$

(502)

2,181

(2,150)

(110)

(1,980)

(4,381)

(627)

—

1,940

(627)

(396)

3,512

(89)

1,479

(1,750)

2018
$

—

8,305

(6,860)

440

(1,768)

96

—

1,641

991

(568)

456

444

(1,012)

(736)

1,429

2019
$

—

(38,774)

(44,388)

832

9,684

4,381

—

—

(4,667)

(1,148)

(60)

1,521

(1,496)

—

2018
$

(90)

(30,701)

(35,091)

722

7,207

—

(627)

—

(2,727)

(1,775)

(456)

3,626

(1,585)

—

(74,115)

(61,497)

—

(74,115)

(74,115)

455

(61,952)

(61,497)

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

102

 
 
 
 
 
 
 
 
Reconciliation of deferred tax liabilities, net

Balance, beginning of year

Deferred tax recovery (expense) during the year  
recognized in profit or loss

2019
$

2018
$

(61,497)

(57,575)

1,750

(1,429)

Deferred tax liability set-up on business acquisition

(17,242)

(4,276)

Deferred tax recovery during the year recognized in common shares

Deferred tax expense during the year recognized 
 in equity component of convertible debentures

Deferred tax recovery during the year recognized  
in contributed surplus

Deferred tax recovery (expense) during the year recognized  
in other comprehensive income

—

—

1,375

(531)

1,407

1,261

1,467

(322)

of reversals of temporary differences will also depend on AGI’s future operating 
results, acquisitions and dispositions of assets and liabilities. The business and 
operations of AGI are complex, and AGI has executed a number of significant 
financings, acquisitions, reorganizations and business combinations over the 
course of its history. The computation of income taxes payable as a result of these 
transactions involves many complex factors, as well as AGI’s interpretation of and 
compliance with relevant tax legislation and regulations. While AGI believes that 
its tax filing positions are probable to be sustained, there are a number of tax filing 
positions that may be the subject of review by taxation authorities. Therefore, it is 
possible that additional taxes could be payable by AGI, and the ultimate value of 
AGI’s income tax assets and liabilities could change in the future, and that changes 
to these amounts could have a material effect on these consolidated financial 
statements.

There are no income tax consequences to the Company attached to the payment of 
dividends in either 2019 or 2018 by the Company to its shareholders.

Balance, end of year

(74,115)

(61,497)

28. Profit per share

The ultimate realization of deferred tax assets is dependent upon the generation of 
future taxable income during the periods in which these temporary differences and 
loss carryforwards become deductible. Based on the analysis of taxable temporary 
differences and future taxable income, management of the Company is of the 
opinion that there is convincing evidence available for the probable realization of 
all deductible temporary differences of the Company’s tax entities incurred, other 
than temporary differences in its Finnish operations of 5,442 Euros [2018 – 5,870 
euros] and its Brazilian operations of 81,685 BRL [2018 – 63,919 BRL]. Accordingly, 
the Company has recorded a deferred tax asset for all other deductible temporary 
differences as at December 31, 2019 and as at December 31, 2018.

Profit per share is based on the consolidated profit for the year divided by the 
weighted average number of shares outstanding during the year. Diluted profit per 
share is computed in accordance with the treasury stock method and based on the 
weighted average number of shares and dilutive share equivalents.

The following reflects the income and share data used in the basic and diluted profit 
per share computations:

Profit attributable to shareholders for basic  
and diluted profit per share

2019
$

2018
$

14,633

26,618

The Company has determined that undistributed profits of its subsidiaries will not 
be distributed in the foreseeable future. The temporary differences associated with 
investments in subsidiaries and associate, for which a deferred tax asset has not 
been recognized, aggregate to $2,408 [2018 – $622].

Basic weighted average number of shares

18,613,273

16,811,440

Dilutive effect of DDCP

Dilutive effect of EIAP

63,007

236,250

54,658

165,015

Diluted weighted average number of shares

18,912,530

17,031,113

Income tax provisions, including current and deferred income tax assets and 
liabilities, and income tax filing positions require estimates and interpretations of 
federal and provincial income tax rules and regulations, and judgments as to their 
interpretation and application to AGI’s specific situation. The amount and timing 

Profit per share

Basic

Diluted

0.79

0.77

1.58

1.56

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

103103

 
 
 
 
 
 
 
 
The 2015, 2017 and 2018 Debentures were excluded from the calculation of diluted 
profit per share in the year ended December 31, 2019, because their effect is anti-
dilutive.

29. Statements of cash flows

[a] Net change in non-cash working capital

Cash and cash equivalents as at the date of the consolidated statements of 
financial position and for the purpose of the consolidated statements of cash flows 
relate to cash at banks and cash on hand. Cash at banks earns interest at floating 
rates based on daily bank deposit rates.

The net change in the non-cash working capital balances related to continuing 
operations is calculated as follows:

Accounts receivable

Inventory

Prepaid expenses and other assets

Accounts payable and accrued liabilities

Customer deposits

Provisions

2019
$

2018
$

(14,778)

(33,683)

24,060

(28,761)

(848)

(8,241)

(17,753)

(13,879)

9,613

3,097

2,795

1,776

(13,585)

(63,017)

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

104
104

 
 
 
 
 
 
 
 
[b] Reconciliation of liabilities arising from financing activities

December 
31, 2018
$

Cash flows
$

Acquisitions
$

Conversion
$

Foreign 
exchange
$

Accretion
$

Amortization
$

Fair value
$

Other
$

December  
31, 2019
$

NON-CASH CHANGES

Long-term debt

271,421

130,766

464

—

(10,604)

—

535

546

—

393,128

Convertible unsecured  
subordinated debentures

284,848

(51,786)

Senior unsecured subordinated debentures

—

165,402

Lease liability

8,791

(2,674)

Total liabilities from financing activities

565,060

241,708

—

—

220

684

(25)

—

—

—

—

(183)

1,984

3,414

—

—

561

—

—

—

—

398

238,833

(489)

165,474

3,195

9,349

(25)

(10,787)

1,984

4,510

546

3,104

806,784

December 
31, 2017
$

Cash flows
$

Acquisitions
$

Conversion
$

Foreign 
exchange
$

Accretion
$

Amortization
$

Fair value
$

December  
31, 2018
$

NON-CASH CHANGES

Long-term debt

302,802

(50,753)

738

—

16,605

—

2,029

—

271,421

Convertible unsecured  
subordinated debentures

Finance leases

Derivatives held to hedge long-term  
borrowings

286,058

1,002

4,816

(872)

(1,768)

(1,690)

—

—

—

(8,678)

—

—

—

100

—

2,205

2,510

(2,063)

284,848

—

—

—

—

—

230

1,768

(1,690)

Total liabilities from financing activities

588,094

(48,499)

738

(8,678)

16,705

2,205

4,539

(295)

554,809

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

105105

 
 
 
 
 
 
 
 
30. Financial instruments and financial risk management

[a] Management of risks arising from financial instruments

AGI’s principal financial liabilities, other than derivatives, comprise loans and 
borrowings and trade and other payables. The main purpose of these financial 
liabilities is to finance the Company’s operations and to provide guarantees to 
support its operations. The Company has deposits, trade and other receivables 
and cash and short-term deposits that are derived directly from its operations. The 
Company also holds investments and enters into derivative transactions.

The Company’s activities expose it to a variety of financial risks: market risk 
[including foreign exchange risk and interest rate risk], credit risk and liquidity risk. 
The Company’s overall risk management program focuses on the unpredictability 
of financial markets and seeks to minimize potential adverse effects on the 
Company’s financial performance. The Company uses derivative financial 
instruments to mitigate certain risk exposures. The Company does not purchase 
any derivative financial instruments for speculative purposes. Risk management 
is the responsibility of the corporate finance function, which has the appropriate 
skills, experience and supervision. The Company’s domestic and foreign operations, 
along with the corporate finance function identify, evaluate and, where appropriate, 
mitigate financial risks. Material risks are monitored and are regularly discussed 
with the Audit Committee of the Board of Directors. The Audit Committee reviews 
and monitors the Company’s financial risk-taking activities and the policies and 
procedures that were implemented to ensure that financial risks are identified, 
measured and managed in accordance with Company policies.

The risks associated with the Company’s financial instruments are as follows:

Market risk

Market risk is the risk that the fair value of future cash flows of a financial 
instrument will fluctuate because of changes in market prices. Components of 
market risk to which AGI is exposed are discussed below. Financial instruments 
affected by market risk include trade accounts receivable and payable, investments 
and derivative financial instruments.

Foreign currency risk

The objective of the Company’s foreign exchange risk management activities is 
to minimize transaction exposures and the resulting volatility of the Company’s 
earnings. Foreign currency risk is created by fluctuations in the fair value or cash 

flows of financial instruments due to changes in foreign exchange rates and 
exposure.

During the year ended December 31, 2019, the Company entered into a short-term 
forward contract that resulted in a gain of $235, which has been recorded in gain 
on financial instruments in the consolidated statements of income.

The Company had no outstanding foreign exchange forward contracts at December 
31, 2019.

A significant part of the Company’s sales is transacted in U.S. dollars and euros 
and, as a result, fluctuations in the rate of exchange between the U.S. dollar, the 
euro and Canadian dollar can have a significant effect on the Company’s cash flows 
and reported results. To mitigate exposure to the fluctuating rate of exchange, AGI 
denominates a portion of its debt in U.S. dollars. As at December 31, 2019, AGI’s 
U.S. dollar denominated debt totalled $197 million [2018 – $152 million].

AGI’s sales denominated in U.S. dollars for the year ended December 31, 2019 
were U.S. $424 million, and the total of its cost of goods sold and its selling, 
general and administrative expenses denominated in that currency was U.S. $323 
million. Accordingly, a 10% increase or decrease in the value of the U.S. dollar 
relative to its Canadian counterpart would result in a $42.4 million increase or 
decrease in sales and a total increase or decrease of $32.3 million in its cost of 
goods sold and its selling, general and administrative expenses.

Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial 
instrument will fluctuate because of changes in market interest rates. Furthermore, 
as AGI regularly reviews the denomination of its borrowings, the Company is 
subject to changes in interest rates that are linked to the currency of denomination 
of the debt. AGI’s Series B secured notes, Series C secured notes, convertible 
unsecured subordinated debentures and senior unsecured subordinated 
debentures outstanding at December 31, 2019 and December 31, 2018 are at a 
fixed rate of interest.

Interest rate swap contracts

The Company enters into interest rate swap contracts to manage its exposure 
to fluctuations in interest rates on its core borrowings. The interest rate swap 
contracts are derivative financial instruments and changes in the fair value were 
recognized as a gain (loss) on financial instruments in other operating income. 

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

106

 
 
 
 
 
 
 
 
Through these contracts, the Company agreed to receive interest based on the 
variable rates from the counterparty and pay interest based on fixed rates between 
3.6% and 4.1%. The notional amounts are $89,354 in aggregate, resetting the last 
business day of each month.

the dividend income they may generate and any capital appreciation. In return, 
the Company has agreed to pay the counterparty a funding cost calculated daily 
based on floating rate option [CAD-BA-CDOR] plus a spread of 2.0% and any 
administrative fees or expenses that are incurred by the counterparty directly.

The interest rate swap contracts were designated as cash flow hedges, and 
changes in the fair value were recognized as a component of OCI to the extent 
that they have been assessed to be effective. In 2018, the hedge was discontinued 
as the forecasted cash flows were no longer probable. Consequently, the interest 
rate swap was reclassified from fair value through OCI to fair value through profit 
or loss. During the year ended December 31, 2019, a loss of $1,466 [2018 – $78] 
was recorded in loss on financial instruments in other operating expense. As at 
December 31, 2019, the unrealized gain on the interest rate swap was $224 [2018 
– $1,690].

The open interest rate swap contracts as at December 31, 2019 are as follows for 
which no hedge accounting is applied:

Maturity date

Contract rate
%

Notional amount
$

Unrealized gain
$

Canadian dollar contracts

May 2022

3.6 – 4.1

U.S. dollar contracts

November 2020

3.8

40,000

38,000

147

77

The open interest rate swap contracts as at December 31, 2018 are as follows:

Maturity date

Contract rate
%

Notional amount
$

Unrealized gain
$

Canadian dollar contracts May 2019 – 2022

3.6 – 4.3

U.S. dollar contracts

May 2019

3.8

90,000

38,000

681

1,009

Equity swap

On March 18, 2016, the Company entered into an equity swap agreement with 
a financial institution to manage the cash flow exposure due to fluctuations in its 
share price related to the EIAP.

Pursuant to this agreement, the counterparty has agreed to pay the Company 
the total return of the defined underlying common shares, which includes both 

As at December 31, 2019, the equity swap agreement covered 722,000 common 
shares of the Company at a price of $38.76, and the agreement matures on April 6, 
2021.

As at December 31, 2019, the unrealized gain on the equity swap was $5,641 [2018 
– $5,959] and in the year ended December 31, 2019, the Company has recorded a 
loss on financial instruments of $327 [2018 – $3,739] in other operating expense 
[note 25[a]].

Credit risk

Credit risk is the risk that a customer will fail to perform an obligation or fail to 
pay amounts due, causing a financial loss. A substantial portion of AGI’s accounts 
receivable is with customers in the agriculture industry and is subject to normal 
industry credit risks. A portion of the Company’s sales and related accounts 
receivable are also generated from transactions with customers in overseas 
markets, several of which are in emerging markets such as countries in Eastern 
Europe and Asia. It is often common business practice for international customers 
to pay invoices over an extended period of time. Accounts receivable are subject 
to credit risk exposure and the carrying values reflect management’s assessment 
of the associated maximum exposure to such credit risk. The Company regularly 
monitors customers for changes in credit risk. The Company’s credit exposure 
is mitigated through the use of credit practices that limit transactions according 
to the customer’s credit quality and due to the accounts receivable being spread 
over a large number of customers. Trade receivables from international customers 
are often insured for events of non-payment through third-party export insurance. 
In cases where the credit quality of a customer does not meet the Company’s 
requirements, a cash deposit or letter of credit is received before goods are 
shipped.

Assessments about the recoverability of financial assets, including accounts 
receivable, require significant judgment in determining whether there is objective 
evidence that a loss event has occurred and estimates of the amount and timing 
of future cash flows. The Company maintains an allowance for doubtful accounts 
for estimated losses resulting from the inability to collect on its trade receivables, 

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

107107

 
 
 
 
 
 
 
 
01

Brasil

which is netted against the accounts receivable on the consolidated statements of financial position. Emerging markets are subject to various additional risks including 
currency exchange rate fluctuations, foreign economic conditions and foreign business practices. One or more of these factors could have a material effect on the future 
collectability of such receivables. In assessing whether objective evidence of impairment exists at each reporting period, the Company considers its past experience of 
collecting payments, historical loss experience, customer credit ratings and financial data as available, collateral on amounts owing including insurance coverage from export 
credit agencies, as well as observable changes in national or local economic conditions.

The requirement for an impairment provision is analyzed at each reporting date based on the expected credit loss model. The calculation reflects the probability-weighted 
outcome, the time value of money and reasonable and supportable information that is available at the reporting date about past events, current conditions and forecasts of 
future economic conditions.

The Company does not believe that any single customer group represents a significant concentration of credit risk.

Liquidity risk

Liquidity risk is the risk that AGI will encounter difficulties in meeting its financial liability obligations. AGI manages its liquidity risk through cash and debt management. 
In managing liquidity risk, AGI has access to committed short- and long-term debt facilities as well as to equity markets, the availability of which is dependent on market 
conditions. AGI believes it has sufficient funding through the use of these facilities to meet foreseeable borrowing requirements.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

108

 
 
 
 
 
 
 
 
The tables below summarize the undiscounted contractual payments of the Company’s financial liabilities as at December 31, 2019 and 2018:

DECEMBER 31, 2019

Accounts payable and accrued liabilities

Dividends payable

Due to vendor

Contingent consideration

Optionally convertible redeemable preferred shares

Lease liability

Term debt

Convertible unsecured subordinated debentures [includes interest]

Senior unsecured subordinated debentures [includes interest]

TOTAL
$

105,378

3,732

8,370

5,270

30,258

9,932

395,862

273,323

218,429

20 20
$

105,378

3,732

4,541

5,270

—

2,798

722

86,813

9,186

20 21
$

—

—

3,066

—

18,155

2,102

348

8,063

9,186

Total financial liability payments

1,050,554

218,440

40,920

DECEMBER 31, 2018

Accounts payable and accrued liabilities

Dividends payable

Due to vendor

Contingent consideration

Term debt

Convertible unsecured subordinated debentures [includes interest]

Total financial liability payments

TOTAL
$

101,504

3,673

9,345

6,596

349,460

339,632

810,210

2019
$

101,504

3,673

7,973

4,576

14,502

66,281

20 20
$

—

—

823

1,010

14,453

86,814

198,509

103,100

2022
$

—

—

763

—

12,103

1,652

208

178,447

9,186

202,359

2021
$

—

—

549

1,010

14,443

8,064

24,066

2023
$

2024 +
$

—

—

—

—

—

1,028

115

—

9,186

10,329

2022
$

—

—

—

—

14,334

178,473

192,807

—

—

—

—

—

2,352

394,469

—

181,685

578,506

2023 +
$

—

—

—

—

291,728

—

291,728

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

109109

 
 
 
 
 
 
 
 
[b] Fair value

Set out below is a comparison, by class, of the carrying amounts and fair value of the Company’s financial instruments that are carried in the consolidated financial 
statements, as well as their level on the fair value hierarchy:

Level

Carrying Amount
$

Fair value 
$

Carrying Amount
$

Fair value
$

D EC EMBER 31, 2019

DECEMBER 31, 2018

Financial assets

Amortized cost:

Cash and cash equivalents

Cash held in trust and restricted cash

Accounts receivable

Note receivable

Fair value through profit or loss:
Derivative instruments

Fair value through OCI:
Equity investment

Financial liabilities

Amortized cost:

Interest-bearing loans and borrowings

Accounts payable and accrued liabilities

Dividends payable

Due to vendor

Contingent consideration

Convertible unsecured subordinated debentures

Senior unsecured subordinated debentures

Fair value through profit or loss:
Optionally convertible redeemable preferred shares

1

1

2

2

2

3

2

2

2

2

3

2

2

3

48,421

5,416

162,543

622

48,421

5,416

162,543

622

5,865

5,865

—

—

402,477

105,378

3,732

8,370

5,270

238,833

165,474

402,931

105,378

3,732

8,370

5,270

246,128

166,456

26,320

26,320

33,610

2,955

134,239

735

7,649

900

271,651

101,504

3,673

9,349

6,386

33,610

2,955

134,239

735

7,649

900

269,685

101,504

3,673

9,349

6,386

284,848

305,935

—

—

—

—

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

110

 
 
 
 
 
 
 
 
During the reporting years ended December 31, 2019 and December 31, 
2018, there were no transfers between Level 1, Level 2 and Level 3 fair value 
measurements.

Reconciliation of recurring fair value measurements categorized within Level 3 of 
the fair value hierarchy:

The fair values of the financial assets and liabilities are included at the amount at 
which the instrument could be exchanged in a current transaction between willing 
parties, other than in a forced or liquidation sale.

Contingent consideration and OCRPS:

Balance, beginning of year

The following methods and assumptions were used to estimate the fair values:

Acquisitions

Fair value change

•  Cash and cash equivalents, cash held in trust, restricted cash, accounts 

Reclassification to due to vendor

receivable, dividends payable, accounts payable and accrued liabilities, due to 
vendor, and other financial liabilities approximate their carrying amounts largely 
due to the short-term maturities of these instruments.

Exchange differences

Balance, end of year

2019
$

6,386

31,599

173

(4,000)

(2,568)

31,590

2018
$

9,037

2,708

1,187

(6,849)

303

6,386

•  The fair value of unquoted instruments and loans from banks is estimated by 

discounting future cash flows using rates currently available for debt on similar 
terms, credit risk and remaining maturities.

•  The Company enters into derivative financial instruments with financial 

institutions with investment-grade credit ratings. Derivatives include interest rate 
swaps and equity swaps that are marked-to-market at each reporting period. The 
fair values of derivatives are determined by the derivative counterparty using a 
discounted cash flow technique, which incorporates various inputs including the 
related interest rate swap curves and/or the Company’s stock price for the equity 
swaps.

•  The fair value of contingent consideration and the OCRPS arising from business 

combinations is estimated by discounting future cash flows based on the 
probability of meeting set performance targets.

•  AGI included its equity investment, which is in a private company, in Level 3 of 

the fair value hierarchy as it traded infrequently and has little price transparency. 
AGI reviews the fair value of this investment at each reporting period, and 
when recent arm’s length market transactions are not available, management’s 
estimate of fair value is determined using a market approach based on external 
information and observable conditions where possible, supplemented by internal 
analysis as required.

Set out below are the significant unobservable inputs to valuation as at December 
31, 2019:

Valuation  
technique

Significant  
unobservable  
inputs

Range

Sensitivity of the  
input to fair value

Contingent  
consideration  
and OCRPS

Discounted  
cash flow  
method

Probability  
of achieving  
earnings  
target

Weighted  
average cost  
of capital  
[“WACC”]

0%–100%  
achievement

5.0%–9.2%

Increase (decrease)  
in the probability would 
increase (decrease)  
the fair value

Increase (decrease)  
in the WACC would  
result in decrease  
(increase) in fair value

Fair value [“FV”] hierarchy

AGI uses the following hierarchy for determining and disclosing the fair value of 
financial instruments by valuation technique:

Level 1

The fair value measurements are classified as Level 1 in the FV hierarchy if the fair 
value is determined using quoted, unadjusted market prices for identical assets or 
liabilities.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

111111

 
 
 
 
 
 
 
 
Level 2

32. Related party disclosures

Fair value measurements that require inputs other than quoted prices in Level 1, 
and for which all inputs that have a significant effect on the recorded fair value are 
observable, either directly or indirectly, are classified as Level 2 in the FV hierarchy.

Level 3

Fair value measurements that require unobservable market data or use statistical 
techniques to derive forward curves from observable market data and unobservable 
inputs are classified as Level 3 in the FV hierarchy.

Interest from financial instruments is recognized in finance costs and finance 
income. Foreign currency impacts for loans and receivables are reflected in finance 
expense.

31. Capital disclosure and management

The Company’s capital structure comprises of shareholders’ equity and long-term 
debt. AGI’s objectives when managing its capital structure are to maintain and 
preserve its access to capital markets, continue its ability to meet its financial 
obligations, including the payment of dividends, and finance future organic growth 
and acquisitions.

AGI manages its capital structure and makes adjustments to it in light of changes 
in economic conditions and the risk characteristics of the underlying assets. The 
Company is not subject to any externally imposed capital requirements other 
than financial covenants in its credit facilities, and as at December 31, 2019 and 
December 31, 2018, all of these covenants were complied with [note 20[c]].

The Board of Directors does not establish quantitative capital structure targets for 
management, but rather promotes sustainable and profitable growth. Management 
monitors capital using non-GAAP financial metrics, primarily total debt to the 
trailing twelve months EBITDA and net debt to total shareholders’ equity. There 
may be instances where it would be acceptable for total debt to trailing EBITDA 
to temporarily fall outside of the normal targets set by management such as in 
financing an acquisition to take advantage of growth opportunities or industry 
cyclicality. This would be a strategic decision recommended by management and 
approved by the Board of Directors with steps taken in the subsequent period 
to restore the Company’s capital structure based on its capital management 
objectives.

Relationship between parent and subsidiaries

The main transactions between the corporate entity of the Company and its 
subsidiaries are providing cash funding based on the equity and convertible debt 
funds of AGI. Furthermore, the corporate entity of the Company is responsible for 
the billing and management of international contracts with external customers and 
the allocation of sub-projects to the different subsidiaries of the Company. Finally, 
the parent company provides management services to the Company entities. 
Between the subsidiaries, there are limited intercompany sales of inventories 
and services. Because all subsidiaries are currently 100% owned by AGI, these 
intercompany transactions are 100% eliminated on consolidation.

Other relationships

Burnet, Duckworth & Palmer LLP provides legal services to the Company, and a 
Director of AGI is a partner of Burnet, Duckworth & Palmer LLP. During the year 
ended December 31, 2019, the total cost of these legal services related to general 
matters was $435 [2018 – $1,435], and $450 is included in accounts payable and 
accrued liabilities as at December 31, 2019.

These transactions are measured at the exchange amount and were incurred during 
the normal course of business.

Compensation of key management personnel of AGI

AGI’s key management consists of 25 individuals including its CEO, CFO, its 
Officers and other senior management, divisional general managers and its 
Directors.

Short-term employee benefits

Termination benefits

Contributions to defined contribution plans

Salaries

Share-based payments

Total compensation paid to key management personnel

2019
$

159

—

172

8,391

5,968

14,690

2018
$

138

1,770

221

7,410

8,004

17,543

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

112

 
 
 
 
 
 
 
 
33. Reportable business segment

[b] Letters of credit

The Company manufactures agricultural equipment with a focus on grain and rice 
handling and milling, storage and conditioning products, and technology. As at 
December 31, 2019, aggregation of operating segments was applied to determine 
that the Company had only one reportable segment. The primary factors considered 
in the application of the aggregation criteria included the similar long-term average 
gross margins and growth rates across the segments, the nature of the products 
manufactured by the segments all being related to the handling, storage and 
conditioning of agricultural commodities, and the similarity in the production 
processes of the segments.

The Company operates primarily within three geographical areas: Canada, United 
States and International. The following details the sales, property, plant and 
equipment, goodwill, intangible assets and investment by geographical area, 
reconciled to the Company’s consolidated financial statements:

                                  Sales

2 019
$

325,080

421,661

249,046

995,787

2 018
$

329,778

380,969

220,917

931,664

Property, plant and equipment,  
goodwill, intangible assets  
and equity investments

2019
$

413,751

318,613

265,057

997,421

2018
$

407,987

282,586

132,790

823,363

Canada

United States

International

The sales information above is based on the location of the customer. The Company 
has no single customer that represents 10% or more of the Company’s sales.

34. Commitments and contingencies

[a] Contractual commitment for the purchase of property, plant and 
equipment

As of the reporting date, the Company has commitments to purchase property, 
plant and equipment of $8,488 [2018 – $9,308].

As at December 31, 2019, the Company has outstanding letters of credit in the 
amount of $16,885 [2018 – $11,020].

[c] Legal actions

The Company is involved in various legal matters arising in the ordinary course 
of business. The resolution of these matters is not expected to have a material 
adverse effect on the Company’s financial position, results of operations or cash 
flows.

35. Subsequent events

On January 2, 2020, the Company redeemed its 5.00% convertible unsecured 
subordinated debentures due December 31, 2020 [“2015 Debentures”] in 
accordance with the terms of the supplemental trust indenture dated September 
29, 2015 [note 21].

On January 16, 2020, the Company acquired 100% of the shares outstanding 
of Affinity Management Ltd. [“Affinity”]. The transaction was funded from the 
Company’s operating facilities. Affinity, headquartered in Oakville, Ontario, is a 
provider of software solutions to the agriculture industry under the brand name 
Compass® and includes a comprehensive Enterprise Resource Planning [“ERP”] 
system for growers and ag retailers, as well as an agronomy tool. The Compass® 
product suite is highly complementary to AGI’s current offering and will be a key 
component of the full AGI SureTrack platform.

On February 13, 2020, the Company entered an agreement with a syndicate of 
underwriters, pursuant to which AGI will issue on a “bought deal” basis, subject to 
regulatory approval, $85 million aggregate principal amount of senior subordinated 
unsecured debentures [the “2020 Debentures”] at a price of $1,000 per Debenture 
(the “Offering”). On March 5, 2020, the Company closed the offering of the 2020 
Debentures. AGI has also granted to the Underwriters an over-allotment option, 
exercisable in whole or in part for a period expiring 30 days following closing, 
to purchase up to an additional $12,750,000 aggregate principal amount of 
Debentures at the same price. If the over-allotment option is fully exercised, the 
total gross proceeds from the Offering to AGI will be $97.75 million.

The net proceeds of the Offering will be used to repay indebtedness and for 
general corporate purposes.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

113113

 
 
 
 
 
 
 
 
The Debentures will bear interest from the date of issue at 5.25% per annum, payable semi-annually in arrears on June 30 and December 31 each year commencing June 
30, 2020. The Debentures will have a maturity date of December 31, 2026.

The Debentures will not be redeemable by the Company before December 31, 2022, except upon the occurrence of a change of control of the Company in accordance 
with the terms of the indenture [the “Indenture”] governing the Debentures. On and after December 31, 2022 and prior to December 31, 2023, the Debentures may be 
redeemed at the Company’s option at a price equal to 103.9375% of their principal amount plus accrued and unpaid interest. On and after December 31, 2023 and prior to 
December 31, 2024, the Debentures may be redeemed at the Company’s option at a price equal to 102.625% of their principal amount plus accrued and unpaid interest. On 
and after December 31, 2024 and prior to December 31, 2025, the Debentures may be redeemed at the Company’s option at a price equal to 101.3125% of their principal 
amount plus accrued and unpaid interest. On and after December 31, 2025 and prior to maturity, the Debentures will be redeemable at the Company’s option at a price 
equal to their principal amount plus accrued and unpaid interest.

The Company will have the option to satisfy its obligation to repay the principal amount of the Debentures due at redemption or maturity by issuing and delivering that 
number of freely tradeable common shares in accordance with the terms of the Indenture.

The Debentures will not be convertible into common shares of the Company at the option of the holders at any time.

On March 20, 2020, the Company amended and extended the Credit Facility. Under the amended and extended Credit Facility, the revolving facilities bear interest at 
bankers’ acceptance (BA) or London Interbank Offered Rate (LIBOR) plus 1.20% to BA or LIBOR plus 2.50%, and the swing lines bear interest at prime plus 0.20% to prime 
plus 1.5% per annum, in each case based on certain performance calculations. The Credit Facility matures on March 20, 2025. Collateral for the Credit Facility ranks pari 
passu with the collateral for the Series B and Series C Secured Notes and includes a general security agreement over all assets, first position collateral mortgages on land 
and buildings, assignments of rents and leases and security agreements for patents and trademarks.

Since December 31, 2019, the outbreak of the novel strain of coronavirus, specifically identified as “COVID-19”, has resulted in governments worldwide enacting emergency 
measures to combat the spread of the virus. These measures, which include the implementation of travel bans, self-imposed quarantine periods and social distancing 
have caused material disruption to businesses globally resulting in an economic slowdown. Global equity markets have experienced significant volatility and weakness. 
Governments and central banks have reacted with significant monetary and fiscal interventions designed to stabilize economic conditions. The duration and impact of the 
COVID-19 outbreak is unknown at this time, as is the efficacy of the government and central bank interventions. It is not possible to reliably estimate the length and severity 
of these developments and the impact on the financial results and condition of the Corporation and its operating subsidiaries in future periods.

S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

9
1
0
2

114

 
 
 
 
 
 
 
 
S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

0
2
0
2

115115

 
 
 
 
 
 
 
 
S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

0
2
0
2

116

 
 
 
 
 
 
 
 
S
T
N
E
M
E
T
A
T
S

L
A

I

C
N
A
N

I

F

D
E
T
A
D

I

L
O
S
N
O
C

|

T
R
O
P
E
R

L
A
U
N
N
A

0
2
0
2

117117

AG G ROW T H. COM